{
  "graph": {
    "directed": false,
    "type": "BEL-V1.0",
    "label": "Treg Signaling-2.0-Hs",
    "metadata": {
      "description": "The Treg Signaling network depicts the causal mechanisms that are activated in CD4+ Foxp3+ regulatory T-cells following T-cell receptor (TCR) ligation. Expanding on these processes, the network highlights the chemokines secreted by macrophages and dendritic cells, as well as the cognate T-cell receptors, involved in mediating T-cell recruitment to compromised lung tissue during COPD development.",
      "species_common_name": "Human",
      "version": "2.0",
      "boundary_conditions": "The human model sets represent early COPD (GOLD stage I and II) processes. If supporting literature from early COPD studies were not available, stage-independent COPD studies were used. If COPD studies were not found, we expanded our inclusion criteria to studies from healthy context and incorporated mechanisms active in processes implicated in COPD into the disease models. Literature describing processes active in acute exacerbation in COPD patients was excluded from supporting edges of the network models. We prioritized data collected from studies of lung and COPD-relevant cell types, but excluded literature related to asthma or bronchitis. Human-specific connections were preferred, but rat and mouse were also included where human data was not available."
    },
    "nodes": [
      {
        "id": "p(HGNC:CXCR6)",
        "label": "p(HGNC:CXCR6)",
        "metadata": {
          "coordinate": [
            0.23658562997455193,
            0.7188119967324076
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405396c"
        }
      },
      {
        "id": "cat(p(HGNC:CRLF2))",
        "label": "cat(p(HGNC:CRLF2))",
        "metadata": {
          "coordinate": [
            0.6253451729925822,
            0.17557474617808377
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405396d"
        }
      },
      {
        "id": "bp(GOBP:\"lymphocyte chemotaxis\")",
        "label": "bp(GOBP:\"lymphocyte chemotaxis\")",
        "metadata": {
          "coordinate": [
            0.045454545454545456,
            0.33428638114132336
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405396e"
        }
      },
      {
        "id": "p(HGNC:TBX21)",
        "label": "p(HGNC:TBX21)",
        "metadata": {
          "coordinate": [
            0.26203367805511935,
            0.2893569844789357
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405396f"
        }
      },
      {
        "id": "p(HGNC:CCL3)",
        "label": "p(HGNC:CCL3)",
        "metadata": {
          "coordinate": [
            0.5035194109047594,
            0.8967790874080991
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053970"
        }
      },
      {
        "id": "tscript(p(HGNC:FOXO3))",
        "label": "tscript(p(HGNC:FOXO3))",
        "metadata": {
          "coordinate": [
            0.780740700633494,
            0.7818298517913409
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053971"
        }
      },
      {
        "id": "cat(p(HGNC:IL7R))",
        "label": "cat(p(HGNC:IL7R))",
        "metadata": {
          "coordinate": [
            0.8088959878715686,
            0.20883416968140972
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053972"
        }
      },
      {
        "id": "p(HGNC:TSLP)",
        "label": "p(HGNC:TSLP)",
        "metadata": {
          "coordinate": [
            0.7314689479668633,
            0.12305986696230599
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053973"
        }
      },
      {
        "id": "p(HGNC:CXCL9)",
        "label": "p(HGNC:CXCL9)",
        "metadata": {
          "coordinate": [
            0.14074936379879796,
            0.5256739409499358
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053974"
        }
      },
      {
        "id": "p(HGNC:IL10)",
        "label": "p(HGNC:IL10)",
        "metadata": {
          "coordinate": [
            0.45587200173263304,
            0.40138872680592835
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053975"
        }
      },
      {
        "id": "complex(p(HGNC:IL12A),p(HGNC:IL12B))",
        "label": "complex(p(HGNC:IL12A),p(HGNC:IL12B))",
        "metadata": {
          "coordinate": [
            0.2993935784287184,
            0.13297934414750848
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053976"
        }
      },
      {
        "id": "p(HGNC:SMAD7)",
        "label": "p(HGNC:SMAD7)",
        "metadata": {
          "coordinate": [
            0.8386756186041475,
            0.640623176566694
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053977"
        }
      },
      {
        "id": "p(HGNC:STAT4)",
        "label": "p(HGNC:STAT4)",
        "metadata": {
          "coordinate": [
            0.4499160755861173,
            0.045454545454545456
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053978"
        }
      },
      {
        "id": "p(HGNC:CTLA4)",
        "label": "p(HGNC:CTLA4)",
        "metadata": {
          "coordinate": [
            0.8348854837836375,
            0.5116699731590617
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053979"
        }
      },
      {
        "id": "p(HGNC:IL7R)",
        "label": "p(HGNC:IL7R)",
        "metadata": {
          "coordinate": [
            0.7179327521793275,
            0.33136888785155794
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405397a"
        }
      },
      {
        "id": "cat(p(HGNC:CCR5))",
        "label": "cat(p(HGNC:CCR5))",
        "metadata": {
          "coordinate": [
            0.4125561752125183,
            0.9545454545454546
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405397b"
        }
      },
      {
        "id": "p(HGNC:ITCH)",
        "label": "p(HGNC:ITCH)",
        "metadata": {
          "coordinate": [
            0.630218203476095,
            0.6855525732290817
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405397c"
        }
      },
      {
        "id": "p(HGNC:SMAD2)",
        "label": "p(HGNC:SMAD2)",
        "metadata": {
          "coordinate": [
            0.4174292056960312,
            0.5122534718170149
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405397d"
        }
      },
      {
        "id": "p(HGNC:IL7)",
        "label": "p(HGNC:IL7)",
        "metadata": {
          "coordinate": [
            0.9188098976663598,
            0.20825067102345665
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405397e"
        }
      },
      {
        "id": "cat(p(HGNC:TNFRSF4))",
        "label": "cat(p(HGNC:TNFRSF4))",
        "metadata": {
          "coordinate": [
            0.9545454545454545,
            0.6645466215427706
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405397f"
        }
      },
      {
        "id": "p(HGNC:FOXO3)",
        "label": "p(HGNC:FOXO3)",
        "metadata": {
          "coordinate": [
            0.743380800259895,
            0.9247870229898472
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053980"
        }
      },
      {
        "id": "tscript(p(HGNC:SMAD3))",
        "label": "tscript(p(HGNC:SMAD3))",
        "metadata": {
          "coordinate": [
            0.5739076289999459,
            0.581106313455479
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053981"
        }
      },
      {
        "id": "p(HGNC:TNFRSF4)",
        "label": "p(HGNC:TNFRSF4)",
        "metadata": {
          "coordinate": [
            0.9480480805674373,
            0.7911658303185903
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053982"
        }
      },
      {
        "id": "p(HGNC:FOXP3)",
        "label": "p(HGNC:FOXP3)",
        "metadata": {
          "coordinate": [
            0.755834100384428,
            0.5530983778737308
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053983"
        }
      },
      {
        "id": "p(HGNC:FOXO1)",
        "label": "p(HGNC:FOXO1)",
        "metadata": {
          "coordinate": [
            0.6442958470951323,
            0.8366787256389311
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053984"
        }
      },
      {
        "id": "cat(p(HGNC:CXCR6))",
        "label": "cat(p(HGNC:CXCR6))",
        "metadata": {
          "coordinate": [
            0.12775461584276354,
            0.775411366553857
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053985"
        }
      },
      {
        "id": "p(HGNC:CD80)",
        "label": "p(HGNC:CD80)",
        "metadata": {
          "coordinate": [
            0.7693702961719638,
            0.432897654335395
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053986"
        }
      },
      {
        "id": "cat(p(HGNC:CXCR3))",
        "label": "cat(p(HGNC:CXCR3))",
        "metadata": {
          "coordinate": [
            0.156992798743841,
            0.40955770801727154
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053987"
        }
      },
      {
        "id": "p(HGNC:KLF10)",
        "label": "p(HGNC:KLF10)",
        "metadata": {
          "coordinate": [
            0.9388434674319129,
            0.519838954370405
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053988"
        }
      },
      {
        "id": "p(HGNC:CRLF2)",
        "label": "p(HGNC:CRLF2)",
        "metadata": {
          "coordinate": [
            0.6058530510585305,
            0.051289532034076324
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053989"
        }
      },
      {
        "id": "tscript(p(HGNC:TBX21))",
        "label": "tscript(p(HGNC:TBX21))",
        "metadata": {
          "coordinate": [
            0.37032324435540637,
            0.30977943750729375
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405398a"
        }
      },
      {
        "id": "tscript(p(HGNC:SMAD2))",
        "label": "tscript(p(HGNC:SMAD2))",
        "metadata": {
          "coordinate": [
            0.5208457415128053,
            0.4743260590500642
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405398b"
        }
      },
      {
        "id": "p(HGNC:CXCL16)",
        "label": "p(HGNC:CXCL16)",
        "metadata": {
          "coordinate": [
            0.08335589365964588,
            0.6645466215427706
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405398c"
        }
      },
      {
        "id": "p(HGNC:CCR5)",
        "label": "p(HGNC:CCR5)",
        "metadata": {
          "coordinate": [
            0.3448751962748389,
            0.8203407632162447
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405398d"
        }
      },
      {
        "id": "p(HGNC:CCR3)",
        "label": "p(HGNC:CCR3)",
        "metadata": {
          "coordinate": [
            0.2750284260111538,
            0.5618508577430272
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405398e"
        }
      },
      {
        "id": "tscript(p(HGNC:STAT4))",
        "label": "tscript(p(HGNC:STAT4))",
        "metadata": {
          "coordinate": [
            0.44287725377659865,
            0.16798926362469366
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c3405398f"
        }
      },
      {
        "id": "p(SFAM:\"Chemokine Receptor Family\")",
        "label": "p(SFAM:\"Chemokine Receptor Family\")",
        "metadata": {
          "coordinate": [
            0.3194271481942715,
            0.6487921577780372
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053990"
        }
      },
      {
        "id": "tscript(p(HGNC:FOXP3))",
        "label": "tscript(p(HGNC:FOXP3))",
        "metadata": {
          "coordinate": [
            0.6572905950511668,
            0.4434006301785506
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053991"
        }
      },
      {
        "id": "cat(p(HGNC:CD80))",
        "label": "cat(p(HGNC:CD80))",
        "metadata": {
          "coordinate": [
            0.879284205966755,
            0.4054732174116
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053992"
        }
      },
      {
        "id": "p(HGNC:TGFB1)",
        "label": "p(HGNC:TGFB1)",
        "metadata": {
          "coordinate": [
            0.6843629866262385,
            0.5816898121134322
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053993"
        }
      },
      {
        "id": "path(SDIS:\"regulatory t-cell differentiation\")",
        "label": "path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "coordinate": [
            0.572824733336943,
            0.3547088341696814
          ],
          "bel_function_type": "pathology",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053994"
        }
      },
      {
        "id": "tscript(p(HGNC:FOXO1))",
        "label": "tscript(p(HGNC:FOXO1))",
        "metadata": {
          "coordinate": [
            0.7217228869998376,
            0.7018905356517681
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053995"
        }
      },
      {
        "id": "a(SCHEM:Tretinoin)",
        "label": "a(SCHEM:Tretinoin)",
        "metadata": {
          "coordinate": [
            0.5235529806703124,
            0.7333994631812347
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053996"
        }
      },
      {
        "id": "path(SDIS:\"T-cell migration\")",
        "label": "path(SDIS:\"T-cell migration\")",
        "metadata": {
          "coordinate": [
            0.2577020954031079,
            0.9393744894386744
          ],
          "bel_function_type": "pathology",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053997"
        }
      },
      {
        "id": "p(HGNC:SMAD3)",
        "label": "p(HGNC:SMAD3)",
        "metadata": {
          "coordinate": [
            0.4591206887216417,
            0.6482086591200841
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053998"
        }
      },
      {
        "id": "p(HGNC:CXCR3)",
        "label": "p(HGNC:CXCR3)",
        "metadata": {
          "coordinate": [
            0.29722778710271264,
            0.4469016221262691
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351bd3fbfd4c34053999"
        }
      },
      {
        "id": "p(HGNC:USP7)",
        "label": "p(HGNC:USP7)",
        "metadata": {
          "coordinate": [
            0.0296781766366578,
            0.0590392141877856
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "q.lu",
          "nodeId": "5302292989e3620bbcdf9483"
        }
      },
      {
        "id": "p(HGNC:UBE2N)",
        "label": "p(HGNC:UBE2N)",
        "metadata": {
          "coordinate": [
            0.356670755127757,
            0.45050025333208
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "q.lu",
          "nodeId": "53022c6489e3620bbcdfe89d"
        }
      },
      {
        "id": "p(HGNC:SOCS1)",
        "label": "p(HGNC:SOCS1)",
        "metadata": {
          "coordinate": [
            0.786182092868808,
            0.650243759923728
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "q.lu",
          "nodeId": "53022ebe89e3620bbce0293e"
        }
      },
      {
        "id": "p(HGNC:STUB1)",
        "label": "p(HGNC:STUB1)",
        "metadata": {
          "coordinate": [
            0.597825063670904,
            0.713403559156416
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "q.lu",
          "nodeId": "5302304c89e3620bbce03ca9"
        }
      },
      {
        "id": "tscript(p(HGNC:NFKBID))",
        "label": "tscript(p(HGNC:NFKBID))",
        "metadata": {
          "coordinate": [
            0.0164378206322146,
            0.0828827210156632
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "q.lu",
          "nodeId": "530234be89e3620bbce049cc"
        }
      },
      {
        "id": "tscript(p(HGNC:GATA3))",
        "label": "tscript(p(HGNC:GATA3))",
        "metadata": {
          "coordinate": [
            0.890914574680344,
            0.722352146973066
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "mberra",
          "nodeId": "551150de89e3620b9c5dbfcc"
        }
      },
      {
        "id": "tscript(p(HGNC:STAT3))",
        "label": "tscript(p(HGNC:STAT3))",
        "metadata": {
          "coordinate": [
            0.656263841621701,
            0.261096812440593
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "q.lu",
          "nodeId": "5306a4a489e36201901f6912"
        }
      },
      {
        "id": "p(HGNC:STAT3,pmod(\"p\",Y,705))",
        "label": "p(HGNC:STAT3,pmod(\"p\",Y,705))",
        "metadata": {
          "coordinate": [
            0.732346702242432,
            0.693105238812559
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "q.lu",
          "nodeId": "5306a52b89e36201901f701f"
        }
      },
      {
        "id": "tscript(p(HGNC:BACH2))",
        "label": "tscript(p(HGNC:BACH2))",
        "metadata": {
          "coordinate": [
            0.613304933353004,
            0.639932514000653
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "q.lu",
          "nodeId": "5306a94b89e36201901f800a"
        }
      },
      {
        "id": "p(HGNC:FURIN)",
        "label": "p(HGNC:FURIN)",
        "metadata": {
          "coordinate": [
            0.82671172256894,
            0.700637171371205
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "q.lu",
          "nodeId": "5306aa1789e36201901f8661"
        }
      },
      {
        "id": "act(p(HGNC:TGFB1))",
        "label": "act(p(HGNC:TGFB1))",
        "metadata": {
          "coordinate": [
            0.465838176415226,
            0.420774328718322
          ],
          "bel_function_type": "molecularActivity",
          "createdBy": "q.lu",
          "nodeId": "5306aab789e36201901f8a8d"
        }
      },
      {
        "id": "tscript(p(HGNC:NR4A2))",
        "label": "tscript(p(HGNC:NR4A2))",
        "metadata": {
          "coordinate": [
            0.734740004285583,
            0.88587628299644
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "q.lu",
          "nodeId": "5306b1bd89e362019020ebdc"
        }
      },
      {
        "id": "tscript(p(HGNC:IFNG))",
        "label": "tscript(p(HGNC:IFNG))",
        "metadata": {
          "coordinate": [
            0.519512574895989,
            0.72766977582484
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "q.lu",
          "nodeId": "5306b23b89e3620190211787"
        }
      },
      {
        "id": "p(HGNC:HIF1A)",
        "label": "p(HGNC:HIF1A)",
        "metadata": {
          "coordinate": [
            0.321648015324794,
            0.581943379520412
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "q.lu",
          "nodeId": "5306b5a989e3620190213461"
        }
      },
      {
        "id": "tscript(p(HGNC:CREBBP))",
        "label": "tscript(p(HGNC:CREBBP))",
        "metadata": {
          "coordinate": [
            0.88708865730422,
            0.581493237326617
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "mberra",
          "nodeId": "54fae00a89e36215ccbb27c6"
        }
      },
      {
        "id": "p(SFAM:\"IFNA Family\")",
        "label": "p(SFAM:\"IFNA Family\")",
        "metadata": {
          "coordinate": [
            0.898051537525864,
            0.817703482144374
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "mberra",
          "nodeId": "55114e0d89e3620b9c5b97f5"
        }
      },
      {
        "id": "p(HGNC:GATA3)",
        "label": "p(HGNC:GATA3)",
        "metadata": {
          "coordinate": [
            0.754150352791953,
            0.744507598571716
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "mberra",
          "nodeId": "55114e0d89e3620b9c5b97f7"
        }
      },
      {
        "id": "bp(GOBP:\"regulatory T cell differentiation\")",
        "label": "bp(GOBP:\"regulatory T cell differentiation\")",
        "metadata": {
          "coordinate": [
            0.70685205408691,
            0.0585395070065462
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "mnbk",
          "nodeId": "552981af89e3620d90dbb174"
        }
      },
      {
        "id": "p(HGNC:IL6)",
        "label": "p(HGNC:IL6)",
        "metadata": {
          "coordinate": [
            0.072418623637603,
            0.413171810756052
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "mnbk",
          "nodeId": "5529828789e3620d90dbf902"
        }
      }
    ],
    "edges": [
      {
        "source": "p(HGNC:ITCH)",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "p(HGNC:ITCH) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405394f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ITCH) increases p(HGNC:FOXP3)",
              "summary_text": "Itch cooperated with TIEG1 to induce Foxp3 expression, which was reversed by TIEG1 deficiency.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2008 Mar 9(3) 245-53",
                "id": "18278048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081605"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:IL12A),p(HGNC:IL12B))",
        "relation": "increases",
        "target": "tscript(p(HGNC:TBX21))",
        "directed": false,
        "label": "complex(p(HGNC:IL12A),p(HGNC:IL12B)) increases tscript(p(HGNC:TBX21))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053949",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:IL12A),p(HGNC:IL12B)) increases tscript(p(HGNC:TBX21))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408160a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CTLA4)",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:CD80))",
        "directed": false,
        "label": "p(HGNC:CTLA4) directlyIncreases cat(p(HGNC:CD80))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053940",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CTLA4) directlyIncreases cat(p(HGNC:CD80))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408160c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:KLF10)",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "p(HGNC:KLF10) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405395b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:KLF10) increases p(HGNC:FOXP3)",
              "summary_text": "Itch cooperated with TIEG1 to induce Foxp3 expression, which was reversed by TIEG1 deficiency.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2008 Mar 9(3) 245-53",
                "id": "18278048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081658"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:IL12A),p(HGNC:IL12B))",
        "relation": "increases",
        "target": "tscript(p(HGNC:STAT4))",
        "directed": false,
        "label": "complex(p(HGNC:IL12A),p(HGNC:IL12B)) increases tscript(p(HGNC:STAT4))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405394a",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:IL12A),p(HGNC:IL12B)) increases tscript(p(HGNC:STAT4))",
              "summary_text": "from full text - Both cytokines (IL-12 and IL-23) activate TYK2 and JAK2 as well as STAT1, STAT3, STAT4, and STAT5 [60].",
              "citation": {
                "type": "PubMed",
                "name": "World J Gastroenterol 2008 Jul 21 14(27) 4280-8",
                "id": "18666314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081659"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TGFB1)",
        "relation": "increases",
        "target": "tscript(p(HGNC:FOXO3))",
        "directed": false,
        "label": "p(HGNC:TGFB1) increases tscript(p(HGNC:FOXO3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405393c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:FOXO3))",
              "summary_text": "Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2010 Jul 5 207(7) 1381-91",
                "id": "20439537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408166d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "path(SDIS:\"regulatory t-cell differentiation\")",
        "relation": "increases",
        "target": "p(HGNC:IL10)",
        "directed": false,
        "label": "path(SDIS:\"regulatory t-cell differentiation\") increases p(HGNC:IL10)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053967",
          "evidences": [
            {
              "bel_statement": "path(SDIS:\"regulatory t-cell differentiation\") increases p(HGNC:IL10)",
              "summary_text": "Interleukin (IL)-10 is the most important cytokine with anti-inflammatory properties besides TGF-?? and IL-35. It is produced by activated immune cells, in particular monocytes/macrophages and T cell subsets including Tr1, Treg, and Th1 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine Growth Factor Rev 2010 Oct 21(5) 331-44",
                "id": "21115385"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081672"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCR3)",
        "relation": " isA",
        "target": "p(SFAM:\"Chemokine Receptor Family\")",
        "directed": false,
        "label": "p(HGNC:CCR3)  isA p(SFAM:\"Chemokine Receptor Family\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053946",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:CD80)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:CD80))",
        "directed": false,
        "label": "p(HGNC:CD80) actsIn cat(p(HGNC:CD80))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053938",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CD80) actsIn cat(p(HGNC:CD80))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081687"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:CRLF2))",
        "relation": "directlyIncreases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "cat(p(HGNC:CRLF2)) directlyIncreases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053953",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:CRLF2)) directlyIncreases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408168c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TSLP)",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:IL7R))",
        "directed": false,
        "label": "p(HGNC:TSLP) directlyIncreases cat(p(HGNC:IL7R))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053955",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TSLP) directlyIncreases cat(p(HGNC:IL7R))",
              "summary_text": "There are 2 known ligands for IL-7Ralpha: IL-7 itself and thymic stromal lymphopoietin (TSLP).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Oct 15 112(8) 3283-92",
                "id": "18664628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081692"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCR5)",
        "relation": " isA",
        "target": "p(SFAM:\"Chemokine Receptor Family\")",
        "directed": false,
        "label": "p(HGNC:CCR5)  isA p(SFAM:\"Chemokine Receptor Family\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053945",
          "evidences": [

          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TBX21))",
        "relation": "increases",
        "target": "p(HGNC:CXCR3)",
        "directed": false,
        "label": "tscript(p(HGNC:TBX21)) increases p(HGNC:CXCR3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405395d",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TBX21)) increases p(HGNC:CXCR3)",
              "summary_text": "T-bet transfection also induced IL-12Rbeta2 and CXCR3 expression on human T(H)2 cells, whereas the IL-18 receptor was only induced as a consequence of T-bet-mediated increased responsiveness to IL-12.",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy Clin Immunol 2004 May 113(5) 987-94",
                "id": "15131585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th2 cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TBX21))",
        "relation": "decreases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "tscript(p(HGNC:TBX21)) decreases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405395e",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TBX21)) decreases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "Signal transducer and activator of transcription 4 (STAT4) is critical for the response to IL-12, although there is a parallel pathway involving T box expressed in T cells (T-bet), and cells from mice double-deficient in STAT4 and T-bet are refractory to the inhibition of aTreg-cell development by IL-12. ",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2009 Aug 127(4) 587-95",
                "id": "19604309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081702"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:CD80))",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "cat(p(HGNC:CD80)) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405393f",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:CD80)) increases p(HGNC:FOXP3)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081716"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CXCR6)",
        "relation": " isA",
        "target": "p(SFAM:\"Chemokine Receptor Family\")",
        "directed": false,
        "label": "p(HGNC:CXCR6)  isA p(SFAM:\"Chemokine Receptor Family\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053944",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:IL7R)",
        "relation": "increases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "p(HGNC:IL7R) increases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405396a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:IL7R) increases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "Combined deletion of IL-7 and TSLP receptor greatly reduced Treg cell development in the thymus but was not required for survival of mature peripheral Treg cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Oct 15 112(8) 3283-92",
                "id": "18664628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081785"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:FOXO3))",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "tscript(p(HGNC:FOXO3)) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053962",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:FOXO3)) increases p(HGNC:FOXP3)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408179b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FOXP3)",
        "relation": "increases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "p(HGNC:FOXP3) increases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053969",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FOXP3) increases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "Unlike IL6, LIF supported expression of Foxp3, the Treg lineage transcription factor, and LIF opposed IL6 by suppressing IL-6-induced IL-17A protein release.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 May 1 8(9) 1444-50",
                "id": "19342884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817c2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CXCR3)",
        "relation": " isA",
        "target": "p(SFAM:\"Chemokine Receptor Family\")",
        "directed": false,
        "label": "p(HGNC:CXCR3)  isA p(SFAM:\"Chemokine Receptor Family\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053943",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:CRLF2)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:CRLF2))",
        "directed": false,
        "label": "p(HGNC:CRLF2) actsIn cat(p(HGNC:CRLF2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053936",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CRLF2) actsIn cat(p(HGNC:CRLF2))",
              "summary_text": " Blocking thymic stromal lymphopoietin receptor(TSLPR) with a TSLPR monoclonal antibody partially prevented progesterone suppression of IL-17-producing T cells differentiation, and progesterone promotion of CD4+CD25+Foxp3+ regulatory T cells differentiation. ",
              "citation": {
                "type": "PubMed",
                "name": "Microbes Infect 2013 Jul 5",
                "id": "23835188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817e4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CRLF2) actsIn cat(p(HGNC:CRLF2))",
              "summary_text": "Combined deletion of IL-7 and TSLP receptor greatly reduced Treg cell development in the thymus but was not required for survival of mature peripheral Treg cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Oct 15 112(8) 3283-92",
                "id": "18664628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081765"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:SMAD2))",
        "relation": "increases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "tscript(p(HGNC:SMAD2)) increases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053965",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:SMAD2)) increases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "In this study, we generated T cell-specific Smad2 conditional knockout (KO) mice and unexpectedly found that Smad2 and Smad3 were redundantly essential for TGF-beta-mediated induction of Foxp3-expressing regulatory T cells and suppression of IFN-gamma production in CD4(+) T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 15 185(2) 842-55",
                "id": "20548029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408182d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TGFB1)",
        "relation": "increases",
        "target": "tscript(p(HGNC:SMAD2))",
        "directed": false,
        "label": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405393b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "The changes in glucocorticoid binding were associated with identical changes in GR protein and mRNA levels Functional inactivation of Smad 2/3 and AP-1 limited the response to TGF-beta 1, indicating a role for these transcription factors TGF-beta 1 increases glucocorticoid binding and signaling in inflammatory cells through a Smad 2/3- and AP-1-mediated process",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int 2003 Jun 63(6) 2028-36",
                "id": "12753290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408175d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "TGF-beta phosphorylation of Smad2/3, an obligatory step of intracellular TGF-beta signaling, was also suppressed by VEGF. VEGF attenuation of TGF-beta action was also demonstrated in two other endothelial cell lines. In conclusion, VEGF attenuates TGF-beta action in the human endothelial cell, specifically at the level of transcription of PAI-1 gene and Smad2/3 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 31 279(53) 55104-8",
                "id": "15494412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081705"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "By RT-PCR we have shown that TGFbeta up-regulates expression not only of plasminogen activator inhibitor type-1 (PAI-1), but also of the urokinase-type plasminogen activator receptor (uPAR), whose inhibition by specific antibodies blunted the TGFbeta angiogenic response in vitro. The SMAD2/3 and FAK signaling pathways were activated by TGFbeta in MVEC",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2009 Mar 1 77(5) 813-25",
                "id": "19041849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408166b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Jul 1 175(1) 547-54",
                "id": "15972691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408164d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "Both SMAD2 and SMAD1/5 were activated upon exposure to TGF-beta1",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 May 296(5) L825-38",
                "id": "19270180"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081601"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "TGFb1 signaling activates receptor SMADs, SMAD2 and SMAD3, which associate with a variety of nuclear factors to regulate gene transcription",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Sep 17 285(38) 29044-8",
                "id": "20656683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081834"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th17 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "In this study, we generated T cell-specific Smad2 conditional knockout (KO) mice and unexpectedly found that Smad2 and Smad3 were redundantly essential for TGF-beta-mediated induction of Foxp3-expressing regulatory T cells and suppression of IFN-gamma production in CD4(+) T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 15 185(2) 842-55",
                "id": "20548029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408182a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "Blocking TGF-beta1 signaling pathway by knocking down Smad2 significantly blunted the aldosterone induced fibronectin production. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Sep 15 348(1) 70-5",
                "id": "16876110"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "TGF-beta1 (1 ng/ml) significantly upregulated SMAD phosphorylation in COPD ASMC following 2-h stimulation (P < 0.05; n = 5; Fig. 4A); however, the differences were not significant for other ASMC types.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2012 Feb 1 302(3) L325-33",
                "id": "22003087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "FIGURE 11. TGF-beta1 induces activation of Smad2/3 pathway in AML12 cell line",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 27 282(30) 22089-101",
                "id": "17513865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081786"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "In our previous studies we have shown that both Smad2 and p38 MAPK were activated in human lung fibroblasts within 10 min of TGF1 stimulation, and peak activation was reached at 1 h (19).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 May 9 283(19) 12898-908",
                "id": "18353785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408175a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 22 277(12) 9870-9",
                "id": "11784716"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408174d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD2))",
              "summary_text": "Expression of wild-type Dab2 in a TGFbeta-signaling mutant restores TGFbeta-mediated Smad2 phosphorylation, Smad translocation to the nucleus and Smad-dependent transcriptional responses.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Jun 1 20(11) 2789-801",
                "id": "11387212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081675"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:IL7R))",
        "relation": "actsIn",
        "target": "p(HGNC:IL7R)",
        "directed": false,
        "label": "cat(p(HGNC:IL7R)) actsIn p(HGNC:IL7R)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053960",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:IL7R)) actsIn p(HGNC:IL7R)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081837"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TBX21)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:TBX21))",
        "directed": false,
        "label": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405395f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "Transfection of T-bet into T(H)2 cells induced high levels of IFN-gamma and suppressed IL-5, but IL-2 and IL-4 production remained unchanged. ",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy Clin Immunol 2004 May 113(5) 987-94",
                "id": "15131585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408183f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th2 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "Therefore, we examined accessibility of the IFN-? locus by assessing DNase I hypersensitivity (HS) in transduced Stat4 ?/?cells. The canonical HS site I of TH1 cells (21) was induced specifically by T-bet retrovirus (Fig. 2B), suggesting that chromatin remodeling is targeted to the IFN-g locus by T-bet. Finally, we also found that ectopic T-bet specifically induced robust transcription of both endogenous (cellular) T-bet and IL-12 receptor b2 (IL-12Rb2) (Fig. 2C). Thus, consistent with its ability to induce other TH1 attributes (5), T-bet can activate its own expression, target remodeling of the IFN-? locus, and induce expression of IL-12Rb2. ",
              "citation": {
                "type": "PubMed",
                "name": "Science 2001 Jun 8 292(5523) 1907-10",
                "id": "11397944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408183e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "We observed that treatment of activated T cellenriched LPMCs with TGF- but not IL-4 suppressed T-bet expression suggesting a reciprocal relationship between T-bet and TGF- levels (Fig. 8 A). Furthermore, we found that T cell enriched LPMC in T-bet knockout mice produced increased amounts of TGF- compared with cells from wild-type littermates (Fig. 8 B)",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2002 May 6 195(9) 1129-43",
                "id": "11994418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817e8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "By combining chromatin immunoprecipitation from Th1 cells with human cytosine-phosphate-guanine-island array analysis, Onecut 2 (OC2), which encodes a member of the ONECUT class of transcriptional activators, was identified as a direct target gene of T-bet. OC2 is expressed in Th1 but not Th2 cells and reporter assays showed that T-bet transactivates OC2 transcription through putative T-bet half-sites locating -451 to -347 of OC2 promoter region.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Immun 2008 Jun 9(4) 302-8",
                "id": "18418398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081795"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "We now show for the first time that suppression of T-bet ameliorates EAE by limiting the differentiation of autoreactive Th1 cells, as well as inhibiting pathogenic Th17 cells via regulation of IL-23R. (from text:) We consistently found that the number of Th17 cells in the CNS of EAE-affected mice was highest at the acute phase of disease as shown in Fig. 4 and decreased over time as shown in Fig. 5. However, the number of Th17 cells in the CNS was usually undetectable in the siRNA-T-bet-treated mice at all time points.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Feb 1 178(3) 1341-8",
                "id": "17237380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081775"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "Finally, we show that retroviral T-bet expression in developing and established Th2 cells leads to down-regulation of GATA-3 levels. (from text): As shown in Fig. 5 E, although GATA-3 mRNA levels in untreated T-betexpressing D10 cells were suppressed to about half of the level found in the wild-type cells, the kinetics of degradation of GATA-3 mRNA was similar in T-betexpressing and nonexpressing D10 cells. These results suggest that T-bet suppresses GATA-3 at a transcriptional level rather than at a posttranscriptional level. However, it should be noted that some posttranslational control may also exist because the down-regulation of GATA-3 by T-bet is more evident at the protein level than it is at the mRNA level.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2006 Mar 20 203(3) 755-66",
                "id": "16520391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816f3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "We confirmed that C57BL/6-derived V{alpha}14i NKT cells express CD38, NKG2D, 2B4, CD94, and Ly6C. However, the expression of these markers by T-betdeficient V{alpha}14i NKT cells was decreased and/or absent (Figure 2B). ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2006 Apr 1 107(7) 2797-805",
                "id": "16357323"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816eb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "Moreover, T-bet and eomesodermin were responsible for inducing enhanced expression of CD122",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2005 Dec 6(12) 1236-44",
                "id": "16273099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816e0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "T-bet is required for the progression to the Th1 phenotype, because Tbx21-/- Th1beta cultures maintain the IL-17-secreting phenotype after 2 weeks of culture. Addition of IFN-gamma to Tbx21-/- Th1beta cultures cannot recover the progression to the Th1 phenotype, suggesting T-bet, rather than IFN-gamma, mediates Th1beta to Th1 progression.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2006 Sep 1 108(5) 1595-601",
                "id": "16670261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816d8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "mTORC2 promoted phosphorylation of protein kinase B (PKB, or Akt) and PKC, Akt activity, and nuclear NF-kappaB transcription factors in response to T cell activation. Complementation with active Akt restored only T-bet transcription factor expression and Th1 cell differentiation,",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2010 Jun 25 32(6) 743-53",
                "id": "20620941"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081698"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "Although it has been shown that T-bet is a crucial factor in suppressing Il4 gene expression, it is unclear whether a continuous presence of T-bet is required to silence the Il4 gene in Th1 cells. To address this problem, we used an inducible form of T-bet - a T-bet-oestrogen receptor fusion molecule (T-bet-ER). We found that the activation of T-bet during primary or secondary culture was sufficient to silence IL-4-producing potential. On the other hand, the inactivation of T-bet after na??ve CD4(+) T cells had differentiated into Th1 cells resulted in derepression of Il4 gene transcription. Additionally, we found that T-bet is required to maintain Ifng expression. Our data demonstrate that the continuous expression of T-bet is required for Th1 cells to silence their IL-4-producing potential.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2009 Sep 128(1) 34-42",
                "id": "19689734"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081669"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "There was an increased expression of GATA-3 in the nuclear extracts from Lamina propria mononuclear cells (LPMCs) of T-bet knockout mice, consistent with an increased presence of Th2 cells in the mucosa.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2002 May 6 195(9) 1129-43",
                "id": "11994418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081623"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "We now show for the first time that suppression of T-bet ameliorates EAE by limiting the differentiation of autoreactive Th1 cells, as well as inhibiting pathogenic Th17 cells via regulation of IL-23R. (from text:) We consistently found that the number of Th17 cells in the CNS of EAE-affected mice was highest at the acute phase of disease as shown in Fig. 4 and decreased over time as shown in Fig. 5. However, the number of Th17 cells in the CNS was usually undetectable in the siRNA-T-bet-treated mice at all time points.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Feb 1 178(3) 1341-8",
                "id": "17237380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081614"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "To determine whether silencing T-bet in vivo also resulted in down-regulation of the IL-23R, whole-cell lysates were prepared directly ex vivo from the splenocytes of EAE-affected mice that had been treated with siRNA-NS or siRNA-T-bet. Western blot analysis demonstrated a 45% reduction in IL-23R at day 18, and IL-23R was undetectable by day 44 in the siRNA-T-bet mice (Fig. 3b)",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Feb 1 178(3) 1341-8",
                "id": "17237380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817c1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "LPS matured T-bet-/- BMDCs, similar to colonic DCs, overproduce TNF-a compared to WT BMDCs (Figure 4B). The observations that loss of T-bet expression in colonic and BMDCs results in increased TNF-a production suggested that T-bet may directly regulate TNF-a in DCs. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Oct 5 131(1) 33-45",
                "id": "17923086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408184a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "Expression of Hopx is induced by T-bet and increases upon repeated antigenic restimulation of Th1 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 2010 Nov 40(11) 2993-3006",
                "id": "21061432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081827"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "Signal transducer and activator of transcription 4 (STAT4) is critical for the response to IL-12, although there is a parallel pathway involving T box expressed in T cells (T-bet), and cells from mice double-deficient in STAT4 and T-bet are refractory to the inhibition of aTreg-cell development by IL-12. ",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2009 Aug 127(4) 587-95",
                "id": "19604309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081811"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "both transcription factors T-bet and Runx3 are required for maximal production of interferon-gamma (IFN-gamma) and silencing of the gene encoding interleukin 4 (Il4) in T(H)1 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2007 Feb 8(2) 145-53",
                "id": "17195845"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817a6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "Th1 or Th1beta Tbx21-/- cultures secrete higher than WT levels of IL-17 in response to T-cell receptor (TCR) or IL-23 + IL-18 stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2006 Sep 1 108(5) 1595-601",
                "id": "16670261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081722"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "For example, T-bet induces IL-12Rb2 expression by differentiating Th1 cells . ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(5) e10636",
                "id": "20498708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081710"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "The T-bet-/-OT-I cultures exhibited a reduction in IFN-?-producing cells and a concomitant increase in the number of cells producing IL-4 and IL-10 (Fig. 2c). Differences in IL-2 intracellular staining were variable, although the levels of secreted IL-2 were consistently elevated in the absence of T-bet (Fig. 2 b and c).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Dec 23 100(26) 15818-23",
                "id": "14673093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816b8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "Remarkably, retroviral gene transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, respectively, as evidenced by the simultaneous induction of IFNgamma and repression of IL-4 and IL-5.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2000 Mar 17 100(6) 655-69",
                "id": "10761931"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408165f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "[Figure 2]  Model for T helper (Th) or T regulatory (Treg) differentiation from nave CD4+ T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2009 Jun 129(6) 1339-50",
                "id": "19322214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408162f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "CD4+ T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "We also find that T-bet-dependent expression of Opn in T cells",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Nov 22 102(47) 17101-6",
                "id": "16286640"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815f6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TBX21) actsIn tscript(p(HGNC:TBX21))",
              "summary_text": "We detected a dramatic decrease in Cxcr3 mRNA levels in T-bet-/- CD4+ expression T cells relative to wild type cells (Fig. 6B). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 28 281(17) 11992-2000",
                "id": "16473879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815f1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CXCR6)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:CXCR6))",
        "directed": false,
        "label": "p(HGNC:CXCR6) actsIn cat(p(HGNC:CXCR6))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053947",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CXCR6) actsIn cat(p(HGNC:CXCR6))",
              "summary_text": "Exposure of HASMC to CXCL16 increased NF-kappa B DNA binding activity, induced kappa B-driven luciferase activity, and up-regulated tumor necrosis factor-alpha expression in an NF-kappa B-dependent manner. However, treatment with pertussis toxin (G(i) inhibitor), wortmannin or LY294002 (phosphatidylinositol 3-kinase (PI3K inhibitors)), or Akt inhibitor or overexpression of dominant-negative (dn) PI3K gamma, dnPDK-1, kinase-dead (kd) Akt, kdIKK-beta, dnIKK-gamma, dnI kappa B-alpha, or dnI kappa B-beta significantly attenuated CXCL16-induced NF-kappa B activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 30 279(5) 3188-96",
                "id": "14625285"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR6) actsIn cat(p(HGNC:CXCR6))",
              "summary_text": "Chemokine receptors signal through Galphai2 proteins to activate DOCK2 (dedicator of cytokinesis 2) and other guanine nucleotide exchange factors (GEFs), leading to the activation of RAC1 and RHOA. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 Sep 9(9) 630-44",
                "id": "19696767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081853"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR6) actsIn cat(p(HGNC:CXCR6))",
              "summary_text": "Table 1.  Lymphoid chemokine receptors",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2004 Feb 25(2) 67-74",
                "id": "15102365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CXCL9)",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:CXCR3))",
        "directed": false,
        "label": "p(HGNC:CXCL9) directlyIncreases cat(p(HGNC:CXCR3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405395a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CXCL9) directlyIncreases cat(p(HGNC:CXCR3))",
              "summary_text": "By using a CXCR3 ligand reporter mouse, we found that stromal cells predominately expressed the chemokine ligand CXCL9 whereas hematopoietic cells expressed CXCL10 in lymph nodes (LNs). Dendritic cell (DC)-derived CXCL10 facilitated T cell-DC interactions in LNs during T cell priming while both chemokines guided intranodal positioning of CD4(+) T cells to interfollicular and medullary zones. Thus, different chemokines acting on the same receptor can function locally to facilitate DC-T cell interactions and globally to influence intranodal positioning, and both functions contribute to Th1 cell differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2012 Dec 14 37(6) 1091-103",
                "id": "23123063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081867"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCL9) directlyIncreases cat(p(HGNC:CXCR3))",
              "summary_text": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
              "citation": {
                "type": "PubMed",
                "name": "Clin Lab Med 2008 Sep 28(3) 375-84, v",
                "id": "19028258"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408184c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCL9) directlyIncreases cat(p(HGNC:CXCR3))",
              "summary_text": " T cells in peripheral airways of COPD patients show increased expression of CXCR3, a receptor activated by interferon-{gamma} inducible protein of 10 kDa (IP-10; CXCL10), monokine induced by interferon-{gamma} (Mig; CXCL9), and interferon-inducible T cell-{alpha} chemoattractant (I-TAC; CXCL11). All three cytokines activate CXCR3, although CXCL11 has the highest affinity.",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48",
                "id": "15602009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081857"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FOXO1)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:FOXO1))",
        "directed": false,
        "label": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405394d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Conversely, a gain-of-function Foxo1 mutation targeted to liver and pancreatic beta-cells results in diabetes arising from a combination of increased hepatic glucose production and impaired beta-cell compensation due to decreased Pdx1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2002 Oct 32(2) 245-53",
                "id": "12219087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081863"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "phosphorylation of FoxO by Akt also disrupts FoxO interactions with DNA. The phosphorylation of FoxO at the second of the three AKT/SGK sites (S256 for FoxO1) introduces a negative charge in the positively charged DNA-binding domain, thereby inhibiting DNA binding in in vitro binding assays (Nasrin et al., 2000; Zhang et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2276-88",
                "id": "18391970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081861"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The antiapoptotic effect was reversed by inhibition of the PI3K/Akt pathway. Forkhead transcription factors (FOXO1, FOXO3a, FOXO4) exert proapoptotic effects and are phosphorylated and, thereby, inactivated by Akt.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Jun 19(8) 974-6",
                "id": "15824087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408185e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Transcriptional control by FOXO also extends to the regulation of pro-apoptotic genes Bim and Fas Ligand and to the stress response genes like GADD45, Mn superoxide dismutase and catalase.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2005 Jul 4(7) 908-13",
                "id": "15917664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081843"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Two FoxO-responsive elements were identified and characterized by generation of point mutation and deletion constructs. Similarly, SeP mRNA was upregulated in response to activation of FoxO1a in rat hepatoma cells stably transfected with a hydroxytamoxifen-regulatable form of FoxO1a.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2008 Jan 11 365(2) 316-21",
                "id": "17986386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081841"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Conversely, a gain-of-function Foxo1 mutation targeted to liver and pancreatic beta-cells results in diabetes arising from a combination of increased hepatic glucose production and impaired beta-cell compensation due to decreased Pdx1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2002 Oct 32(2) 245-53",
                "id": "12219087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408183d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Elevated growth factors during puberty and persistent growth factor signals due to Western life style stimulate the export of FoxO1 out of the nucleus into the cytoplasm via activation of the phos-phoinositide-3-kinase (PI3K)/Akt pathway. By this mechanism, genes and nuclear receptors involved in acne are derepressed leading to increased androgen receptor-mediated signal transduction, increased cell proliferation of androgen-dependent cells, induction of sebaceous lipogenesis and upregulation of Toll-like-receptor-2-dependent inflammatory cytokines.",
              "citation": {
                "type": "PubMed",
                "name": "J Dtsch Dermatol Ges 2010 Feb 8(2) 105-14",
                "id": "20151947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081820"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "mechanism by which IGF-1 inversely regulates these markers, and found that the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway, which we had previously characterized as being critical for hypertrophy, is also required to be active in order for IGF-1-mediated transcriptional changes to occur. We had recently demonstrated that the IGF1/PI3K/Akt pathway can block dexamethasone-induced up-regulation of the atrophy-induced ubiquitin ligases MuRF1 and MAFbx by blocking nuclear translocation of a FOXO transcription factor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2737-44",
                "id": "15550386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408180f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "In this study, we demonstrated that high glucose significantly increased intracellular ROS levels in human aortic endothelial cells (HAECs). Additionally, high glucose reduced the antioxidant activity of thioredoxin. To investigate the mechanisms involved, we found that glucose enhanced the expression of thioredoxin interacting protein (Txnip), a Trx inhibitory protein, through p38 mitogen-activated protein kinase (MAPK). We also showed that glucose regulated Txnip at transcription level and p38 MAPK and forkhead box O1 transcriptional factor (FOXO1) were involved in the process.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2009 Apr 17 381(4) 660-5",
                "id": "19254690"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Forkhead family members FOXO1, FOXO3a, and FOXO4 are multifunctional transcription factors, which regulate transcription of a number of genes that play critical roles in inducing either cell cycle arrest or apoptosis. Activation of each member of this family in transformed and nontransformed cells results in up-regulation of the cyclin-dependent kinase inhibitor p27KIP1 and/or down-regulation of D-type cyclins, thereby arresting cells at G1",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Feb 1 102(5) 1649-54",
                "id": "15668399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408179c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "We found that, in contrast to Akt1 that induces CREB phosphorylation at Ser-133 and CREB target gene expression, Akt2 was unable to induce CREB phosphorylation at Ser-133 in vivo and CREB target gene expression. This difference is specific to CREB as both Akt1 and Akt2 similarly inhibits FoxO1 mediated gene expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Mar 23 354(4) 1061-6",
                "id": "17276404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081728"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "We studied the effects of FOXO1 on human PPARgamma gene expression in primary rat adipocytes and found that both genes are endogenously expressed. FOXO1 coexpression dose-dependently repressed transcription from either the PPARgamma 1 or PPARgamma2 promoter reporter by 65%; Progressive 5'-deletion and gel retardation analyses revealed that this repression involves direct and specific binding of FOXO1 to the PPARgamma2 promoter; chromatin immunoprecipitation analysis confirmed that this binding occurs in cellulo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 21 281(29) 19881-91",
                "id": "16670091"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081700"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The forkhead box class O (FOXO) transcription factors family members, FOXO1a and FOXO3a, are phosphorylated in an AKT-dependent manner in SCF-stimulated BMMCs [76]. FOXO3a phosphorylation leads to its proteosomal degradation following ubiquitination thereby blocking its transcriptional control of the pro-apopototic factor, Bim. SCF also induces the AKT- and MAPK-dependent phosphorylation of Bim in mouse bone marrow-derived mast cells and it has been proposed that this also leads to its proteosomal degradation [76]. Thus these observations would account for the ablity of PI3K-AKT driven pathways to promote mast cell survival.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2008 Oct 29(10) 493-501",
                "id": "18775670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Since previous reports have demonstrated that acti- vated FKHR induces p27KIP1 protein (Dijkers et al., 2000; Medema et al., 2000; Nakamura et al., 2000) and our data demonstrate that FKHR phosphorylation (inactivation) in MM.1S cells is triggered by IL-6 via PI3-K/Akt (Figure 2),",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Sep 20 20(42) 5991-6000",
                "id": "11593406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The effects of PRL on gene expression were mimicked by constitutive overexpression of signal transducer and activator of transcription-5b. PRL induced signal transducer and activator of transcription-5 binding to a consensus sequence in the rat FoxO1 promoter, reduced nuclear FoxO1 protein levels, and induced its phosphorylation and cytoplasmic redistribution. ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2008 Nov 149(11) 5401-14",
                "id": "18599550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816e3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "new data suggest a potential role for the forkhead family of transcription factors through phosphorylation by Akt-related protein kinases39, and the PPARg co-activator PGC-1 (ref. 67).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 May 29 423(6939) 550-5",
                "id": "12754525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Here we show that Forkhead transcription factors FKHRL1 and FKHR, substrates of the Akt kinase, are aberrantly localized to the cytoplasm and cannot activate transcription in PTEN-deficient cells. Restoration of PTEN function restores FKHR to the nucleus and restores transcriptional activation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Dec 20(23) 8969-82",
                "id": "11073996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Akt (PKB) directly phosphorylates multiple protein targets of relevance to apoptosis (Figure 2B), suppressing cell death clearly within the intrinsic pathway (e.g., BAD inactivation, human caspase-9 suppression) and possibly also the extrinsic pathway (e.g., FasL expression) in some types of cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Jan 3(1) 17-22",
                "id": "12559172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The forkhead transcription factor FKHR (now referred to as Foxo1a) [125] has also been shown recently to be downregulated upon incubation of H4 hepatoma cells with AICAR",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Oct 1 375(Pt 1) 1-16",
                "id": "12839490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Moreover, the expression of a constitutively activated FOXO1 mutant, incapable of being inactivated by AKT, rapidly triggered cellular senescence along with the activation of Rb, but not p53 (Figure 6D).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Dec 10(6) 459-72",
                "id": "17157787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Small heterodimer partner (SHP; NR0B2), an exceptional member of the mammalian nuclear receptor family, directly modulates the activities of conventional nuclear receptors by acting as an inducible and tissue-specific corepressor. Recent progress in dissecting underlying molecular mechanisms, identifying target factors and target genes, and uncovering physiological functions points to the regulatory involvement of SHP in diverse metabolic and intracellular pathways that awaits future clarification. In this review, we carry out a comprehensive survey of all published data and discuss our current understanding of molecular mechanisms and physiological consequences governing SHP action.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Endocrinol Metab 2005 Dec 16(10) 478-88",
                "id": "16275121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816c0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "It has been reported that inhibition of FoxO activity is an important mechanism for Ang1-stimulated Tie2-mediated endothelial function. Consistent with this, we found that phosphorylation of FoxO mediated by Tie2 activation was attenuated by lipid raft disruption. Therefore, we propose that lipid rafts serve as signaling platforms for Tie2 receptor tyrosine kinase in vascular endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2009 Oct 1 315(16) 2818-23",
                "id": "19615361"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "in activated B cells FOXO proteins exert their effects through up-regulation of proapoptotic genes such as Bim",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Aug 1 104(3) 784-7",
                "id": "15069012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081693"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "In addition, phosphorylation of the second site (S256 in FoxO1) prevents FoxO re-entry into the nucleus by introducing a negative charge in the basic stretch of residues that forms the nuclear localization signal (Figure 3) (Rena et al., 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2276-88",
                "id": "18391970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081690"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2010 Jul 5 207(7) 1381-91",
                "id": "20439537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081684"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Recently, we have shown that inhibition of the pro-apoptotic transcription factor, forkhead, by vascular endothelial growth factor (VEGF) is essential for endothelial cell (EC) survival and proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 15",
                "id": "16980307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081664"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Reporter gene studies in HepG2 hepatoma cells show that FKHR stimulates insulin-like growth factor-binding protein-1 promoter activity through an IRS, and introduction of IRSs confers this effect on a heterologous promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 11 274(24) 17184-92",
                "id": "10358076"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081661"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The data indicate that the glucose-6-phosphate transporter promoter contains a glucocorticoid response unit consisting of binding sites for Fox O1 and the glucocorticoid receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2003 Nov 27 320 59-66",
                "id": "14597389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408165b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "the level of active Akt decreases significantly after CsA treatment, which results in the decrease of Forkhead phosphorylation and its translocation to the nucleus. It correlated with an increase of binding to the Forkhead-responsive element FHRE from the FasL promoter",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Oct 23 22(48) 7617-27",
                "id": "14576824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081649"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer chemotherapy and pharmacology 2001 Aug;48(2):141-4",
                "id": "11561780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081629"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "mechanism by which IGF-1 inversely regulates these markers, and found that the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway, which we had previously characterized as being critical for hypertrophy, is also required to be active in order for IGF-1-mediated transcriptional changes to occur. We had recently demonstrated that the IGF1/PI3K/Akt pathway can block dexamethasone-induced up-regulation of the atrophy-induced ubiquitin ligases MuRF1 and MAFbx by blocking nuclear translocation of a FOXO transcription factor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2737-44",
                "id": "15550386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081627"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "siRNA knockdown of PKA-alpha enhanced transcriptional activity of FoxO1 relative to results from the control group (Fig. 7B). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2011 Feb 25 286(8) 6423-32",
                "id": "21177856"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081624"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The increase in Bim gene expression was significantly greater in the FoxO1AAA-ER than FoxO1AAA/Arg215-ER cells, indicating that FoxO1 regulates the expression of Bim through DNA-binding-dependent and -independent mechanisms.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2009 Sep 297(3) C548-55",
                "id": "19553561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081622"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Whereas angiopoietin 2 (Ang2) was exclusively regulated by Foxo1, eNOS, which is essential for postnatal neovascularization, was regulated by Foxo1 and Foxo3a. Consistent with these findings, constitutively active Foxo1 and Foxo3a repressed eNOS protein expression and bound to the eNOS promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Sep 115(9) 2382-92",
                "id": "16100571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408161c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "SIRT1 binds acetylated FOXO4 and restores its activity. Thus SIRT1 activates FOXO1 and FOXO4, which promote cell-cycle arrest by inducing p27kip",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Sci 2005 Jul 98(3) 200-4",
                "id": "16006743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408161b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "We show here that the promotor region of the rate-limiting lipolytic enzyme, adipose triglyceride lipase (ATGL), has two FoxO1-binding sites, and co-transfection with wild type and unphosphorylated FoxO1 mutant activates the expression of luciferase driven by the ATGL promotor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 May 15 284(20) 13296-300",
                "id": "19297333"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081619"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "This set includes the gene for thioredoxin-interacting protein (TXNIP), the expression of which is directly repressed by FOXO1a. ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS ONE 2008 3(2) e1670",
                "id": "18301748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081617"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Interestingly, SIRT1, a mammalian homolog of yeast Sir2, bound to and deacetylated FOXO1 and inhibited its transcriptional activity. FHL2 enhanced the interaction of FOXO1 and SIRT1",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Mar 9 24(5) 1021-32",
                "id": "15692560"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081611"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "We found that Foxo1 increased the expression of CCAAT/enhancer binding protein (C/EBPbeta, a positive regulator of monocyte chemoattractant protein (MCP)-1 and interleukin (IL)-6 genes, through directly binding to its promoter. Furthermore, knockdown of Foxo1 as well as C/EBPbeta inhibits TNF-alpha-induced expression of MCP-1 and IL-6 in 3T3-L1 adipocytes. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2009 Jan 9 378(2) 290-5",
                "id": "19026986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408160f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The repressive action of insulin on FoxO1 is mediated by phosphorylation at S319 and S499 in mouse FoxO1 (Perrot and Rechler, 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2276-88",
                "id": "18391970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081600"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "FKHR is phosphorylated by protein kinase B (PKB) at Thr24, Ser256 and Ser319 in response to growth factors, stimulating the nuclear exit and inactivation of this transcription factor.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 May 1 21(9) 2263-71",
                "id": "11980723"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "When FOXO1A was overexpressed in human endometrial stromal cells, expression of IGFBP1, DCN, and PRL increased, whereas levels of TIMP3 and CNR1 decreased",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2006 Aug 147(8) 3870-6",
                "id": "16690806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "expression of a Foxo1- responsive reporter gene increased up to twofold in cells treated with high glucose or with H2O2 (but not with mannitol) in a time-dependent manner (Fig. 2C).",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2009 Oct 58(10) 2344-54",
                "id": "19584310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Lipoprotein lipase (LPL) plays a role in lipid usage in skeletal muscle by hydrolyzing plasma triglycerides into fatty acids, which are further utilized for beta-oxidation. Lipid usage is stimulated during fasting, diabetes mellitus and exercise, concomitant with enhanced LPL expression in skeletal muscle. Here we show that the forkhead type transcription factor FKHR is strongly induced in skeletal muscle in fasting mice, in mice with streptozotocin-induced diabetes and in mice after treadmill running. Ectopic expression of FKHR enhanced LPL gene expression in C2C12 muscle cells in culture. These results implicate FKHR as an important modulator of lipid metabolism in skeletal muscle.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Feb 11 536(1-3) 232-6",
                "id": "12586369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815de"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Western blot analysis revealed that FOXO1a accumulated preferentially in the nucleus upon ROS stimuli, resulting in the transactivation of IRS promoter activity driven by H(2)O(2)-activated FOXO1a.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2008 Jan 15 281(1-2) 47-55",
                "id": "18035477"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408186a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The enhanced FA utilization induced by FoxO1 was mediated by a severalfold increase in plasma membrane level of the fatty acid translocase FAT/CD36 and eliminated by cell treatment with the CD36 inhibitor sulfo-N-succinimidyl-oleate.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 8 280(14) 14222-9",
                "id": "15691844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408185c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "FoxO1a and FoxO3a correlated with the expression of the pro-apoptotic FoxO target Bim, which was associated with paclitaxel-induced apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3",
                "id": "14527951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081855"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2002 Dec 110(12) 1839-47",
                "id": "12488434"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081850"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 28 279(22) 23158-65",
                "id": "15047713"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081847"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Akt has been well characterized as a prosurvival molecule, and part of this function is mediated through its suppression of the activity of the FoxO proteins (Greer and Brunet, 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2006 Oct 6 127(1) 125-37",
                "id": "16962653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081846"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "engagement of CC chemokine receptor 9 (CCR9) with thymus-expressed CC chemokine leads to phosphorylation of AKT, GSK3 and FKHR, thereby blocking CHX induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408181d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 7 277(23) 20825-32",
                "id": "11893744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408181b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Reporter assays demonstrated that the promoter activity of phosphoenolpyruvate carboxykinase and fructose 1,6-bis phosphatase via hepatocyte nuclear factor 4, or that of G6Pase via the forkhead transcription factor Foxo1, was down-regulated by treatment with chenodeoxicholic acid and with transfected SHP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 28 279(22) 23158-65",
                "id": "15047713"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081817"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2001 Sep 3 154(5) 995-1005",
                "id": "11524433"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081813"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Reporter assays demonstrated that the overexpression of FKHR stimulated ALP promoter activity through the forkhead response element in its promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2002 Feb 9(2) 147-52",
                "id": "11786925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408180d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "TABLE II - Gene with decreased expression in the skeletal muscle of FOXO1 mice",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 24 279(39) 41114-23",
                "id": "15272020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408180a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "adenoviral overexpression of FKHRL1 and FKHR in the LAPC4 prostate cancer cell line resulted in apoptosis and induced the expression of many genes The following comes from Table I.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47928-37",
                "id": "12351634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081801"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Disinhibition of the forkhead transcription factor FoxO1, increases expression of the biliary cholesterol transporters Abcg5 and Abcg8, resulting in an increase in biliary cholesterol secretion. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2008 Jul 14(7) 778-82",
                "id": "18587407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817f6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "forced expression of FOXO1 causes a delay in the transition from G2 to M phase. This effect is blocked completely by overexpression of CDK1 and cyclin B1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 14",
                "id": "18408765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "hyperglycemia suppresses MafA expression in vivo and that MafA inhibition can be prevented by transgenic expression of constitutively nuclear FoxO1 in beta cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Metab 2005 Sep 2(3) 153-63",
                "id": "16154098"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817f0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45485-45491",
                "id": "12966085"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Foxa1 was shown to be an essential activator of glucagon gene expression in vivo. An additional winged-helix protein, Foxo1, contributes to pancreatic beta-cell function by regulating the Pdx1 gene",
              "citation": {
                "type": "PubMed",
                "name": "Clin Sci (Lond) 2005 Mar 108(3) 195-204",
                "id": "15631623"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817e2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Mar 52(3) 642-9",
                "id": "12606503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Infection with the adenoviral constitutively active forkhead box-containing protein, O subfamily (FOXO)1 mutant suppressed induction of cyclin D2, aromatase, inhibin-alpha, SF-1, and epiregulin. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 11 280(10) 9135-48",
                "id": "15613482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817bd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Table 4. Neurotransmitter receptors and monoamine synthetic pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 15",
                "id": "17107961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817b0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Table 1 - Selected list of transcription factors for which PGC-1a functions as a coactivator",
              "citation": {
                "type": "PubMed",
                "name": "Adv Physiol Educ 2006 Dec 30(4) 145-51",
                "id": "17108241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 4 278(14) 12361-6",
                "id": "12517744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817a8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Jun 8 19(25) 2921-9",
                "id": "10871843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "adenoviral overexpression of FKHRL1 and FKHR in the LAPC4 prostate cancer cell line resulted in apoptosis and induced the expression of many genes The following comes from Table I.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47928-37",
                "id": "12351634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The phosphorylation of FOXO1 at Ser249 disrupted FOXO1 binding with 14-3-3 proteins and thereby promoted the nuclear accumulation of FOXO1 and stimulated FOXO1-dependent transcription,",
              "citation": {
                "type": "PubMed",
                "name": "Science 2008 Mar 21 319(5870) 1665-8",
                "id": "18356527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408179f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "when PTEN is exogenously expressed, FOXO1 relocates to the nucleus and restores transcriptional activation (Nakamura et al., 2000).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2312-9",
                "id": "18391973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408179e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Furthermore, elevated Foxo1 production in liver augmented hepatic apoC-III expression, resulting in increased plasma triglyceride levels",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Nov 114(10) 1493-503",
                "id": "15546000"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408179d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The putative transcriptional activators of PDK isozymes, peroxisome proliferator-activated receptor-alpha (PPAR-alpha) protein, and forkhead homolog in rhabdomyosarcoma (FKHR) mRNA were also measured.",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2004 Jun 96(6) 2082-7",
                "id": "14966024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081790"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "% Adenoviral-mediated overexpression of forkhead transcription factor Foxo1 increased angptl4 mRNA expression,",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Sep 8 347(4) 1138-44",
                "id": "16870142"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081787"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2002 Dec 110(12) 1839-47",
                "id": "12488434"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408177f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "SIRT1 increases adiponectin transcription in adipocytes by activating Foxo1 and enhancing Foxo1 and C/EBPa interaction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 6",
                "id": "17090532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408177a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "A subset of FOXO genes has been associated with disorders like tumorogenesis and rhabdomyosarcomas.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 19 278(38) 35959-67",
                "id": "12857750"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081779"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 2 279(1) 133-41",
                "id": "14565960"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081771"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 11 100(23) 13519-24",
                "id": "14597716"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081764"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Mar 3 22(5) 1147-57",
                "id": "12606579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081760"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "IGF-1 treatment decreased GSTFKHR-stimulated transcription by 60%and, in agreement with our previous results in HepG2 cells [18], this effect was blocked by an inhibitor of PI 3-kinase (LY 294002),",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2001 Mar 15 354(Pt 3) 605-12",
                "id": "11237865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081759"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "We found that the phosphorylation of Ser-256 and introduction of a negative charge at this site (by replacing Ser-256 with an aspartate) also inhibits transactivation by FKHR, even when the phosphorylation of Thr-24 and Ser-319 has been prevented by replacing these residues with alanine.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 22 277(47) 45276-84",
                "id": "12228231"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081745"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Fig. 1.  TNF stimulates activation of FOXO1 in vitro. Adult human dermal fibroblasts were stimulated with TNF-? (20 ng/ml) for 06 h. After nuclear extraction, activation of FOXO1 or NF?B was measured by EMSA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 1 280(13) 12096-102",
                "id": "15632117"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081743"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Reporter assays demonstrated that the overexpression of FKHR stimulated ALP promoter activity through the forkhead response element in its promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2002 Feb 9(2) 147-52",
                "id": "11786925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081740"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Forkhead (FKHR) recognizes IRS sequences, is phosphorylated in response to insulin, and mediates insulin inhibition of basal IGFBP-1 transcription in an IRS-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 7 276(36) 33705-10",
                "id": "11445561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408173c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "FKHR augmented ER alpha transactivation through an estrogen response element. Conversely, ER alpha repressed FKHR-mediated transactivation through an insulin response sequence, and cell cycle arrest induced by FKHRL1 in MCF7 cells was abrogated by estradiol. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 7 276(36) 33554-60",
                "id": "11435445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081733"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "FoxO1 acetylation also enhances the phosphorylation at S253 by Akt, which further decreases DNA binding (Matsuzaki et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2276-88",
                "id": "18391970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081727"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Moreover, expression of a constitutively active form of FoxO1 increased myostatin mRNA ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C188-99",
                "id": "16885393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081724"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "In beta cell, FoxO1 regulates Pdx1 expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes Metab J 2011 Feb 35(1) 65-71",
                "id": "21537415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081723"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Expression of glucose-6-phosphatase (G6Pase), one of the rate-limiting enzymes of hepatic gluconeogenesis, has recently been shown to be transactivated by the transcription factor FKHR.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Jan 17 300(3) 764-9",
                "id": "12507516"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408171e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The FOXO1 is inactivated by Akt through direct phosphorylation, resulting in translocation to the cytoplasm and degradation by proteosomes (23,24). Akt-induced inactivation of Foxo1 results in transcriptional inhibition of the p27Kip1 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Feb 55(2) 318-25",
                "id": "16443763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081719"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Table I. FKHR activation augments the expresson of genes involved in myotube fusion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Mar 3 22(5) 1147-57",
                "id": "12606579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816e9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "the repression is mediated through protein-protein interaction between FKHR and the androgen receptor activated androgen receptor blocked FKHR's DNA binding activity and impaired its ability to induce Fas ligand expression and prostate cancer cell apoptosis and cell cycle arrest",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jan 23(1) 104-18",
                "id": "12482965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "the human P6Pase promoter contains 3 well characterized FOXO1-binding sites",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Apr 1 100(7) 4012-7",
                "id": "12651943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816da"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The data revealed the existence of a novel set of VEGF-responsive genes that require FKHR activity for optimal expression in ECs, including bone morphogenic protein 2, cbp/p300-interacting transactivator 2, decay accelerating factor (DAF), vascular cell adhesion molecule-1 (VCAM-1), manganese superoxide dismutase, endothelial-specific molecule-1, RING1 and YY1 binding protein, and matrix metalloproteinase-10 and MGC5618",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 15",
                "id": "16980307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Table 1 FROM SUPPLEMENT captures information from the abstract.  Table 1. Gene list of the 50 most induced and 50 most repressed genes upon decidualization ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2007 Jul 3",
                "id": "17609436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "endometrium"
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "It was recently shown that a constitutively active form of the forkhead transcription factor FOXO1 inhibits the induction of PPARgamma expression and adipocyte differentiation in culture (Nakae et al. 2003 )",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jun 1 17(11) 1352-65",
                "id": "12782654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "VEGF transiently phosphorylates and inhibits the activity of forkhead transcription factors, resulting in decreased expression of forkhead target genes, such as the cell-cycle inhibitor, p27kip1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 15",
                "id": "16980307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "coronary artery endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 14 278(7) 5242-9",
                "id": "12456685"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Supplemental Table S4. Transcripts found in Class III\t[transcriptional downregulation]",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2002 Jul 2(1) 81-91",
                "id": "12150827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408169d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "The forkhead transcription factor FoxO1 has been identified as a negative regulator of insulin/IGF-1 signaling. Expression of a 3A/LXXAA mutant, in which 3 Akt phosphorylation sites (T24, S253, and S316) and 2 leucine residues in the LXXLL motif (L462 and L463) were replaced by alanine, decreased both Igfbp-1 and G6Pase promoter activity and endogenous Igfbp-1 and G6Pase gene expression in simian virus 40-transformed (SV40-transformed) hepatocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2006 Sep 116(9) 2473-83",
                "id": "16917544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408169c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Fig. 2.  TNF stimulates Activation of FOXO1 in vivo. FOXO1 activation was measured by EMSA in nuclear extracts of the scalp of mice 1 h following TNF injection. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 1 280(13) 12096-102",
                "id": "15632117"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081683"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Interestingly, SIRT1, a mammalian homolog of yeast Sir2, bound to and deacetylated FOXO1 and inhibited its transcriptional activity. FHL2 enhanced the interaction of FOXO1 and SIRT1",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Mar 9 24(5) 1021-32",
                "id": "15692560"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081678"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408162d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "p27Kip1, a pro-apoptotic factor whose transcription is enhanced by FKHR.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 24 278(43) 41756-67",
                "id": "12904304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO1) actsIn tscript(p(HGNC:FOXO1))",
              "summary_text": "from full text - we found that in turn, ectopic expression of WT and Foxo1 mutants in primary cultures of rat hepatocytes increased the phosphorylation of ERK1/2, JNK1/2, and p38",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2007 Feb 15",
                "id": "17303659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815ef"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:SMAD2)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:SMAD2))",
        "directed": false,
        "label": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053966",
          "evidences": [
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "from Figure 1 - Fig 1. The transforming growth factor beta (TGF-b) signaling pathway. TGF-b binds type II TGF-b receptor (TbRII), directly or through TbRIII, inducing association of TbRII with TbRI. TbRII then phosphorylates and activates TbRI, which then phosphorylates Smad2 or Smad3. Phosphorylated Smad2 or Smad3 associates with Smad4 and they translocate into the nucleus, where they activate transcription of target genes. Smad7 inhibits TGF-b signaling by preventing the activation of Smad2 or Smad3 by TbRI.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Mar 20 23(9) 2078-93",
                "id": "15774796"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081872"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "We also compared the effects of TGF-??1 on myofibroblast differentiation and on type I collagen expression in a murine lung fibroblast cell line (MLg2908). TGF-??1 induced rapid expression of p-Smad2/3 in nuclei, after which ASMA organization in the cytoplasm of fibroblasts was observed. However, TGF-??1 produced no effect on the quantity of ASMA, either in mRNA levels or protein levels, even after the phosphorylation of Smad2/3. In contrast, TGF-??1 upregulated the expression of type I collagen mRNA. ",
              "citation": {
                "type": "PubMed",
                "name": "J Nihon Med Sch 2012 79(1) 46-59",
                "id": "22398790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081859"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "In this study, we generated T cell-specific Smad2 conditional knockout (KO) mice and unexpectedly found that Smad2 and Smad3 were redundantly essential for TGF-beta-mediated induction of Foxp3-expressing regulatory T cells and suppression of IFN-gamma production in CD4(+) T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 15 185(2) 842-55",
                "id": "20548029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408184e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "This analysis demonstrated that Smad2 ablation but not ERK inactivation was on average associated with hyperresponsiveness and or extended activation of Smad3-dependent IEGs (Fig. 2 a and b). In fact, some IEGs (Smoc1 and Tnfrsf1b) were significantly activated only in Smad2KO cells (Table 1), and none of the IEGs (except for expressed sequence R75030) was significantly reduced in Smad2KO compared with WT fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Sep 2 100(18) 10269-74",
                "id": "12930890"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081840"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "TGF-beta1 (1 ng/ml) significantly upregulated SMAD phosphorylation in COPD ASMC following 2-h stimulation (P < 0.05; n = 5; Fig. 4A); however, the differences were not significant for other ASMC types.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2012 Feb 1 302(3) L325-33",
                "id": "22003087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081802"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Here we provide evidence that TGFbeta signalling prevents recruitment of Myc to the p15INK4b transcriptional initiator by Myc-interacting zinc-finger protein 1 (Miz-1). This relieves repression and enables transcriptional activation by a TGFbeta-induced Smad protein complex that recognizes an upstream p15INK4b promoter region and contacts Miz-1. (from Weinberg - Pathways in Human Cancer poster, SMAD = SMAD 2/3) (MIZ-1 = ZBTB17)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Apr 3(4) 400-8",
                "id": "11283614"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "In the nucleus, SKI proteins repress SMAD ability to transactivate TGF-? target genes by disrupting active heteromeric complexes of SMAD2 or SMAD3 with SMAD4, by recruiting a transcriptional repressor complex containing N-CoR SMRT, Sin3A, and HDAC-1, and by blocking the binding of transcriptional coactivators . ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2011 10(1) 2",
                "id": "21211030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Simplified schematic drawing of the TGF-?-Smad pathway. Binding of TGF-? to its type II receptor in concert with the type I receptor (A) leads to formation of a receptor complex and phosphorylation of the type I receptor. The type I receptor subsequently phosphorylates Smad2 or 3 (B), allowing this complex to associate with Smad4 and move into the nucleus (C). In the nucleus, the Smad complex associates with a transcription factor and this complex binds to specific enhancers in target genes (down-) regulating transcription (D). TNF is able to interfere with TGF-? signaling through the upregulation of the inhibitory Smad7 protein (E). Smad7 is capable of inhibiting the Smad2 and 3 phosphorylating process by competing with the receptor interaction but Smad7 also can dephosphorylate the complex. In addition, Smad7 itself is capable to upregulate TGF? gene expression. As described in the discussion, CSE is most likely capable to interfere with the Smad pathway although this is not yet fully elucidated. (F). Phosphorylated Smad3 is able to stimulate the transcription of the decorin gene (G).",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2008 9 83",
                "id": "19087346"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "In this study, we demonstrate that p15(Ink4B) induction was mediated by a TGF-beta-induced complex of Smad2, Smad3, Smad4 and Sp1.. Smad3 interacted indirectly with Sp1 through its association with Smad2 and/or Smad4, and bound directly to the p15(Ink4B) promoter.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2000 Oct 2 19(19) 5178-93",
                "id": "11013220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081750"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Finally, SPARC and SPARC-EC stimulated TGF-beta-responsive reporter gene expression through a TGF-beta receptor- and Smad2/3-dependent pathway in Mv1Lu cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Oct 14(10) 3977-88",
                "id": "14517312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408174c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "the SGK promoter contains consensus DNA elements for Smad and Fast-1 binding (hatched boxes labeled SMAD 3/4 and Fast-1 in figure 2) that are activated by TGF-beta receptor signaling, This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants encoding the same protein have been observed.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2003 13(1) 1-12",
                "id": "12649597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408173e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Jul 1 175(1) 547-54",
                "id": "15972691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081730"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "As shown in Figures 12 and 13, both Smad2/3 phosphorylation (p-Smad2/3) and nuclear translocation were markedly increased in the UUO kidney in both WT and KO mice at day 5 and day 10. Importantly, deletion of ROCK1 significantly enhanced further phosphorylation levels of p-Smad2/3 (Figure 12) and p-Smad2/3 nuclear translocation within the diseased kidney at day 5 and day 10 after UUO (Figure 13), demonstrating that deletion of ROCK1 enhanced Smad signaling in the obstructed kidney.",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2006 Nov 17(11) 3105-14",
                "id": "17005937"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816fc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Dominant negative RhoA blocked nuclear translocation of Smad2 and Smad3 because of the inhibition of phosphorylation of both Smads and inhibited Smad-dependent SBE promoter activity, whereas constitutively active RhoA significantly enhanced SBE promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 20 281(3) 1765-70",
                "id": "16317010"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816f2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "neural crest"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Transient transfection with Smad7, which interferes with receptor-mediated activation of Smad2, diminished Ang II-induced connective tissue growth factor promoter activation, gene and protein expression and fibronectin, type I procollagen and type III procollagen overexpression,",
              "citation": {
                "type": "PubMed",
                "name": "Exp Dermatol 2009 Nov 18(11) 947-53",
                "id": "19397700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Surprisingly, Smad2/3-dependent Mad1 induction and keratinocyte differentiation are independent of Smad4, the almost universal coregulator of canonical TGFbeta signaling. IKKalpha also is needed for nuclear accumulation of activated Smad2/3 in the epidermis, and Smad2/3 are required for epidermal differentiation",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2008 Feb 11",
                "id": "18268325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "TGF-beta led to activation of Smad2/3, p38, p42/44, and c-Jun NH2-terminal kinase (JNK) pathways, assessed by phosphorylation, immunofluorescence, and reporter gene analysis. TGF-beta-dependent growth inhibition was specifically attenuated by pharmacological blockade of the TGF-beta type I receptor (TbetaRI) kinase or p38 mitogen-activated protein kinase pathways, whereas blockade of p42/44 or JNK kinases did not influence the effect of TGF-beta. TbetaRI kinase inhibition blocked all downstream pathways including Smad and p38 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2005 Dec 315(3) 1005-12",
                "id": "16120811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Although short-term exposure to CINC-2 and ICAM did not induce ERK or Smad2 activation (data not shown), both cytokines induced sustained ERK and Smad2 phosphorylation after 24 hours of treatment (Figure 4C). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2011 Dec 45(6) 1212-21",
                "id": "21700959"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816a2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "By RT-PCR we have shown that TGFbeta up-regulates expression not only of plasminogen activator inhibitor type-1 (PAI-1), but also of the urokinase-type plasminogen activator receptor (uPAR), whose inhibition by specific antibodies blunted the TGFbeta angiogenic response in vitro. The SMAD2/3 and FAK signaling pathways were activated by TGFbeta in MVEC",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2009 Mar 1 77(5) 813-25",
                "id": "19041849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081688"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Phosphorylation of the C-terminal serine residues in R-Smads by type I receptor kinases is a crucial step in TGF-b family signalling (Abdollah et al., 1997; Macias-Silva et al., 1996; Souchelnytskyi et al., 1997). The two most C-terminal serine residues become phosphorylated and, together with a third, non-phosphorylated serine residue, form an evolutionarily conserved SSXS motif in all R-Smads.... TGF-b and activin receptors phosphorylate Smad2 and Smad3, and BMP receptors phosphorylate Smad1, Smad5 and Smad8 (Chen et al., 1998) (Fig. 1). The consequence of R-Smad phosphorylation is the formation of oligomeric complexes with the Co-Smad, Smad4.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2001 Dec 114(Pt 24) 4359-69",
                "id": "11792802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081679"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "The functional relevance of Sp1/Smad2 interaction was confirmed by transient transfection experiments, which showed that overexpression of Smad2 increased vascular endothelial growth factor promoter activity and endogenous vascular endothelial growth factor protein expression, whereas dominant negative Smad2 blocked activin A responsiveness.",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2004 Jun 126(7) 1828-43",
                "id": "15188178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081671"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Overexpression of Nodal in normal trophoblast cells (HTR8/SVneo) and several choriocarcinoma cell lines resulted in a significant decrease in the number of metabolically active cells. The effect of Nodal could be mimicked by constitutively active ALK7 (ALK7-ca), but was blocked by kinase-deficient ALK7. The growth inhibitory effect of Nodal was also blocked by dominant-negative Smad2/3. Overexpression of Nodal and ALK7-ca induced apoptosis in trophoblast cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31277-86",
                "id": "15150278"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408166e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Overexpression of Jab1/CSN5 increases Smad2 phosphorylation and enhances TGF-beta-induced transcriptional activity. The inhibition of endogenous Jab1/CSN5 expression by small interfering RNA (siRNA) induces Smad7 expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Mar 24(6) 2251-62",
                "id": "14993265"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081668"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Furthermore, acute and long-term pretreatment of ECs with thrombin or PAR1 peptide agonist suppressed the TGF-beta-induced serine phosphorylation of Smad2, a critical mediator of TGF-beta signaling. Moreover, activation of PAR1 led to a profound and spread cytosolic clustering formation of Smad2/3 and markedly prevented Smad2/3 nuclear translocation evoked by TGF-beta1.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Mar 1 105(5) 1977-85",
                "id": "15522964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081662"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Here we report that Smad-TGF-beta-dependent transcriptional responses are prevented by expression of a constitutively activated Ca(2+)-calmodulin-dependent protein kinase II (Cam kinase II). Smad2 is a target substrate for Cam kinase II in vitro at serine-110, -240, and -260.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Nov 20(21) 8103-11",
                "id": "11027280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081646"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "In addition, overexpression of Smad2 or Smad3, major signal transducing Smads, was sufficient to inhibite the IFN-gamma and TNF-alpha-induced TARC production in HaCaT cells",
              "citation": {
                "type": "PubMed",
                "name": "J Dermatol Sci 2003 Feb 31(1) 53-8",
                "id": "12615364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081633"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "p-Smad2/3 and Smad4 protein in murine lung fibroblasts induced by TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2006 7 16",
                "id": "16438734"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408162b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "from full text - Smad2 and Smad3 are bound to SARA (SMAD anchor for receptor activation) in the cytoplasm (Tsukazaki et al., 1998) which presents Smad2 and Smad3 to the activated TGF-b receptor complex. TbRI then directly phosphorylates the carboxy terminal of Smad2 and Smad3, resulting in decreased affinity to SARA and heterotrimerization of Smad2 and Smad3 with Smad4  (SARA = ZFYVE9)   ",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem Mol Biol 2005 Jan 31 38(1) 1-8",
                "id": "15715939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081626"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "\\\"TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Oct 31 272(44) 27678-85",
                "id": "9346908"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408161d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "P/CAF potentiated the transcriptional activity of heterologous Gal4-Smad2 and Gal4-Smad3 fusion proteins. In addition, P/CAF potentiated the TGF-beta/Smad3-induced transcriptional responses, which could be further enhanced by co-activators p300 and Smad4.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2000 Nov 1 28(21) 4291-8",
                "id": "11058129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081615"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Analysis of the downstream signaling pathways shows that Smad2/3 are crucial for efficient FGF-BP1 repression by TGF-beta.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jun 30 345(2) 595-601",
                "id": "16690027"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081610"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Lo and Massagu1 found that the ubiquitination of Smad2 was achieved by certain E2 enzymes, including UbcH5b or UbcH5c and, to a lesser extent, Ubc3, but not by others, such as E2-20K.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 1999 Dec 1(8) E195-7",
                "id": "10587654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081603"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "YY1 interacts with the conserved N-terminal Mad homology 1 domain of Smad4 and to a lesser extent with Smad1, Smad2, and Smad3. The YY1 zinc finger domain mediates the association with Smads and is necessary for the repressive effect of YY1 on Smad transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jul 23(13) 4494-510",
                "id": "12808092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Figure 5 Caveolin-1 inhibits base-line and TGF -beta1-stimulated phosphorylation of the receptor-linked SMAD (SMAD2). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 2 276(9) 6727-38",
                "id": "11102446"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815eb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "TGFbeta markedly and specifically decreases both mRNA and protein levels of a HIF-1alpha-associated prolyl hydroxylase (PHD), PHD2, through the Smad signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Aug 25 281(34) 24171-81",
                "id": "16815840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815e4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Foxh1 and Smads bind the Mixl1 promoter and mediate the TGFbeta-dependent induction of Mixl1. (A, C, F, G, I) HepG2 cells were transiently transfected with the Mixl1-luc reporter, Foxh1 and Smads (S2, S3, S4), Cripto, ActRIB or ActRII, as indicated. Error bars represent standard deviation of the mean. (B, D, E, H) EMSA. A 248-bp Mixl1 promoter fragment containing a wild-type or mutated Foxh1-binding site was incubated with bacterially expressed proteins (B, E) or crude extracts from COS-1 cells transiently transfected with the indicated DNA (D, H). Protein?DNA complexes were visualized by autoradiography. For supershift assays (D, H), anti-myc (M), anti-Flag (F), and anti-Smad4 (S4) antibodies were added to the reactions.Co-expression of Foxh1 with the Mixl1-luc reporter yielded strong TGFbeta-dependent activation of the Mixl1-luc reporter (Figure 1A). Direct binding of Foxh1 to the Mixl1 promoter fragment was confirmed by electrophoretic mobility shift assays (EMSA) using bacterially expressed Foxh1 (Figure 1B). Moreover, Smad2 and Smad4 enhanced both the basal and TGFbeta-induced Foxh1-dependent activation of the Mixl1-luc reporter (Figure 1C).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2007 Jul 11 26(13) 3132-43",
                "id": "17568773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Activin signals through a pathway that involves the activation of the transcriptional coregulators Smad2 and Smad3",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2005 Jul 19(7) 1849-58",
                "id": "15761025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815d7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "c-Jun NH(2)-terminal kinase tended to induce the phosphorylation of Smad2/3L in human colorectal adenoma-carcinoma sequence (phosphorylation increases formation of SMAD234 complex)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jan 1 65(1) 157-65",
                "id": "15665291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081875"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "TGF? binds to TGF? receptor II on T cells, which leads to the recruitment of TGF? receptor I to the complex and activation of cytoplasmic transcription factors SMAD2 and SMAD3. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Sep 17 285(38) 29044-8",
                "id": "20656683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081870"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "TGF-beta phosphorylation of Smad2/3, an obligatory step of intracellular TGF-beta signaling, was also suppressed by VEGF. VEGF attenuation of TGF-beta action was also demonstrated in two other endothelial cell lines. In conclusion, VEGF attenuates TGF-beta action in the human endothelial cell, specifically at the level of transcription of PAI-1 gene and Smad2/3 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 31 279(53) 55104-8",
                "id": "15494412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408186e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Fig. 8. TGF-beta1-induced SMAD2/3 activation and nuclear accumulation is suppressed by inhibition of Rho/ROCK signaling. ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2008 Mar 44(3) 527-38",
                "id": "18255094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408186c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2005 Feb 15 65(3) 599-608",
                "id": "15664386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081869"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28458-65",
                "id": "15107418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081864"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "We now identify SARA (for Smad anchor for receptor activation), a FYVE domain protein that interacts directly with Smad2 and Smad3.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1998 Dec 11 95(6) 779-91",
                "id": "9865696"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408185a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Ras acting via Erk MAP kinases causes phosphorylation of Smad2 and Smad3 at specific sites in the region linking the DNA-binding domain and the transcriptional activation domain.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081852"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Ha-Ras stimulation of the canonical Smad2/3 signalling pathway independently of TGFbeta production or activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Fibrogenesis Tissue Repair 2011 4(1) 8",
                "id": "21362163"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408184d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 31 278(5) 3275-85",
                "id": "12421823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408183b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2001 Apr 59(4) 716-24",
                "id": "11259615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408183a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Feb 5 23(5) 1043-51",
                "id": "14762439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081835"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "TGZ inhibited TGFbeta2-induced early Smad2 and Smad3 and late Smad3 phosphorylation but had no influence on TGFbeta2-induced p38 MAPK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Vis 2008 14 95-104",
                "id": "18253093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408182c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "retinal epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "We show here that SMAD2 is essential for Th17 cell differentiation and that it acts in part by modulating the expression of IL-6R on T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Sep 17 285(38) 29044-8",
                "id": "20656683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081821"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th17 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "In our previous studies we have shown that both Smad2 and p38 MAPK were activated in human lung fibroblasts within 10 min of TGF1 stimulation, and peak activation was reached at 1 h (19).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 May 9 283(19) 12898-908",
                "id": "18353785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408181e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "In eNOS-/- mice, the Ang II-induced cardiac oxidative stress and TGF-beta-Smad 2/3 signaling pathway were enhanced, and pitavastatin treatment attenuated the enhanced oxidative stress and the signaling pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Jan 4 102(1) 68-76",
                "id": "17967781"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408181c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "An approximately 2.5-fold increase of Smad2 phosphorylation at Ser 465/467 was also detected in LDLR expressing, LRP1-deficient SMCs (Figure 6B, C).",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2009 4(9) e6922",
                "id": "19742316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081818"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408180e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Contrary to expectations, BMP9 also stimulated Smad2 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jun 5 284(23) 15794-804",
                "id": "19366699"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081809"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Smad7 expression inhibited both Smad2- and Smad3-mediated TGF-beta signaling in podocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2002 Nov 13(11) 2657-66",
                "id": "12397035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081808"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "podocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Increased Smad DNA binding was noted in SK-N-SH human neuroblastoma cells when treated with LY294002, an inhibitor of PI3-K, by transcription factor/DNA array analysis and electrophoretic mobility shift assay.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2006 Jan 18",
                "id": "16412560"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081800"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Treatment with TGF-beta and/or overexpression of SMAD2, -3, or -4 also resulted in a significant increase in myostatin promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C188-99",
                "id": "16885393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "\\\"Inhibition of transforming growth factor-beta/Smad signaling by phosphatidylinositol 3-kinase pathway.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2006 Jan 18",
                "id": "16412560"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "FIGURE 11. TGF-beta1 induces activation of Smad2/3 pathway in AML12 cell line",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 27 282(30) 22089-101",
                "id": "17513865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817fb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Pharmacological inhibitors and specific siRNA knockdown experiments demonstrate that the TGF-beta1 type 1 receptor (TbetaRI/ALK5), Smad2/3, and Smad4 are essential for TGF-beta1-stimulated hAT(1)R expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 Sep 293(3) L790-9",
                "id": "17601799"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "We observed that transfection of Epac1 in the Mv1Lu cells inhibited TGFbeta/TbetaRI-dependent phosphorylation of Smad2 (Figure 6A).",
              "citation": {
                "type": "PubMed",
                "name": "J Proteome Res 2007 Jan 6(1) 287-97",
                "id": "17203972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817d0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Erbin does not affect the level of TGFbeta-induced phosphorylation of Smad2/3, but physically sequesters Smad2/3 from their association with Smad4 and hence negatively modulates TGFbeta-dependent transcriptional responses and cell growth inhibition. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Jun 25",
                "id": "17591701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Smad7 was recently shown to antagonize TGF-beta-induced activation of signal-transducing Smad2 and Smad3 proteins",
              "citation": {
                "type": "PubMed",
                "name": "Mech Dev 2000 May 93(1-2) 71-81",
                "id": "10781941"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Expression of activated ALK7 in PC12 cells resulted in activation of Smad2 and Smad3, but not Smad1, as well as the mitogen-activated protein kinases extracellular signal-regulated kinase and c-Jun N-terminal kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 5140-6",
                "id": "11084022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ba"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "In HPASMC, we (61) have shown that the TGF-1-induced increase in Nox4 transcripts is inhibited by transfection of expression plasmids containing constructs for dominant negative Smads 2 and 3.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 Jun 292(6) L1543-55",
                "id": "17369289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Here we report that oncogenic Ras inhibits TGFbeta signaling in mammary and lung epithelial cells by negatively regulating the TGFbeta mediators Smad2 and Smad3.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14466-73",
                "id": "11278290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081796"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "SMAD2 phosphorylation, a downstream signaling target of TGF-b1, was shown to be significantly increased following Wnt3a treatment (Figure 4B). ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(5) e19809",
                "id": "21611174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081793"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Phosphorylated Smad2 increase CAGA-box binding activity and up-regulate Smad7 mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 22 275(38) 29308-17",
                "id": "10887185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081788"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "We demonstrate that Smad2-mediated transcription requires the histone acetyltransferase, p300. Smad2-recruited p300 exhibits an altered substrate specificity, specifically acetylating nucleosomal histone H3 at lysines 9 and 18, and these modifications are also detected on an endogenous Smad2-dependent promoter in a ligand-induced manner.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 4 25(19) 4490-502",
                "id": "16990801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408177d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "The changes in glucocorticoid binding were associated with identical changes in GR protein and mRNA levels Functional inactivation of Smad 2/3 and AP-1 limited the response to TGF-beta 1, indicating a role for these transcription factors TGF-beta 1 increases glucocorticoid binding and signaling in inflammatory cells through a Smad 2/3- and AP-1-mediated process",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int 2003 Jun 63(6) 2028-36",
                "id": "12753290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081774"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "ActRIIB and its subfamily receptor, ActRIIA, cooperatively mediate the Gdf11 signal in patterning the axial vertebrae, and that Gdf11 binds to both ActRIIA and ActRIIB, and induces phosphorylation of Smad2",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2002 Nov 1 16(21) 2749-54",
                "id": "12414726"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081768"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Western blotting revealed higher expression of phosphorylated SMAD2 in wt-ACVR2 transfectants versus controls, suggesting cells deficient in ACVR2 had impaired SMAD signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Nov 1 64(21) 7690-6",
                "id": "15520171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408175b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "c-Jun, which enhances the association of Smad2 with the nuclear transcriptional corepressor TG-interacting factor (TGIF), thereby interfering with the assembly of Smad2 and the coactivator p300 in response to TGF-beta signaling",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 May 22 98(11) 6198-203",
                "id": "11371641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081757"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "WtTGFbetaRIII inhibited phosphorylation of Smad 2 and 3 (Fig. 3A) as well as Akt and ERK by TGF-beta (Fig. 3B).",
              "citation": {
                "type": "PubMed",
                "name": "Biomed Pharmacother 2010 Sep 64(7) 472-6",
                "id": "20359848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081753"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "natural and recombinant IGFBP-3 stimulated the time- and dose-dependent phosphorylation of TGF-betaR1 as well as Smad2 and Smad3",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 1 277(9) 7255-61",
                "id": "11751851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081752"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Moreover, TGF-beta1-mediated induction of matrix metalloproteinase-2 was selectively dependent on Smad2,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 8 276(23) 19945-53",
                "id": "11262418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081748"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "TGFbeta stimulation triggers a transient increase in association of Dab2 with Smad2 and Smad3",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Jun 1 20(11) 2789-801",
                "id": "11387212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408172e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "AT1A-mediated activation of kidney JNK1 and SMAD2",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2004 Sep 287(3) F474-80",
                "id": "15126250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081718"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "BMC Neurosci 2004 Jan 13 5(1) 1",
                "id": "14720305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081717"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "c-Jun NH(2)-terminal kinase tended to induce the phosphorylation of Smad2/3L in human colorectal adenoma-carcinoma sequence (phosphorylation increases formation of SMAD234 complex)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jan 1 65(1) 157-65",
                "id": "15665291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081712"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "endoglin interferes with ALK-5 signaling through Smad2/3 which normally inhibits endothelial cell proliferation and migration.",
              "citation": {
                "type": "PubMed",
                "name": "Panminerva Med 2005 Sep 47(3) 169-86",
                "id": "16462725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ee"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Both SMAD2 and SMAD1/5 were activated upon exposure to TGF-beta1",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 May 296(5) L825-38",
                "id": "19270180"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Western blot analysis revealed that KLF2-transduced HUVECs contain lower levels of P-Smad2 and P-Smad3 compared with mock-transduced cells",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2007 Mar 27(3) 532-9",
                "id": "17194892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Blocking TGF-beta1 signaling pathway by knocking down Smad2 significantly blunted the aldosterone induced fibronectin production. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Sep 15 348(1) 70-5",
                "id": "16876110"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "BMP receptors activate Smad1, Smad5, and Smad8 (called BR-Smads in this review) whereas Smad2 and Smad3 are phosphorylated by the activin of Tgfbeta recepetors ALK3 and ALK6 can activate all three BR-Smads but ALK2 only phophorylates SMAD1 and SMAD5",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Jul 3 546(1) 133-9",
                "id": "12829249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "treatment with the ALK4/5 inhibitor SB431542 prevented phosphorylation of Smad2/3 and CTGF expression. Furthermore, production of collagen was also induced by activin A. Activin A-ACVRIB/ALK4-Smad-dependent collagen production was augmented in SSc fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Autoimmun 2011 May 36(3-4) 181-8",
                "id": "21377836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Treatment of differentiating cells with Activin A leads to activation of Smad2/3 and expression of nodal, lefty-A and lefty-B, while inhibition of ALK4/5/7 by the kinase inhibitor SB-431542 blocks activation of Smad2/3",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 22 279(43) 45076-84",
                "id": "15308665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "While Smad7 has no effect on TGF-beta-induced activation of p38 MAPK and ERK, it blocks the phosphorylation of Akt by TGF-beta and enhances TGF-beta-induced phosphorylation of c-Jun.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2005 Jul 1 307(1) 231-46",
                "id": "15922743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Tables 1,2, and 3 - Gene expression changes as a result of knockdown of SMAD2, SMAD3, or SMAD4 in the presence of TGFB1 in Hep3B cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 May 215(2) 422-33",
                "id": "17960585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Our data reveal that SMAD 2/3 signaling directly supports NANOG expression, while SMAD 1/5/8 activation moderately represses SOX2.",
              "citation": {
                "type": "PubMed",
                "name": "Stem Cells Dev 2008 Dec 17(6) 1065-77",
                "id": "18393632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Traumatic brain injury with a needle stab resulted in local activation of Smad2/3-dependent genes and a severalfold increase in bioluminescence in living mice",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Jul 1 175(1) 547-54",
                "id": "15972691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816a6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Mar 1 60(5) 1394-402",
                "id": "10728705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "ii) Smad2 positively cooperates with Smad4 to activate the promoter,(iii) activation of Smad4 by exogenous TGF-beta induces Smad4 binding to the promoter,",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jul 29 23(34) 5729-38",
                "id": "15184872"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081674"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2001 Aug 188(2) 264-73",
                "id": "11424093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081673"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "TbetaRI-phosphorylated Smad2",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2003 Oct 38(4) 879-89",
                "id": "14512875"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815e9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD2) actsIn tscript(p(HGNC:SMAD2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 22 277(12) 9870-9",
                "id": "11784716"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FOXO3)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:FOXO3))",
        "directed": false,
        "label": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053963",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "FKHR augmented ER alpha transactivation through an estrogen response element. Conversely, ER alpha repressed FKHR-mediated transactivation through an insulin response sequence, and cell cycle arrest induced by FKHRL1 in MCF7 cells was abrogated by estradiol. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 7 276(36) 33554-60",
                "id": "11435445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081860"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "As induction of p27 is due to an increase in gene transcription, we investigated the role of the Forkhead box O (FOXO) transcription factor family, which has been shown to potently induce p27 promoter activity. We demonstrate that pharmacologic inhibitors of PI3K or BCR engagement lead to decreased inactive cytoplasmic levels and increased active functional nuclear FOXO3a",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 May 1 172(9) 5522-7",
                "id": "15100294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081848"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "B cell lymphoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "(from text) The expression of the triple mutant FOXO3a (AAA), which is predominately nuclear, and treatment of LMB, which prevents nuclear export of FOXO3a, significantly decreased HIF-1 transcriptional activity in the LnCaP cells (Fig. 5Fig. 5. E and F)...FOXO3a coimmunoprecipitates with the HIF-1? protein complex in the presence of LMB (Fig. 6Fig. 6.A).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2008 Feb 19 105(7) 2622-7",
                "id": "18268343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081803"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "The treatment with 4-OHT induced expression of Bim and Puma in FOXO3(A3):ER-infected BMMCs but not in control cells (Figure 6C). This indicates that FOXO3a is involved not only in regulating the transcription of Bim, as previously described,26 but also identifies Puma as a FOXO3a downstream target in mast cells. The transcription factor FOXO3a has been shown to regulate the BH3-only protein Bim (Dijkers PF, Curr Biol. 2000) and also was recently described to control Puma expression in response to growth factor deprivation in lymphoid cells and mouse embryonic fibroblasts (You H,  J Exp Med. 2006)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Nov 1 110(9) 3209-17",
                "id": "17634411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817c9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "NF-{kappa}B primarily remained in the cytoplasm either in Ad-GFP or Ad-TM-FOXO3a transfected HUVECs (Figure 2B, upper panels). When stimulated with TNF-{alpha}, a well-known positive regulator of NF-{kappa}B, p65 still remained in the cytoplasm in FOXO3a-transduced ECs, whereas it was swiftly translocated into the nucleus in the control ECs (Figure 2B, lower panels). This suppression of NF-{kappa}B activation by FOXO3a was confirmed by electrophoretic mobility shift assay, which showed reduced nuclear translocation of NF-{kappa}B in TM-FOXO3a transduced HUVECs (supplemental Figure IIIB).",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2008 Jan 28(1) 112-20",
                "id": "18032780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "The forkhead box class O (FOXO) transcription factors family members, FOXO1a and FOXO3a, are phosphorylated in an AKT-dependent manner in SCF-stimulated BMMCs [76]. FOXO3a phosphorylation leads to its proteosomal degradation following ubiquitination thereby blocking its transcriptional control of the pro-apopototic factor, Bim. SCF also induces the AKT- and MAPK-dependent phosphorylation of Bim in mouse bone marrow-derived mast cells and it has been proposed that this also leads to its proteosomal degradation [76]. Thus these observations would account for the ablity of PI3K-AKT driven pathways to promote mast cell survival.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2008 Oct 29(10) 493-501",
                "id": "18775670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408177c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "FOXO3 upregulation of p27kip1 in A14 cells, mouse embryo fibroblasts, DLD-1 and 786-0 cells (Medema et al., 2000; Nakamura et al., 2000) results in a potent cell cycle arrest, it causes apoptosis in Ba/F3 cells (Dijkers et al., 2000).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2312-9",
                "id": "18391973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081729"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Following its dephosphorylation, FOXO3 translocates into the nucleus (Fig. 3A) and upregulates multiple autophagy-related genes such as ULK2, Beclin 1, VPS34, BNIP3 and BNIP3L, ATG12, ATG4B, LC3, and GABARAPL1 (Mammucari et al., 2007).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2010 Oct 22 40(2) 280-93",
                "id": "20965422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408171b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "While both kinases can phosphorylate Thr-32, SGK displays a marked preference for Ser-315 whereas Akt favors Ser-253.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(3) 952-65",
                "id": "11154281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "SIRT1 had a dual effect on FOXO3 function: SIRT1 increased FOXO3's ability to induce cell cycle arrest and resistance to oxidative stress but inhibited FOXO3's ability to induce cell death.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Mar 26 303(5666) 2011-5",
                "id": "14976264"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816e1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Whereas angiopoietin 2 (Ang2) was exclusively regulated by Foxo1, eNOS, which is essential for postnatal neovascularization, was regulated by Foxo1 and Foxo3a. Consistent with these findings, constitutively active Foxo1 and Foxo3a repressed eNOS protein expression and bound to the eNOS promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Sep 115(9) 2382-92",
                "id": "16100571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Here we show that Forkhead transcription factors FKHRL1 and FKHR, substrates of the Akt kinase, are aberrantly localized to the cytoplasm and cannot activate transcription in PTEN-deficient cells. Restoration of PTEN function restores FKHR to the nucleus and restores transcriptional activation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Dec 20(23) 8969-82",
                "id": "11073996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2010 Jul 5 207(7) 1381-91",
                "id": "20439537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816d9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "We show that BMPER is a downstream target of FoxO3a and consistently exerts activating effects on endothelial cell sprouting and migration in vitro and in vivo. Accordingly, when BMPER is depleted from endothelial cells, sprouting is impaired.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Oct 10 103(8) 804-12",
                "id": "18787191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408169e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Despite such multiple target interactions of Akt1, parallel coinhibition of Akt1 and Par-4 expression by RNA interference resulted in the inhibition of apoptosis, indicating the failure of the other Akt1 substrates to induce apoptosis in the absence of Par-4 expression or function. Moreover, coinhibition of Akt1 and other Akt1 substrates did not inhibit apoptosis, implying that the observed apoptosis upon Akt1 inhibition can be ascribed primarily to Par-4. These observations highlight both the significance of Akt1 inhibition of endogenous Par-4 to promote cancer cell survival and the Par-4 dependent nature of apoptosis upon inhibition of Akt1 (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Mar 15 66(6) 2889-92",
                "id": "16540633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081691"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "The expression of the death adapter FADD and caspase-8 was required for Fas-induced FOXO3a cleavage, but activation of survival pathways by overexpression of FLICE-inhibitory protein or phorbol myristate acetate treatment prevented it. FOXO3a was cleaved in vitro by caspase-3-like proteases at the consensus sequence DELD304A, releasing the N-terminal DNA-binding domain of FOXO3a from its C-terminal transactivating domain.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jul 17 22(29) 4557-68",
                "id": "12881712"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081681"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "We and others have shown that GR activation can indirectly down-regulate specific genes via serum and glucocorticoid (GC) regulated kinase-1-mediated inhibition of forkhead box O3a (FOXO3a) transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2008 May 149(5) 2637-45",
                "id": "18239069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408166c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "The signaling pathway from phosphoinositide 3-kinase to the protein kinase Akt controls organismal life-span in invertebrates and cell survival and proliferation in mammals by inhibiting the activity of members of the FOXO family of transcription factors. Table 1. Identification of FOXO3a target genes by transcriptional profiling.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2002 Apr 19 296(5567) 530-4",
                "id": "11964479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081660"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "DAF-16 and its mammalian homologues, including FKHR (FOXO1), FKHRL1 (FOXO3a), and AFX (FOXO4) interact directly with IRSs from the IGFBP-1 promoter in a sequence-specific fashion in in vitro assays and in cells. In liver-derived cells, FOXO proteins stimulate the activity of promoters for IGFBP-1, glucose-6 phosphatase, and PEPCK. In other cell types, FOXO proteins also stimulate the expression of proteins that inhibit cell cycle progression, including p27Kip, Rb2, and GADD45, and proteins that promote cells death, including Bim and Fas ligand.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 22 277(47) 45276-84",
                "id": "12228231"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081655"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "TABLE 3 Genes involved in proliferation and cell cycle regulation that are repressed by FOXO3.A3.ER and FOXO3.A3.ER.H212R as identified by functional annotation clustering.  Affymetrix HG-U133 Plus 2.0 arrays according to the manufacturer?s instructions (Affymetrix, Santa Clara, CA).A Custom CDF Version 11 with Entrez-based gene definitions was used to annotate the arrays (28). Raw fluorescence intensity values were normalized, applying quantile normalization. Differential gene expression was analyzed based on log linear mixed model analysis of variance (29) using the commercial software package SAS JMP7 Genomics, version 3.1 from SAS (SAS Institute, Cary, NC). A false positive rate of   0.05 with Holm correction was taken as level of significance. To be significantly regulated, only genes with a -fold change of 1.5 and a p value less than or equal to the threshold estimated by the Holm multiple testing algorithm, as compared with the empty vector without 4OHT, were considered. Additionally, genes with a significantly different regulation between FOXO3.A3.ER and FOXO3.A3.ER.H212R according to Holm correction and a 2-fold differential regulation between FOXO3.A3.ER and FOXO3.A3.ER.H212R were resorted from the co-regulated group to FOXO3.A3.ER or FOXO3.A3.ER.H212R, respectively.   ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Apr 2 285(14) 10163-78",
                "id": "20123982"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081654"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "This reflects a need for Foxo3a to maintain neutrophil vitality during inflammation by suppressing Fas ligand; because Foxo3a can bind and suppress the Fasl promoter,",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2005 Jun 11(6) 666-71",
                "id": "15895074"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081647"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "The treatment with 4-OHT induced expression of Bim and Puma in FOXO3(A3):ER-infected BMMCs but not in control cells (Figure 6C). This indicates that FOXO3a is involved not only in regulating the transcription of Bim, as previously described,26 but also identifies Puma as a FOXO3a downstream target in mast cells. The transcription factor FOXO3a has been shown to regulate the BH3-only protein Bim (Dijkers PF, Curr Biol. 2000) and also was recently described to control Puma expression in response to growth factor deprivation in lymphoid cells and mouse embryonic fibroblasts (You H,  J Exp Med. 2006)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Nov 1 110(9) 3209-17",
                "id": "17634411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081645"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2004 Feb 24(2) 294-300",
                "id": "14656735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081643"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Induction of Foxo3a phosphorylation by FLT3-ITD receptors in Ba/F3 cells correlates with the suppression of Foxo-target genes p27Kip1 and the proapoptotic Bcl-2 family member Bim.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 22 23(19) 3338-49",
                "id": "14981546"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081642"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "expression of ERalpha was correlated with active FOXO3a levels. Ectopic FOXO3a expression induced ERalpha protein levels and promoter activity, while a dominant negative FOXO3a decreased ERalpha levels.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Oct 24(19) 8681-90",
                "id": "15367686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408162a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Overexpression of FOXO1 and FOXO3 in the prostate cancer cell line results in apoptosis and increased expression of TRAIL...TRAIL is a direct target of FOXO3 (Modur et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2312-9",
                "id": "18391973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081625"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "from full text Results - From the data of Figure 5G, it is apparent that the lack of Par-4 leads to increased levels of phospho- Akt-Thr308, phospho-GSK3b and phospho-FOXO3",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Jul 24",
                "id": "18650932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408161a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Role of the SIRT1/FOXO3 pathway in protecting against emphysema. Lung level of SIRT1 is reduced in response to CS or oxidative/carbonyl stress, which leads to acetylation and degradation of FOXO3 and culminates in stress-induced premature senescence. The senescence of lung cells is a contributing factor to airspace enlargement and emphysema. NF-kB is also acetylated and activated in response to CS exposure as a result of SIRT1 reduction. However, inhibition of NF-kB-dependent lung inflammation does not prevent the progression of airspace enlargement. SIRT1 activation by overexpression and pharmacological means protects the lungs against cellular senescence and emphysematous changes.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2012 Jun 1 122(6) 2032-45",
                "id": "22546858"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081616"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "TGF-beta treatment significantly increased levels of p-Akt (activation) and p-FoxO3a (inactivation) in cultured MC.",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2006 Dec 17(12) 3325-35",
                "id": "17082237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "This resulted in the increased constitutive expression of the FKHRL1 targets Fas ligand and Bim, and promoted apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2004 Jan 11(1) 80-9",
                "id": "12970676"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815f2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Here we report that the transcriptional factor Foxo3a initiates apoptosis by transcriptionally repressing miR-21 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 May 28 285(22) 16958-66",
                "id": "20371612"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Recently FOXO3a has been shown to protect quiescent cells from oxidative stress by inducing transcription of manganese superoxide dismutase (12).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 19 278(38) 35959-67",
                "id": "12857750"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Finally, we demonstrate that cytokine and BCR-ABL suppression of TRAIL transcription is mediated through phosphorylation and inhibition of the forkhead FOXO3a transcription factor.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 May 27 100(11) 6523-8",
                "id": "12750477"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Gene reporter experiments demonstrated that in MCF-7 cells maximal induction of Bim promoter was dependent on a FoxO binding site, suggesting that FoxO3a is responsible for the transcriptional upregulation of Bim.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3",
                "id": "14527951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "LC3-II was increased in FoxO3MyHC cardiomyocytes after ex vivo transgene activation (Figure 4F; see Supplementary material online, Figure S6C). Treatment with lysosomal inhibitors revealed that LC3-II levels could still be stimulated in FoxO3MyHC cardiomyocytes, indicating an activation of autophagy rather than a disturbance in autophagic flux.",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2011 Sep 1 91(4) 587-97",
                "id": "21628326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081794"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Together, reduced FOXO3a expression coupled to FOXO3a hyperphosphorylation would suppress FOXO transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2005 Mar 3(3) 163-9",
                "id": "15798096"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081878"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "in activated B cells FOXO proteins exert their effects through up-regulation of proapoptotic genes such as Bim",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Aug 1 104(3) 784-7",
                "id": "15069012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408186f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "The antiapoptotic effect was reversed by inhibition of the PI3K/Akt pathway. Forkhead transcription factors (FOXO1, FOXO3a, FOXO4) exert proapoptotic effects and are phosphorylated and, thereby, inactivated by Akt.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Jun 19(8) 974-6",
                "id": "15824087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081833"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Figure 8. Inhibition of FKHR-L1 transcriptional activity protects cells from apoptosis induced by cytokine withdrawal.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Feb 4 156(3) 531-42",
                "id": "11815629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081831"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "FOXO3 upregulation of p27kip1 in A14 cells, mouse embryo fibroblasts, DLD-1 and 786-0 cells (Medema et al., 2000; Nakamura et al., 2000) results in a potent cell cycle arrest, it causes apoptosis in Ba/F3 cells (Dijkers et al., 2000).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2312-9",
                "id": "18391973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408182f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2004 Apr 53(4) 899-910",
                "id": "15047604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081826"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Nuclear exclusion of the forkhead transcription factor FOXO3a by protein kinase Akt contributes to cell survival.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Apr 16 117(2) 225-37",
                "id": "15084260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081825"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "It has been reported that inhibition of FoxO activity is an important mechanism for Ang1-stimulated Tie2-mediated endothelial function. Consistent with this, we found that phosphorylation of FoxO mediated by Tie2 activation was attenuated by lipid raft disruption. Therefore, we propose that lipid rafts serve as signaling platforms for Tie2 receptor tyrosine kinase in vascular endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2009 Oct 1 315(16) 2818-23",
                "id": "19615361"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408181f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jan 23(1) 104-18",
                "id": "12482965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081816"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "We identified B cell translocation gene 1 (BTG1)/antiproliferative protein 2 as a FoxO3a target gene in erythroid progenitors. Promoter studies indicated BTG1 as a direct target of FoxO3a.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 Jan 19 164(2) 175-84",
                "id": "14734530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081810"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "erythroid progenitor",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogin-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Apr 30 117(3) 399-412",
                "id": "15109499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081805"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Knockdown of Foxo3a expression inhibited the starvation-induced increase in SIRT1 expression.  Stimulation of SIRT1 transcription by Foxo3a was mediated through two p53 binding sites present in the SIRT1 promoter, and a nutrient-sensitive physical interaction was observed between Foxo3a and p53.  SIRT1 expression was not induced in starved p53-deficient mice.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Dec 17 306(5704) 2105-8",
                "id": "15604409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817fa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 2 277(31) 28118-26",
                "id": "12011061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(7) 2025-36",
                "id": "11884591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Transduction with FOXO3a also caused a significant reduction in cardiomyocyte size in mouse hearts in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20814-23",
                "id": "15781459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ea"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Thus, in cardiomyocytes, as in skeletal muscle, FOXO3a activates an atrogene transcriptional program, which retards or prevents hypertrophy and is down-regulated by multiple physiological and pathological stimuli of myocyte growth.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20814-23",
                "id": "15781459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817e9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "hydrogen peroxide can negatively regulate forkhead activity.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2002 Mar 29 295(5564) 2450-2",
                "id": "11884717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Transduction of a nonphosphorylatable, constitutively active mutant of FOXO3a (TM-FOXO3a) led to the down-regulation of FLIP levels. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 9 279(2) 1513-25",
                "id": "14551207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "FOXO3 upregulation of p27kip1 in A14 cells, mouse embryo fibroblasts, DLD-1 and 786-0 cells (Medema et al., 2000; Nakamura et al., 2000) results in a potent cell cycle arrest, it causes apoptosis in Ba/F3 cells (Dijkers et al., 2000).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2312-9",
                "id": "18391973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817d6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "embryo"
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "AKT signalling induces the expression of the anti-apoptotic molecule BCL-XL and inhibits the pro-apoptotic activity of FOXO3A",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Akt (PKB) directly phosphorylates multiple protein targets of relevance to apoptosis (Figure 2B), suppressing cell death clearly within the intrinsic pathway (e.g., BAD inactivation, human caspase-9 suppression) and possibly also the extrinsic pathway (e.g., FasL expression) in some types of cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Jan 3(1) 17-22",
                "id": "12559172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "adenoviral overexpression of FKHRL1 and FKHR in the LAPC4 prostate cancer cell line resulted in apoptosis and induced the expression of many genes The following comes from Table I.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47928-37",
                "id": "12351634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081799"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Sgk is known to phosphorylate and negatively regulate pro-apoptotic forkhead transcription factor FKHRL1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5871-82",
                "id": "12488318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081792"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Here we show that the mammalian SIR2 ortholog SIRT1 deacetylates and represses the activity of the forkhead transcription factor Foxo3a and other mammalian forkhead factors.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Feb 20 116(4) 551-63",
                "id": "14980222"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081791"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "TABLE 3. Foxo3a-upregulated genes not regulated by Epo/SCF (cluster D)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 May 27(10) 3839-3854",
                "id": "17353275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408178c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Indeed, induction of multiple target genes of Myc, including cyclin D2, cdk4, odc, cyclin E2 (B Amati, personal communication), jvt-1 and cad, was strongly inhibited by FoxO3a(A3) (Figure 5A). #  [NC] jvt-1 should be jtv-1 ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Jul 21 23(14) 2830-40",
                "id": "15241468"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081789"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Similarly, induction of FasL by the Akt-regulated forkhead transcription factor FKHRL1 was dependent upon caspase and c-Jun activation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jan 22(2) 680-91",
                "id": "11756562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081784"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "RUNX3-induced apoptosis depended on the expression of Bim, a proapoptotic BH3-only protein, and both RUNX3 and FoxO3a/FKHRL1 were required for induction of Bim expression.... In the Bim promoter, RUNX3 bound to two conserved RUNX-binding elements (RBE1 and RBE2), with RBE1 being immediately downstream of a FoxO-binding element.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 24 281(8) 5267-76",
                "id": "16373335"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081776"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Aug 15 366(Pt 1) 289-97",
                "id": "12027802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081773"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Akt has been well characterized as a prosurvival molecule, and part of this function is mediated through its suppression of the activity of the FoxO proteins (Greer and Brunet, 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2006 Oct 6 127(1) 125-37",
                "id": "16962653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081769"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "expression of a constitutively active form of FOXO3 triggers apoptosis in cerebellar granule neurons through the Fas signaling cascade (Brunet et al., 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2312-9",
                "id": "18391973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081767"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "In invasive ductal carcinomas, 83% of the cases (93/112) diffusely expressed FKHRL1; however, unlike benign tumors, 71% of the cases (66/93) showed the nuclear-targeted, active form of FKHRL1.",
              "citation": {
                "type": "PubMed",
                "name": "Acta Med Okayama 2004 Aug 58(4) 197-205",
                "id": "15551757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081763"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Thapsigargin, an endoplasmic reticulum (ER) stress-inducing agent, significantly decreased threonine32-phosphorylation of FOXO3a, and increased nuclear and decreased cytosolic FOXO3a, suggesting that thapsigargin activates FOXO3a.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 2004 Jul 5 126(1) 45-56",
                "id": "15207915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081761"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "the FOXO transcription factors and muscle atrophy the FOXO family of transcription factors was reported to regulate MAFbx and MuRF1 transcription and to influence muscle atrophy",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Aug 3 2004(244) re11",
                "id": "15292521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081742"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "TABLE 3. Foxo3a-upregulated genes not regulated by Epo/SCF (cluster D)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 May 27(10) 3839-3854",
                "id": "17353275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408173f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "peripheral blood monocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "At a second level, nicotinamide maintains an inhibitory phosphorylation of the forkhead transcription factor FOXO3a at the regulatory sites of Thr and Ser and governs a unique regulatory loop that prevents the degradation of phosphorylated FOXO3a by caspase-3.",
              "citation": {
                "type": "PubMed",
                "name": "J Cereb Blood Flow Metab 2004 Jul 24(7) 728-43",
                "id": "15241181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408173d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 4 278(14) 12361-6",
                "id": "12517744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408172c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "In these cell types, FOXO3 binds directly to the promoters of MAP1LC3, ATG12, and GABARAP genes to increase their expression and induce autophagy . ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Neurodegener 2009 4 16",
                "id": "19348680"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081715"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "cyclins are known to be regulated by AKT signaling through the Forkhead box family of transcription factors class O, FOXOs (FKHR, FKHRL and AFX) which targets include the cdk inhibitor p27kip1 phosphorylation of FOXOs by AKT promotes their export from the nucleus to the cytoplasm, where, they are complexed with 14-3-3 proteins",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408170e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Foxo3a regulates helper T cell activation and tolerance by inhibiting NF-kappaB activity",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2004 Aug 21(2) 203-13",
                "id": "15308101"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081708"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Adenovirus expressing the constitutively active FKHRL1... FKHRL1 overexpression in cultured VSMCs increased p27 expression, leading to G1 phase cell-cycle arrest and increased apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2005 Apr 25(4) 742-7",
                "id": "15662024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081707"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Sep 30 280(39) 33558-65",
                "id": "16061480"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081701"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Jul 1 104(1) 215-23",
                "id": "15031210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "FOXO3a (also known as FKHR-L1) protects quiescent cells from oxidative stress by directly increasing their quantities of manganese superoxide dismutase (MnSOD) messenger RNA and protein.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Sep 19 419(6904) 316-21",
                "id": "12239572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Nov 24(22) 10058-71",
                "id": "15509806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "characterized the human gilz promoter and showed that FoxO3 (Forkhead box class O3) binding to the Forkhead responsive elements identified in the promoter is necessary for induction of gilz expression upon IL-2 withdrawal.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Jul 1 104(1) 215-23",
                "id": "15031210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 15 279(42) 44030-8",
                "id": "15308628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "adenoviral overexpression of FKHRL1 and FKHR in the LAPC4 prostate cancer cell line resulted in apoptosis and induced the expression of many genes The following comes from Table I.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47928-37",
                "id": "12351634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Phosphorylation by AMPK leads to the activation of FOXO3 transcriptional activity without affecting FOXO3 subcellular localization.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Oct 12 282(41) 30107-19",
                "id": "17711846"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jan 22(2) 680-91",
                "id": "11756562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2004 Jan 45(1) 81-8",
                "id": "14563822"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081695"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "the induction of SGK1 results in the nuclear exclusion of FOXO3A",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2006 Mar 6(3) 184-92",
                "id": "16453012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408168e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Induction of Mxi1 by FOXO3a was also observed in a mammary epithelial cell line (MCF-10A) expressing the FOXO3a.A3-ER fusion protein (clone M11, Figure S3 and S5B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Apr 23",
                "id": "17452451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081657"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408164b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Transcriptional control by FOXO also extends to the regulation of pro-apoptotic genes Bim and Fas Ligand and to the stress response genes like GADD45, Mn superoxide dismutase and catalase.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2005 Jul 4(7) 908-13",
                "id": "15917664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408163b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "that FKHRL1, a member of the forkhead in rhabdosarcoma (FKHR) subclass of the Fox family of transcription factors, stimulates transcription from transfected 3-hydroxy-3-methylglutaryl-CoA synthase promoter-luciferase reporter constructs, and that this stimulation is repressed by insulin.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Aug 15 366(Pt 1) 289-97",
                "id": "12027802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081630"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Phosphorylated Akt and Akt-mediated phosphorylation of FOXO3A also decreased in responsive breast cancer cell lines exposed to lapatinib",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2007 May 6(5) 1629-40",
                "id": "17513611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408160e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Recently, another kinase, I-kappa-B kinase-beta, has been shown to phosphorylate and inactivate FOXO3a in breast cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Feb 1 102(5) 1649-54",
                "id": "15668399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408160d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Once in the cytoplasm, FKHRL1 remains phosphorylated and bound to 14-3-3, thereby preventing nuclear reimport.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Mar 4 156(5) 817-28",
                "id": "11864996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXO3) actsIn tscript(p(HGNC:FOXO3))",
              "summary_text": "Using reporter gene assays, we demonstrate that STI571 and FoxO3a activate Bim transcription through a FoxO-binding site (FHRE) located within the promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Mar 31 24(14) 2317-29",
                "id": "15688014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TNFRSF4)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:TNFRSF4))",
        "directed": false,
        "label": "p(HGNC:TNFRSF4) actsIn cat(p(HGNC:TNFRSF4))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053958",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TNFRSF4) actsIn cat(p(HGNC:TNFRSF4))",
              "summary_text": "Moreover, the Ccr6 mRNA level was further elevated in the lung after inhalation of OX40-triggered cell lysate (Fig. 7).",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine 2010 Jun 50(3) 253-9",
                "id": "20400327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081609"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TNFRSF4) actsIn cat(p(HGNC:TNFRSF4))",
              "summary_text": "Survivin was expressed after triggering OX40, and this was not dependent on cell division, as significant expression was retained in the presence of hydroxyurea, aphidicolin, and nocodazole (Figure 3B).",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2005 May 22(5) 621-31",
                "id": "15894279"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408167a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TNFRSF4) actsIn cat(p(HGNC:TNFRSF4))",
              "summary_text": "These experiments (Fig 4) showed that OX40 ligation increased the expression of IL-4 transcription from 2.0 (1.3 to 3.3) to 8.1 (4.7 to 13.6)  10?3 attomoles, corresponding to a fourfold increase. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Nov 1 92(9) 3338-45",
                "id": "9787171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "CD4+ T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TNFRSF4) actsIn cat(p(HGNC:TNFRSF4))",
              "summary_text": "As illustrated in Fig. 2, no CCL20 was detected in the splenocytes treated with OVA alone. Nevertheless, further activation of OX40 by OX40 agonistic antibody caused CCL20 up-regulation in a dose-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine 2010 Jun 50(3) 253-9",
                "id": "20400327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817b3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "CD4+ T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TNFRSF4) actsIn cat(p(HGNC:TNFRSF4))",
              "summary_text": "Here we show that OX40 (CD134) signaling inhibits TGF-beta-driven Foxp3 mRNA and suppresses the conversion of naive Ag-specific transgenic CD4 T cells into CD25(+)Foxp3(+) T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Aug 1 179(3) 1427-30",
                "id": "17641007"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081756"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TNFRSF4) actsIn cat(p(HGNC:TNFRSF4))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2000 Jan 17 191(2) 365-74",
                "id": "10637280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081738"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TNFRSF4) actsIn cat(p(HGNC:TNFRSF4))",
              "summary_text": "OX40/OX40L interaction induces the expression of CXCR5",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 2003 Dec 33(12) 3265-74",
                "id": "14635034"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081632"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "CD4+ T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:FOXO1))",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "tscript(p(HGNC:FOXO1)) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405394c",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:FOXO1)) increases p(HGNC:FOXP3)",
              "summary_text": "Foxo1 is a pivotal regulator of Treg cell function. Mice with Treg-cell specific deletion of Foxo1 develop a fata inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of Treg cells.",
              "citation": {
                "type": "Other",
                "name": "Ouyang W., Liao, W., Luo, CT., Yin, N., Huse, M., Kim, MV., Peng, M., Chan, P., Ma,  Q., Mo, Y., Meijer, D., Zhao, K., Rudensky, AY, Atwal, G., Zhang, MQ., Li, MQ.,(2012), Nature, 491:(7425)554-559.",
                "id": "23135404"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "53018f8f89e3620bbccca332"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "treg"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:FOXO1)) increases p(HGNC:FOXP3)",
              "summary_text": "Foxo1 is a pivotal regulator of Treg cell function. Mice with Treg-cell specific deletion of Foxo1 develop a fata inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of Treg cells.",
              "citation": {
                "type": "Other",
                "name": "Ouyang W., Liao, W., Luo, CT., Yin, N., Huse, M., Kim, MV., Peng, M., Chan, P., Ma,  Q., Mo, Y., Meijer, D., Zhao, K., Rudensky, AY, Atwal, G., Zhang, MQ., Li, MQ.,(2012), Nature, 491:(7425)554-559.",
                "id": "23135404"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "53018f8f89e3620bbccca331"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "treg"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:FOXO1)) increases p(HGNC:FOXP3)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081854"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:USP7)",
        "relation": "increases",
        "target": "tscript(p(HGNC:FOXP3))",
        "directed": false,
        "label": "p(HGNC:USP7) increases tscript(p(HGNC:FOXP3))",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5302292989e3620bbcdf9485",
          "evidences": [
            {
              "bel_statement": "p(HGNC:USP7) increases tscript(p(HGNC:FOXP3))",
              "summary_text": "Foxp3 is a critical Tx for Treg polarization and regulated by one of many mechanisms, including ubiquitination-dependent degradation. Deubiquitinase USP7 decreases Foxp3 polyunibiutination and stabilize Foxp3, thus increases Treg-suppressive capacity.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "23973222"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5302292989e3620bbcdf9415"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:UBE2N)",
        "relation": "increases",
        "target": "p(HGNC:SOCS1)",
        "directed": false,
        "label": "p(HGNC:UBE2N) increases p(HGNC:SOCS1)",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "53022ebe89e3620bbce02940",
          "evidences": [
            {
              "bel_statement": "p(HGNC:UBE2N) increases p(HGNC:SOCS1)",
              "summary_text": "Flow cytometry also showed considerable SOCS1 expression in wild-type Treg cells and much lower SOCS1 expression in Ubc13-deficient Treg cells (Fig. 7e).",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22484734"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "53022ebe89e3620bbce028cb"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:STUB1)",
        "relation": "decreases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "p(HGNC:STUB1) decreases p(HGNC:FOXP3)",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5302304c89e3620bbce03cab",
          "evidences": [
            {
              "bel_statement": "p(HGNC:STUB1) decreases p(HGNC:FOXP3)",
              "summary_text": "Stub1 removes Foxp3 from the transcriptional regulatory landscape by promoting its degradation, immunoblotting of these doubly transduced cells confirmed that Stub1 overexpression coincided with the reduction of Foxp3 protein amounts (Figure S5D). These results suggest that within T cells, Stub1 negatively regulates Foxp3-mediated transcriptional repression.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": ""
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5302304c89e3620bbce03c34"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NFKBID))",
        "relation": "increases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "tscript(p(HGNC:NFKBID)) increases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "530234be89e3620bbce049ce",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NFKBID)) increases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "IkBNS intrinsically regulates Treg cell development",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "23200824"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "530234bd89e3620bbce04955"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:GATA3))",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5303c3a089e36206c0366d57",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
              "summary_text": "GATA-3 affects Treg homeostasis and suppressive function, through binding to Foxp3 promoter, regulating Foxp3 and other Treg cell signature genes expression. GATA-3 prevents transition of Treg into Th17 cells.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21924928"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5303c3a089e36206c0366b6f"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
              "summary_text": "GATA-3 affects Treg homeostasis and suppressive function, through binding to Foxp3 promoter, regulating Foxp3 and other Treg cell signature genes expression. GATA-3 prevents transition of Treg into Th17 cells.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21924928"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5303c3a089e36206c0366bf5"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
              "summary_text": "GATA-3 affects Treg homeostasis and suppressive function, through binding to Foxp3 promoter, regulating Foxp3 and other Treg cell signature genes expression. GATA-3 prevents transition of Treg into Th17 cells.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21924928"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5303c3a089e36206c0366aed"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:GATA3))",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5303c3a089e36206c0366bef",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
              "summary_text": "GATA-3 affects Treg homeostasis and suppressive function, through binding to Foxp3 promoter, regulating Foxp3 and other Treg cell signature genes expression. GATA-3 prevents transition of Treg into Th17 cells.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21924928"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5303c3a089e36206c0366b6f"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
              "summary_text": "GATA-3 affects Treg homeostasis and suppressive function, through binding to Foxp3 promoter, regulating Foxp3 and other Treg cell signature genes expression. GATA-3 prevents transition of Treg into Th17 cells.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21924928"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5303c3a089e36206c0366bf5"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
              "summary_text": "GATA-3 affects Treg homeostasis and suppressive function, through binding to Foxp3 promoter, regulating Foxp3 and other Treg cell signature genes expression. GATA-3 prevents transition of Treg into Th17 cells.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21924928"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5303c3a089e36206c0366aed"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:TNFRSF4))",
        "relation": "decreases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "cat(p(HGNC:TNFRSF4)) decreases p(HGNC:FOXP3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053957",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:TNFRSF4)) decreases p(HGNC:FOXP3)",
              "summary_text": "A noticeable feature of OX86 expanded Tregs, as compared to control Tregs, is that OX40-expanded Tregs express much lower levels of Foxp3, as shown by the mean fluorescence intensity (MFI).",
              "citation": {
                "type": "Other",
                "name": "Xiao, X, Gong, W, Demirci, G. et al. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J Immunol. 2012 January 15; 188(2): 892901.",
                "id": "22147766"
              },
              "metadata": {
                "created_by": "dulat.bekbolsynov",
                "id": "5304c22d89e36207f8060456"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "no",
                "cell": "tregs",
                "tissue": "spleen"
              }
            },
            {
              "bel_statement": "cat(p(HGNC:TNFRSF4)) decreases p(HGNC:FOXP3)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081631"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:BACH2))",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "tscript(p(HGNC:BACH2)) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5306a94b89e36201901f800c",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:BACH2)) increases p(HGNC:FOXP3)",
              "summary_text": "BACH2 is required during induction for the formation of iTreg cells. In addition, Bach2 overexpression in WT cells enhanced FOXP3 induction under suboptimal polarizing conditions",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "23728300"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5306a94b89e36201901f7f85"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FURIN)",
        "relation": "increases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "p(HGNC:FURIN) increases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5306aa1789e36201901f8663",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FURIN) increases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "We found that adoptive transfer of nave furin-deficient CD4+ cells into T-cell-deficient hosts resulted in the generation of fewer Foxp3+ cells than wild-type cells, perhaps owing to lack of autocrine TGF-1 production (Fig. 4E).",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "18701887"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5306aa1789e36201901f85da"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:IL10)",
        "relation": "increases",
        "target": "tscript(p(HGNC:STAT3))",
        "directed": false,
        "label": "p(HGNC:IL10) increases tscript(p(HGNC:STAT3))",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5306a4a489e36201901f6914",
          "evidences": [
            {
              "bel_statement": "p(HGNC:IL10) increases tscript(p(HGNC:STAT3))",
              "summary_text": "It is notable that in Treg cells, IFN-g and IL-10 also activate STAT1 and STAT3, respectively",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22981537"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5306a4a489e36201901f6892"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            },
            {
              "bel_statement": "p(HGNC:IL10) increases tscript(p(HGNC:STAT3))",
              "summary_text": "IL-10 was a more potent inducer of STAT3 phosphorylation in Treg cells as compared to nave T cells (Figures 1A1C).",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21511185"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5306ad4a89e36201901ff0ce"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "treg"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NR4A2))",
        "relation": "increases",
        "target": "tscript(p(HGNC:FOXP3))",
        "directed": false,
        "label": "tscript(p(HGNC:NR4A2)) increases tscript(p(HGNC:FOXP3))",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5306b1bd89e362019020ebde",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NR4A2)) increases tscript(p(HGNC:FOXP3))",
              "summary_text": "Nr4a2-deficeint Tregs are prone to lose Foxp3 expression and have attenuated suppressive ability both in vitro and in vivo.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21468021"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5306b1bd89e362019020eb50"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NR4A2))",
        "relation": "decreases",
        "target": "tscript(p(HGNC:IFNG))",
        "directed": false,
        "label": "tscript(p(HGNC:NR4A2)) decreases tscript(p(HGNC:IFNG))",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5306b23b89e3620190211789",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NR4A2)) decreases tscript(p(HGNC:IFNG))",
              "summary_text": "Both IFN- and IL-17 were significantly repressed under Th1- and Th17-conditions, respectively, and Foxp3 was induced in both conditions by Nr4a2 (Fig. 3d).",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21468021"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5306b23b89e36201902116f9"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NR4A2))",
        "relation": "increases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "tscript(p(HGNC:NR4A2)) increases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5306b42689e3620190212d1b",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NR4A2)) increases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "Nr4a receptors directly activated the promoter of the gene encoding the transcription factor Foxp3",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "23334790"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5306b42689e3620190212c8a"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HIF1A)",
        "relation": "directlyDecreases",
        "target": "tscript(p(HGNC:FOXP3))",
        "directed": false,
        "label": "p(HGNC:HIF1A) directlyDecreases tscript(p(HGNC:FOXP3))",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5306b5a989e3620190213463",
          "evidences": [
            {
              "bel_statement": "p(HGNC:HIF1A) directlyDecreases tscript(p(HGNC:FOXP3))",
              "summary_text": "Concurrently, HIF-1 attenuates Treg development by binding Foxp3 and\ntargeting it for proteasomal degradation.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21871655"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5306b5a989e36201902133d0"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:STAT4))",
        "relation": "decreases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "tscript(p(HGNC:STAT4)) decreases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053948",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:STAT4)) decreases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "Signal transducer and activator of transcription 4 (STAT4) is critical for the response to IL-12, although there is a parallel pathway involving T box expressed in T cells (T-bet), and cells from mice double-deficient in STAT4 and T-bet are refractory to the inhibition of aTreg-cell development by IL-12. ",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2009 Aug 127(4) 587-95",
                "id": "19604309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816bc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:IL7)",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:IL7R))",
        "directed": false,
        "label": "p(HGNC:IL7) directlyIncreases cat(p(HGNC:IL7R))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053961",
          "evidences": [
            {
              "bel_statement": "p(HGNC:IL7) directlyIncreases cat(p(HGNC:IL7R))",
              "summary_text": "Recent studies demonstrate that IL-7 and thymic stromal lymphopoietin (TSLP) are critical for Treg maturation. Therefore, altered signaling through their receptors (IL-7R, TSLP receptor (TSLPR)), sharing the IL-7R?-chain (IL-7R?), might contribute to impaired Treg development",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 2011 Mar 41(3) 845-53",
                "id": "21287555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081797"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:IL7) directlyIncreases cat(p(HGNC:IL7R))",
              "summary_text": "There are 2 known ligands for IL-7Ralpha: IL-7 itself and thymic stromal lymphopoietin (TSLP).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Oct 15 112(8) 3283-92",
                "id": "18664628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081865"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FURIN)",
        "relation": "increases",
        "target": "act(p(HGNC:TGFB1))",
        "directed": false,
        "label": "p(HGNC:FURIN) increases act(p(HGNC:TGFB1))",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5306aab789e36201901f8a8f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FURIN) increases act(p(HGNC:TGFB1))",
              "summary_text": "We first explored furins criticality in the production of biologically active TGF-beta1 by assessing whether furin-deficient T cells generated normal levels of TGF-beta1 in vitro. To this end, we measured the secretion of TGF-beta1 by CD4+CD25- and CD4+CD25+ T cells and found that furin-deficient T cells secreted considerably reduced levels of activated TGF-beta1 (Fig. 3c).",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "18701887"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5306aab789e36201901f8a04"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:SMAD3))",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "tscript(p(HGNC:SMAD3)) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053950",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:SMAD3)) increases p(HGNC:FOXP3)",
              "summary_text": "Herein we show that RA enhances TGF-beta signaling by increasing the expression and phosphorylation of Smad3, and this results in increased Foxp3 expression even in the presence of IL-6 or IL-21. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Aug 15 181(4) 2277-84",
                "id": "18684916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081628"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:FOXP3))",
        "relation": "increases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "tscript(p(HGNC:FOXP3)) increases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053956",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:FOXP3)) increases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "FoxP3 is the transcription factor driving CD4+ T cell differentiation towards T regulatory cells, which is known to attenuate T cell-mediated immune responses [86].",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cell Biol 2011 2011 470597",
                "id": "22190938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "CD4+ T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:FOXP3)) increases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "Here, we show that retroviral transduction of FOXP3 induces a Treg phenotype in human leukemic CD4(+) Jurkat-T cells, evidenced by increased expression of Treg-associated cell surface markers as well as inhibition of cytokine production. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Oct 12 362(1) 44-50",
                "id": "17706604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408174a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:SMAD3))",
        "relation": "increases",
        "target": "path(SDIS:\"regulatory t-cell differentiation\")",
        "directed": false,
        "label": "tscript(p(HGNC:SMAD3)) increases path(SDIS:\"regulatory t-cell differentiation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053951",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:SMAD3)) increases path(SDIS:\"regulatory t-cell differentiation\")",
              "summary_text": "In this study, we generated T cell-specific Smad2 conditional knockout (KO) mice and unexpectedly found that Smad2 and Smad3 were redundantly essential for TGF-beta-mediated induction of Foxp3-expressing regulatory T cells and suppression of IFN-gamma production in CD4(+) T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 15 185(2) 842-55",
                "id": "20548029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408167c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TGFB1)",
        "relation": "increases",
        "target": "tscript(p(HGNC:FOXO1))",
        "directed": false,
        "label": "p(HGNC:TGFB1) increases tscript(p(HGNC:FOXO1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405393d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:FOXO1))",
              "summary_text": "Foxo3a deficiency results in defective TGF-beta-driven Foxp3 induction......Foxo1 exerts similar effects as Foxo3a on Foxp3 expression. This study reveals that Foxo factors promote transcription of the Foxp3 gene in induced T reg cells, and thus provides new mechanistic insight into Foxo-mediated T cell regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2010 Jul 5 207(7) 1381-91",
                "id": "20439537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081635"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCR5)",
        "relation": "increases",
        "target": "path(SDIS:\"T-cell migration\")",
        "directed": false,
        "label": "p(HGNC:CCR5) increases path(SDIS:\"T-cell migration\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053942",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CCR5) increases path(SDIS:\"T-cell migration\")",
              "summary_text": "Most importantly, CCR5 deficiency resulted in decreased recruitment of memory T cells expressing key effector molecules and impaired control of virus replication during the initial stages of a secondary response. These data highlight the critical importance of early memory T cell recruitment for the efficacy of cellular immunity in the lung.",
              "citation": {
                "type": "Other",
                "name": "immunity 2008 jul 29(1) 101-13",
                "id": "18617426"
              },
              "metadata": {
                "created_by": "davidgaralf",
                "id": "54ddf5a289e3620ad49d61f8"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) increases path(SDIS:\"T-cell migration\")",
              "summary_text": "Most importantly, CCR5 deficiency resulted in decreased recruitment of memory T cells expressing key effector molecules and impaired control of virus replication during the initial stages of a secondary response. ",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2008 Jul 29(1) 101-13",
                "id": "18617426"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081849"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:SMAD3)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:SMAD3))",
        "directed": false,
        "label": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053952",
          "evidences": [
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "In contrast, the DNA binding activity of Smad3/4 was up-regulated by GSK-3{alpha} siRNA and appeared to be unaffected by GSK-3beta siRNA. Moreover, the activity of Smad3/4-responsive transcription was enhanced by GSK-3{alpha} siRNA and its dominant negative mutant but slightly reduced by GSK-3beta siRNA and its R96A mutant (Fig. 4B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 13 281(41) 30479-84",
                "id": "16912034"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081772"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Analysis of the downstream signaling pathways shows that Smad2/3 are crucial for efficient FGF-BP1 repression by TGF-beta.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jun 30 345(2) 595-601",
                "id": "16690027"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081754"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Furthermore, expression of dominant negative Smad3 or Smad4 in cells decreased or abolished the stimulation of beta(5) promoter activity by TGF-beta. Smad4 mutant also inhibited the up-regulation of surface beta(5) level by TGF-beta. Thus, TGF-beta increases expression of the integrin beta(5) gene by mechanisms involving Sp1/Sp3 and Smad transcription factors.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 17 275(46) 36400-6",
                "id": "10964912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1999 Oct 12 96(21) 11776-81",
                "id": "10518526"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081780"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad7 expression inhibited both Smad2- and Smad3-mediated TGF-beta signaling in podocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2002 Nov 13(11) 2657-66",
                "id": "12397035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408172f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "podocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "While Smad7 has no effect on TGF-beta-induced activation of p38 MAPK and ERK, it blocks the phosphorylation of Akt by TGF-beta and enhances TGF-beta-induced phosphorylation of c-Jun.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2005 Jul 1 307(1) 231-46",
                "id": "15922743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408163c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 17 275(46) 36400-6",
                "id": "10964912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815f5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "The results suggest that, through activation of Smad3, TGF-beta decreases Pax8 DNA binding activity as well as Pax8 mRNA and protein levels, which are at least partially involved in TGF-beta-induced down-regulation of NIS gene expression in thyroid follicular cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 30 279(5) 3439-46",
                "id": "14623893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408170b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "thyroid"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "the SGK promoter contains consensus DNA elements for Smad and Fast-1 binding (hatched boxes labeled SMAD 3/4 and Fast-1 in figure 2) that are activated by TGF-beta receptor signaling, This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants encoding the same protein have been observed.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2003 13(1) 1-12",
                "id": "12649597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408187a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Our results show that these responses are associated with prolonged Akt phosphorylation relative to time-matched controls and are dependent on phosphatidylinositol 3-kinase (PI 3-kinase) and Smad2/3 signaling, based on the ability of the PI 3-kinase inhibitor LY294002 or infection with adenoviral dominant negative Smad3 (DN-Smad3) mutant to attenuate induction of cyclin D2, inhibin-alpha, aromatase, SCC, SF-1, and epiregulin. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 11 280(10) 9135-48",
                "id": "15613482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408185f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "enforced expression of ARA55 inhibits transforming growth factor-beta-mediated up-regulation of Smad binding element-luciferase reporter activity in NRP-154 and NRP-152 rat prostate and LNCaP human prostate cell lines",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 18 280(7) 5154-62",
                "id": "15561701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408184b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "\\\"Smad proteins mediate signaling by transforming growth factor-beta (TGF-beta) 1 superfamily members (1-3). Upon binding of TGF-beta to cell surface complexes of type I and type II receptor serine/threonine kinases, the type II receptor phosphorylates the type I receptor, which further phosphorylates the receptor-regulated (R-) Smads, Smad2 and Smad3 (3). Phosphorylated R-Smads oligomerize with the common mediator (Co) Smad4 and accumulate in the nucleus where they regulate gene expression.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Sep 25(18) 8108-25",
                "id": "16135802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081830"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Here we report the discovery of a new functional link between TGF-beta and growth factor signalling pathways, mediated by a physical interaction between the serine-threonine kinase PKB (protein kinase B)/Akt and the transcriptional activator Smad3. Formation of the complex is induced by insulin, but inhibited by TGF-beta stimulation, placing PKB-Smad3 at a point of convergence between these two pathways.  Inhibition of Smad3 by PKB occurs through a kinase-activity-independent mechanism, resulting in a decrease in Smad3-mediated transcription and protection of cells against TGF-beta-induced apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2004 Apr 6(4) 358-65",
                "id": "15048128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408182b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "ex vivo studies of macro-phages derived from Smad3/ mice demonstrated a more activated phenotype with enhanced induction of MCP-1 secretion in response to LPS. Importantly, while TGF-?1 inhibited LPS-stimulated MCP-1 production from Smad3+/+ mice, this TGF-?1 inhibition was completely blocked in macrophages from Smad3/ mice.79",
              "citation": {
                "type": "PubMed",
                "name": "Panminerva Med 2005 Sep 47(3) 169-86",
                "id": "16462725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081824"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "suppression of CTGF promoter activity by PPAR gamma activation is completely rescued by overexpression of Smad3, but not by Smad4. Furthermore, PPAR gamma physically interacts with Smad3 but not Smad4 in vitro in glutathione S-transferase pull-down experiments. Taken together, the data suggest that PPAR gamma inhibits TGF-beta-induced CTGF expression in HASMCs by directly interfering with the Smad3 signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 7 276(49) 45888-94",
                "id": "11590167"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081823"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "TGFbeta stimulates the gene coding for human alpha2(I)-collagen (COL1A2) by inducing binding of an Sp1-containing complex to an upstream promoter element (TGFbeta responsive element or TbRE) that contains a CAGA box. Here we report that the CAGA box of the TbRE is the binding site of the Smad3/Smad4 complex, and that the binding of the complex is required for TGFbeta-induced COL1A2 up-regulation. Recombinant Smad3 and Smad4 bind in vitro to the CAGA box of COL1A2; TGFbeta treatment of cultured fibroblasts induces Smad3/Smad4 binding to the TbRE; transient overexpression of Smad3 and Smad4 in fibroblasts transactivates TbRE-driven transcription;",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 15 275(50) 39237-45",
                "id": "11007770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081807"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Vitamin D receptor (16), estrogen receptor {alpha} (17), Smad (18), Cbfa (19), and Ets-1 (20) have been shown to regulate OPN expression in osteoclasts, whereas metastasis-associated transcription factor (21), Tcf-1, Ets-1, Ets-2, polyomavirus enhancer A-binding protein-3, c-Jun (22) and acute myeloid leukemia-1 (23) are involved in OPN expression in cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2708-13",
                "id": "15557322"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ff"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "osteoclast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Using this stringent approach, we have identified COL1A2, COL3A1, COL6A1, COL6A3, and tissue inhibitor of metalloproteases-1 as definite TGF-beta/Smad3 targets.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 18 276(20) 17058-62",
                "id": "11279127"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Previously we have reported that the intracellular effectors of TGF-beta, Smad3 and Smad4, functionally cooperate with Sp1 to activate the human p21 promoter in hepatoma HepG2 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 22 275(38) 29244-56",
                "id": "10878024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Similarly, when Smad3 was overexpressed ectopically as an alternative to exogenous TGF-b, coexpression of RARs resulted in a significant potentiation of the transactivation of (CAGA)9-lux exerted by Smad3 (Figure 2b).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Nov 6 22(50) 8212-20",
                "id": "14603262"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "As shown in Figures 12 and 13, both Smad2/3 phosphorylation (p-Smad2/3) and nuclear translocation were markedly increased in the UUO kidney in both WT and KO mice at day 5 and day 10. Importantly, deletion of ROCK1 significantly enhanced further phosphorylation levels of p-Smad2/3 (Figure 12) and p-Smad2/3 nuclear translocation within the diseased kidney at day 5 and day 10 after UUO (Figure 13), demonstrating that deletion of ROCK1 enhanced Smad signaling in the obstructed kidney.",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2006 Nov 17(11) 3105-14",
                "id": "17005937"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408178d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Inhibition was dose-dependent on PDK1, but no inhibition was observed in the presence of an inactive kinase-dead PDK1 mutant. In addition, confocal microscopy showed that wild-type PDK1 prevents translocation of Smad3 and Smad4 from the cytoplasm to the nucleus, as well as the redistribution of Smad7 from the nucleus to the cytoplasm in response to TGF-beta. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Apr 20 282(16) 12272-89",
                "id": "17327236"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081778"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We have shown previously that coactivators p300/CREB-binding protein are involved in TGF-beta-mediated transactivation of two Cdk inhibitor genes, p21 and p15. Here we examined the possibility that Smads function to regulate transcription by directly interacting with p300/CREB-binding protein. We show that Smad3 can interact with a C-terminal fragment of p300 in a temporal and phosphorylation-dependent manner. TGF-beta-mediated phosphorylation of Smad3 potentiates the association between Smad3 and p300",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1998 Dec 9(12) 3309-19",
                "id": "9843571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408176d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We also compared the effects of TGF-??1 on myofibroblast differentiation and on type I collagen expression in a murine lung fibroblast cell line (MLg2908). TGF-??1 induced rapid expression of p-Smad2/3 in nuclei, after which ASMA organization in the cytoplasm of fibroblasts was observed. However, TGF-??1 produced no effect on the quantity of ASMA, either in mRNA levels or protein levels, even after the phosphorylation of Smad2/3. In contrast, TGF-??1 upregulated the expression of type I collagen mRNA. ",
              "citation": {
                "type": "PubMed",
                "name": "J Nihon Med Sch 2012 79(1) 46-59",
                "id": "22398790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408175c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "from Figure 1 - Fig 1. The transforming growth factor beta (TGF-b) signaling pathway. TGF-b binds type II TGF-b receptor (TbRII), directly or through TbRIII, inducing association of TbRII with TbRI. TbRII then phosphorylates and activates TbRI, which then phosphorylates Smad2 or Smad3. Phosphorylated Smad2 or Smad3 associates with Smad4 and they translocate into the nucleus, where they activate transcription of target genes. Smad7 inhibits TGF-b signaling by preventing the activation of Smad2 or Smad3 by TbRI.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Mar 20 23(9) 2078-93",
                "id": "15774796"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408174e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "MMP-12 and MCP-1 expression are transcriptionally regulated and depend on the ability of AP-1 transcription factors to bind and activate the promoter region of these genes.81-84 Indeed, in macrophage cell lines, our mechanistic studies demonstrated that TGF- ?1 inhibited cytokine-induced AP-1 DNA binding to these promoters. Further, this inhibitory effect was found to be Smad3 dependent and had distinct effects on AP-1 family members.79",
              "citation": {
                "type": "PubMed",
                "name": "Panminerva Med 2005 Sep 47(3) 169-86",
                "id": "16462725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081749"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Simplified schematic drawing of the TGF-?-Smad pathway. Binding of TGF-? to its type II receptor in concert with the type I receptor (A) leads to formation of a receptor complex and phosphorylation of the type I receptor. The type I receptor subsequently phosphorylates Smad2 or 3 (B), allowing this complex to associate with Smad4 and move into the nucleus (C). In the nucleus, the Smad complex associates with a transcription factor and this complex binds to specific enhancers in target genes (down-) regulating transcription (D). TNF is able to interfere with TGF-? signaling through the upregulation of the inhibitory Smad7 protein (E). Smad7 is capable of inhibiting the Smad2 and 3 phosphorylating process by competing with the receptor interaction but Smad7 also can dephosphorylate the complex. In addition, Smad7 itself is capable to upregulate TGF? gene expression. As described in the discussion, CSE is most likely capable to interfere with the Smad pathway although this is not yet fully elucidated. (F). Phosphorylated Smad3 is able to stimulate the transcription of the decorin gene (G).",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2008 9 83",
                "id": "19087346"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081744"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "In this study, we generated T cell-specific Smad2 conditional knockout (KO) mice and unexpectedly found that Smad2 and Smad3 were redundantly essential for TGF-beta-mediated induction of Foxp3-expressing regulatory T cells and suppression of IFN-gamma production in CD4(+) T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 15 185(2) 842-55",
                "id": "20548029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081731"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We previously reported that liganded glucocorticoid receptor (GR) repressed TGF-beta induction of human plasminogen activator inhibitor-1 gene transcription by directly targeting the transcriptional activation function of Smad3",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 24 278(43) 41779-88",
                "id": "12902338"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408172d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Here we report the identification of Smad Binding Elements (SBEs) composed of the sequence CAGACA in the promoter of the JunB gene, an immediate early gene that is potently induced by TGF-beta, activin, and bone morphogenetic protein (BMP) 2. Two JunB SBEs are arranged as an inverted repeat that is transactivated in response to Smad3 and Smad4 co-overexpression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Aug 14 273(33) 21145-52",
                "id": "9694870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408172a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Here we report that epidermal growth factor (EGF) potentializes transforming growth factor beta (TGF-beta)-induced Smad3 transactivation in rat hepatocytes, an effect abrogated by TAM-67, a dominant negative mutant of AP-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 10524-31",
                "id": "11134003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081726"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "studies examining effects on the expression of inducible nitric oxide synthase (iNOS), monocyte chemoattractant protein-1 (MCP-1), and MMP-9 verified similar inhibitory effects mediated by Smad3 in response to TGF-?1 in macrophages in vitro.76-78",
              "citation": {
                "type": "PubMed",
                "name": "Panminerva Med 2005 Sep 47(3) 169-86",
                "id": "16462725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408171d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Here we provide evidence that TGFbeta signalling prevents recruitment of Myc to the p15INK4b transcriptional initiator by Myc-interacting zinc-finger protein 1 (Miz-1). This relieves repression and enables transcriptional activation by a TGFbeta-induced Smad protein complex that recognizes an upstream p15INK4b promoter region and contacts Miz-1. (from Weinberg - Pathways in Human Cancer poster, SMAD = SMAD 2/3) (MIZ-1 = ZBTB17)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Apr 3(4) 400-8",
                "id": "11283614"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408171c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "GnRH in a dose--(0.01 to 10 microM) and time--(5 to 30 min) dependent manner decreased the rate of Smad3 activation (phospho-Smad3, pSmad3), and altered Smad3 cellular distribution in both cell types.",
              "citation": {
                "type": "PubMed",
                "name": "Reprod Biol Endocrinol 2003 Dec 16 1 125",
                "id": "14678567"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081713"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "uterine stroma"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Herein we show that RA enhances TGF-beta signaling by increasing the expression and phosphorylation of Smad3, and this results in increased Foxp3 expression even in the presence of IL-6 or IL-21. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Aug 15 181(4) 2277-84",
                "id": "18684916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408170f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Phosphorylation of the C-terminal serine residues in R-Smads by type I receptor kinases is a crucial step in TGF-b family signalling (Abdollah et al., 1997; Macias-Silva et al., 1996; Souchelnytskyi et al., 1997). The two most C-terminal serine residues become phosphorylated and, together with a third, non-phosphorylated serine residue, form an evolutionarily conserved SSXS motif in all R-Smads.... TGF-b and activin receptors phosphorylate Smad2 and Smad3, and BMP receptors phosphorylate Smad1, Smad5 and Smad8 (Chen et al., 1998) (Fig. 1). The consequence of R-Smad phosphorylation is the formation of oligomeric complexes with the Co-Smad, Smad4.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2001 Dec 114(Pt 24) 4359-69",
                "id": "11792802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081709"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "The changes in glucocorticoid binding were associated with identical changes in GR protein and mRNA levels Functional inactivation of Smad 2/3 and AP-1 limited the response to TGF-beta 1, indicating a role for these transcription factors TGF-beta 1 increases glucocorticoid binding and signaling in inflammatory cells through a Smad 2/3- and AP-1-mediated process",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int 2003 Jun 63(6) 2028-36",
                "id": "12753290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081704"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "In reporter gene transfection experiments, we found that only Smad3 could uniquely recapitulate the inhibitory effect by TGF-?1 on the cytokine induction of the MMP-12 promoter. In addition, in the presence of TGF-?1 the Smad3 repression was augmented further, whereas a dominant-negative Smad3 completely blocked the TGF-?1 inhibition.72",
              "citation": {
                "type": "PubMed",
                "name": "Panminerva Med 2005 Sep 47(3) 169-86",
                "id": "16462725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081703"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Atherosclerosis",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Smads 3 and 4 have specifically been shown to take part in TGF-beta-mediated CTCF/Smads complex binding of the APP gene promoter that up-regulates APP expression In addition, TGF-beta has been shown to stimulate Smads interaction with the stimulating protein 1 (SP1) transcription factor",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Aug 18(11) 1288-90",
                "id": "15208260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "GnRH in a dose--(0.01 to 10 microM) and time--(5 to 30 min) dependent manner decreased the rate of Smad3 activation (phospho-Smad3, pSmad3), and altered Smad3 cellular distribution in both cell types.",
              "citation": {
                "type": "PubMed",
                "name": "Reprod Biol Endocrinol 2003 Dec 16 1 125",
                "id": "14678567"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endometrial Epithelial Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "TGF-beta led to activation of Smad2/3, p38, p42/44, and c-Jun NH2-terminal kinase (JNK) pathways, assessed by phosphorylation, immunofluorescence, and reporter gene analysis. TGF-beta-dependent growth inhibition was specifically attenuated by pharmacological blockade of the TGF-beta type I receptor (TbetaRI) kinase or p38 mitogen-activated protein kinase pathways, whereas blockade of p42/44 or JNK kinases did not influence the effect of TGF-beta. TbetaRI kinase inhibition blocked all downstream pathways including Smad and p38 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2005 Dec 315(3) 1005-12",
                "id": "16120811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "A recent study [22] provided evidence for the contribution of Smad1, in addition to Smad3, to TGF-bdependent stimulation of collagen and CCN2 genes in cultured dermal fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Opin Rheumatol 2007 Nov 19(6) 568-73",
                "id": "17917537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Intermediate  TGF-{beta}-Responsive Genes Thus, inducible Smad2-dependent recruitment of corepressors to Smad3-dependent protein DNA-binding complexes may mediate a repressor signal that dynamically balances Smad3-dependent gene activation. (Smoc1 and Tnfrsf1b) were significantly activated only in Smad2KO cells",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Sep 2 100(18) 10269-74",
                "id": "12930890"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Here we report that epidermal growth factor (EGF) potentializes transforming growth factor beta (TGF-beta)-induced Smad3 transactivation in rat hepatocytes, an effect abrogated by TAM-67, a dominant negative mutant of AP-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 10524-31",
                "id": "11134003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ca"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Transforming growth factor-beta (TGF-beta) is a potent inhibitor of skeletal muscle differentiation, but the molecular mechanism and signaling events that lead to this inhibition are poorly characterized. Here we show that the TGF-beta intracellular effector Smad3, but not Smad2, mediates the inhibition of myogenic differentiation in MyoD-expressing C3H10T1/2 cells and C2C12 myoblasts by repressing the activity of the MyoD family of transcriptional factors. Central to the induction of myogenic differentiation is the function of the MyoD family of basic helix-loop-helix (bHLH) transcription factors, which include MyoD, myogenin, Myf5, and MRF4 and are collectively referred to as myogenic regulatory factors or MRFs",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Nov 15 15(22) 2950-66",
                "id": "11711431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816c5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Overexpression of KLF4 in J774a macrophages induced the macrophage activation marker inducible nitric-oxide synthase and inhibited the TGF-beta1 and Smad3 target gene plasminogen activator inhibitor-1 (PAI-1). In contrast, KLF4 inhibited the TGF-beta1/Smad3 induction of the PAI-1 promoter independent of KLF4 DNA binding through a novel antagonistic competition with Smad3 for the C terminus of the coactivator p300/CBP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 18 280(46) 38247-58",
                "id": "16169848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816a4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Expression of activated ALK7 in PC12 cells resulted in activation of Smad2 and Smad3, but not Smad1, as well as the mitogen-activated protein kinases extracellular signal-regulated kinase and c-Jun N-terminal kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 5140-6",
                "id": "11084022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816a0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "The CAGA sequence is specific for Smad3/4 binding, implying that CD105 is involved in inhibition of TGF-beta1/Smad3 signalling. Furthermore, CD105 overexpression reduced serine phosphorylation of Smad3 and inhibited subsequent nuclear translocation of Smad3. CD105 resulted in high phosphorylation of JNK1, which is able to activate c-Jun. c-Jun is known to inhibit Smad3 transcriptional activity on CAGA sites, suggesting that CD105 may also inhibit Smad3 signalling through JNK1",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 24(3a) 1337-45",
                "id": "15274293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081699"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Co-transfection of Smad3, JunB, and Cbfa1/Runx2 constructs along with a constitutively active TGF-beta type I receptor construct identified functional interaction of these proteins and transcriptional activation of the collagenase-3 gene by TGF-beta1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 25 279(26) 27764-73",
                "id": "15084595"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408168f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Whereas conditions that mimic the initial inflammatory events stimulate PPARbeta/delta expression, TGF-beta1/Smad3 suppresses this inflammation-induced PPARbeta/delta transcription",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Oct 27 23(21) 4211-21",
                "id": "15470497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081686"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Differential transcriptional regulation of EGR-1 and Smad3/4 by GSK-3 isoforms was also confirmed using isoform-specific siRNA and dominant negative mutants in human neuroblastoma SH-SY5Y cells (Fig. 4C) and further suggests that the opposite effects of these two isoforms in regulating transcription factors are not unique to cortical neurons.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 13 281(41) 30479-84",
                "id": "16912034"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081680"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We report here that inhibition of the p38alpha isoform suppressed the ability of Smad3 to mediate TGF-beta-induced transcriptional responses. The inhibition of p38 activity blocked TGF-beta-mediated phosphorylation of the MSK1 kinase, a substrate of p38 that plays an important role in the remodeling of chromatin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 16 279(29) 30474-9",
                "id": "15133024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408167f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad3E suppressed Nrf2-mediated activation of the GCLC reporter. We demonstrate that TGF-beta increased ATF3 protein levels, as did transient overexpression of Smad3E. Ectopic expression of ATF3 was sufficient to suppress the GCLC reporter activity, as well as endogenous GCLC expression",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Feb 1 38(3) 375-87",
                "id": "15629866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081677"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Traumatic brain injury with a needle stab resulted in local activation of Smad2/3-dependent genes and a severalfold increase in bioluminescence in living mice",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Jul 1 175(1) 547-54",
                "id": "15972691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408166f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Interactions of AGP7, sex-determining region Y protein, actin beta and sterol regulatory element binding protein-2 (SREBP-2) proteins with Smad3 constructs were confirmed by immunoblotting with specific antibodies. Interaction of Smad3 with SREBP-2 was also confirmed by co-immunoprecipitation of myc-Smad3 and Flag-SREBP-2 upon expression in mammalian cells. We found that SREBP-2 inhibited the transcriptional activity of Smad3 in luciferase reporter assays",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Nov 5 577(1-2) 93-100",
                "id": "15527767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408166a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "endoglin interferes with ALK-5 signaling through Smad2/3 which normally inhibits endothelial cell proliferation and migration.",
              "citation": {
                "type": "PubMed",
                "name": "Panminerva Med 2005 Sep 47(3) 169-86",
                "id": "16462725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081667"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "indicate a direct physical and functional interplay between two negative regulators of cell proliferation, Smad3 and P/CAF.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2000 Nov 1 28(21) 4291-8",
                "id": "11058129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081666"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Pharmacological inhibitors and specific siRNA knockdown experiments demonstrate that the TGF-beta1 type 1 receptor (TbetaRI/ALK5), Smad2/3, and Smad4 are essential for TGF-beta1-stimulated hAT(1)R expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 Sep 293(3) L790-9",
                "id": "17601799"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081663"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Finally, SPARC and SPARC-EC stimulated TGF-beta-responsive reporter gene expression through a TGF-beta receptor- and Smad2/3-dependent pathway in Mv1Lu cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Oct 14(10) 3977-88",
                "id": "14517312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408165d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "TGF-beta1 (1 ng/ml) significantly upregulated SMAD phosphorylation in COPD ASMC following 2-h stimulation (P < 0.05; n = 5; Fig. 4A); however, the differences were not significant for other ASMC types.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2012 Feb 1 302(3) L325-33",
                "id": "22003087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408165c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "E2 might act in a classical negative feedback loop on ER activity through the down-regulation of many genes, the products of which are known to enhance ER activity. These would include SRC2, SRC3, TIF1{alpha}, PNRC2, and SMAD3",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2003 Oct 144(10) 4562-74",
                "id": "12959972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408164e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "treatment with the ALK4/5 inhibitor SB431542 prevented phosphorylation of Smad2/3 and CTGF expression. Furthermore, production of collagen was also induced by activin A. Activin A-ACVRIB/ALK4-Smad-dependent collagen production was augmented in SSc fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Autoimmun 2011 May 36(3-4) 181-8",
                "id": "21377836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408164a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We have shown previously that the transforming growth factor-beta (TGFbeta)-regulated Sma-Mad (Smad) protein 3 and Smad4 proteins transactivate the apolipoprotein C-III promoter in hepatic cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Mar 14(3) 1279-94",
                "id": "12631740"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081648"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Overexpression of Nodal in normal trophoblast cells (HTR8/SVneo) and several choriocarcinoma cell lines resulted in a significant decrease in the number of metabolically active cells. The effect of Nodal could be mimicked by constitutively active ALK7 (ALK7-ca), but was blocked by kinase-deficient ALK7. The growth inhibitory effect of Nodal was also blocked by dominant-negative Smad2/3. Overexpression of Nodal and ALK7-ca induced apoptosis in trophoblast cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31277-86",
                "id": "15150278"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081641"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "COL1A2 promoter activity was dose dependently induced by TGF-beta1, which was further augmented by adenoviral overexpression of Smad3, but was downregulated by Smad7.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2006 Jan 290(1) L120-6",
                "id": "16126788"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081640"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Targeted disruption of Smad3 abrogated TGF-beta1-mediated inhibition of anti-CD3 plus anti-CD28-induced steady state IL-2 mRNA and IL-2 protein",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Apr 1 172(7) 4275-84",
                "id": "15034041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408163f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Overexpressed Smad3 strongly induced the primary chondrogenesis of human mesenchymal stem cells. In addition, Smad3 enhanced the transcriptional activity of SOX9 and the expression of alpha1(II) collagen gene (COL2A1), and small interference RNA against Smad3 (si-Smad3) inhibited them",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 4 280(9) 8343-50",
                "id": "15623506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081639"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We observed a co-localization of Smad3 and BRCA1 in nuclear complexes. We also found that TGFbeta1/Smad3 counteracted BRCA1-dependent repair of DNA double-strand breaks in human breast epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Mar 31 24(14) 2289-97",
                "id": "15735739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408162c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "natural and recombinant IGFBP-3 stimulated the time- and dose-dependent phosphorylation of TGF-betaR1 as well as Smad2 and Smad3",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 1 277(9) 7255-61",
                "id": "11751851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081621"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "# Ariadne: We previously showed that Smad3  promotes alpha2(I) collagen gene ( COL1A2 ) activation in human glomerular  mesangial cells, potentially contributing to glomerulosclerosis. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 9 276(10) 6983-92",
                "id": "11114293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408161e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "TGF-beta phosphorylation of Smad2/3, an obligatory step of intracellular TGF-beta signaling, was also suppressed by VEGF. VEGF attenuation of TGF-beta action was also demonstrated in two other endothelial cell lines. In conclusion, VEGF attenuates TGF-beta action in the human endothelial cell, specifically at the level of transcription of PAI-1 gene and Smad2/3 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 31 279(53) 55104-8",
                "id": "15494412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081618"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "from full text - Smad2 and Smad3 are bound to SARA (SMAD anchor for receptor activation) in the cytoplasm (Tsukazaki et al., 1998) which presents Smad2 and Smad3 to the activated TGF-b receptor complex. TbRI then directly phosphorylates the carboxy terminal of Smad2 and Smad3, resulting in decreased affinity to SARA and heterotrimerization of Smad2 and Smad3 with Smad4  (SARA = ZFYVE9)   ",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem Mol Biol 2005 Jan 31 38(1) 1-8",
                "id": "15715939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081608"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We used a luciferase reporter construct that contains CAGA elements which are sites of direct DNA binding for activated Smad3 (CAGA(12)-luc).35 We observed that Epac1 strongly inhibited TGFbeta/TbetaRI-dependent activation of CAGA(12)-luc in Mv1Lu cells, as compared to cells transfected with TbetaRI alone (Figure 7A, B).",
              "citation": {
                "type": "PubMed",
                "name": "J Proteome Res 2007 Jan 6(1) 287-97",
                "id": "17203972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081606"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Neutralizing Ab to TGF-beta1 eliminated TMEV-induced IL-23 production and SMAD-3 activation in RAW264.7 cells, BMM, and SPM.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Oct 1 181(7) 4523-33",
                "id": "18802055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081604"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "TGZ inhibited TGFbeta2-induced early Smad2 and Smad3 and late Smad3 phosphorylation but had no influence on TGFbeta2-induced p38 MAPK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Vis 2008 14 95-104",
                "id": "18253093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "retinal epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "RPTP-kappa induction is dependent on activation of transcription factors Smad3 and Smad4. Inhibition of TGF-beta receptor kinase completely prevents induction of RPTP-kappa. Chromatin immunoprecipitation assays reveal that TGF-beta stimulates Smad3 and Smad4 binding to RPTP-kappa gene promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2010 Jan 21(1) 29-35",
                "id": "19864455"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "TGFb1 treatment for 24 h resulted in significant induction (about 3-fold) of secreted CTGF protein. This induction was markedly attenuated in the presence of Smad3 knockdown. However, Smad2 knockdown had no effect on TGFb1-induced secreted CTGF protein. Neither Smad2 nor Smad3 knockdown affected basal CTGF protein secretion.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Jan 15 393(Pt 2) 601-7",
                "id": "16253118"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "In this study, we demonstrate that p15(Ink4B) induction was mediated by a TGF-beta-induced complex of Smad2, Smad3, Smad4 and Sp1.. Smad3 interacted indirectly with Sp1 through its association with Smad2 and/or Smad4, and bound directly to the p15(Ink4B) promoter.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2000 Oct 2 19(19) 5178-93",
                "id": "11013220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "The phosphatidylinositol 3-kinase (PI3K) inhibitor, LY29004 reverses the ability of IGF-I to inhibit TGF-beta-induced transcriptional responses and the activation of Smad3, suggesting that the suppression of TGF-beta signaling by IGF-I is mediated through activation of PI3K. Moreover, we show that enforced expression of dominant-negative PI3K (DN-p85alpha) or phosphatidylinositol 3-phosphate-phosphatase, PTEN, also reverse the suppressive effect of IGF-I on TGF-beta-induced 3TP-luciferase reporter activity, whereas constitutively active PI3K (p110alphaCAAX) completely blocks TGF-beta-induced 3TP-luciferase reporter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38342-51",
                "id": "12876289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad3 is an important mediator of the TGF beta signaling pathway Smad3-/- follicles have impaired growth, increased atresia, and altered differentiation in the presence of high FSH levels, normal expression of FSHR, and lower expression of cyclin D2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2004 Sep 18(9) 2224-40",
                "id": "15192076"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815e6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad3, to activate expression of stress response factor ATF3 and then recruit this factor to the Id1 promoter",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Apr 11(4) 915-26",
                "id": "12718878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Mutation of the Smad-binding sites, the Ets-binding sites, or Sp1/3-binding sites in the TN-C promoter abrogated the TGF-beta/Smad-inducible promoter activity. Immunoprecipitation analysis revealed that Smad3, Sp1, and Ets1 form a transcriptionally active complex.  Furthermore, the interaction between Smads and CBP/p300 in TGF-beta signaling was confirmed.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Mar 4 23(9) 1656-67",
                "id": "15001984"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "In eNOS-/- mice, the Ang II-induced cardiac oxidative stress and TGF-beta-Smad 2/3 signaling pathway were enhanced, and pitavastatin treatment attenuated the enhanced oxidative stress and the signaling pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Jan 4 102(1) 68-76",
                "id": "17967781"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081874"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "HGF accelerated nuclear export of Smad3",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2008 Apr 134(4) 1180-90",
                "id": "18395096"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081873"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "The Hic-5 effect was mediated by a transactivation domain of Sp1 and functional interaction with p300 through the LIM4 domain. Hic-5 was also shown to interact functionally and physically with Smad3 through the LIM domains and to potentiate p21 promoter activity together with Smad3 and Sp1",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2004 Feb 15 91(3) 633-45",
                "id": "14755691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408186d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 36653-8",
                "id": "10973958"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408185b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Our data reveal that SMAD 2/3 signaling directly supports NANOG expression, while SMAD 1/5/8 activation moderately represses SOX2.",
              "citation": {
                "type": "PubMed",
                "name": "Stem Cells Dev 2008 Dec 17(6) 1065-77",
                "id": "18393632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081851"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad3 mediates this effect in part by inhibiting C/EBP-beta and C/EBP-delta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 16 279(16) 16388-93",
                "id": "14754879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081842"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "In addition, overexpression of Smad2 or Smad3, major signal transducing Smads, was sufficient to inhibite the IFN-gamma and TNF-alpha-induced TARC production in HaCaT cells",
              "citation": {
                "type": "PubMed",
                "name": "J Dermatol Sci 2003 Feb 31(1) 53-8",
                "id": "12615364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081839"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Fig. 8. TGF-beta1-induced SMAD2/3 activation and nuclear accumulation is suppressed by inhibition of Rho/ROCK signaling. ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2008 Mar 44(3) 527-38",
                "id": "18255094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081829"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "These data indicate that PKCdelta is activated by TGF-beta1 in human mesangial cells. TGF-beta1-stimulated PKCdelta activity positively regulates Smad transcriptional activity and is required for COL1A2 gene transcription",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2003 Sep 285(3) F413-22",
                "id": "12759229"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408181a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "In the nucleus, SKI proteins repress SMAD ability to transactivate TGF-? target genes by disrupting active heteromeric complexes of SMAD2 or SMAD3 with SMAD4, by recruiting a transcriptional repressor complex containing N-CoR SMRT, Sin3A, and HDAC-1, and by blocking the binding of transcriptional coactivators . ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2011 10(1) 2",
                "id": "21211030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081815"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "ALK1 via Smad1/5 transcription factors stimulates EC proliferation and migration, whereas ALK5 via Smad2/3 inhibits EC proliferation and migration",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2005 Feb 15 65(3) 599-608",
                "id": "15664386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081814"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Dominant negative RhoA blocked nuclear translocation of Smad2 and Smad3 because of the inhibition of phosphorylation of both Smads and inhibited Smad-dependent SBE promoter activity, whereas constitutively active RhoA significantly enhanced SBE promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 20 281(3) 1765-70",
                "id": "16317010"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408180c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "neural crest"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "BMC Neurosci 2004 Jan 13 5(1) 1",
                "id": "14720305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081806"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 22 275(38) 29308-17",
                "id": "10887185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081804"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "dominant-negative Smad3 potently suppressed the basal and TGF-beta-induced expression of MMP-13 and MMP-1 in SCC cells, and inhibited their basal and TGF-beta-induced invasion through Matrigel and type I collagen",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Apr 27 25(18) 2588-600",
                "id": "16407850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "FosB substantially enhances Smad3 and Smad4-dependent transcription",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 17 275(46) 36295-302",
                "id": "10942775"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "c-Jun NH(2)-terminal kinase tended to induce the phosphorylation of Smad2/3L in human colorectal adenoma-carcinoma sequence (phosphorylation increases formation of SMAD234 complex)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jan 1 65(1) 157-65",
                "id": "15665291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad3 and Smad4, but not Smad2, were absolutely required for induction of the Smad7 promoter reporter gene by TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 14 275(15) 11320-6",
                "id": "10753944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "YY1 interacts with the conserved N-terminal Mad homology 1 domain of Smad4 and to a lesser extent with Smad1, Smad2, and Smad3. The YY1 zinc finger domain mediates the association with Smads and is necessary for the repressive effect of YY1 on Smad transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jul 23(13) 4494-510",
                "id": "12808092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2001 Dec 25(6) 732-8",
                "id": "11726399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "TGF-beta-induced Smad3 phosphorylation was elevated in the presence of YSR2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 14 278(11) 9276-82",
                "id": "12515830"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Treatment of differentiating cells with Activin A leads to activation of Smad2/3 and expression of nodal, lefty-A and lefty-B, while inhibition of ALK4/5/7 by the kinase inhibitor SB-431542 blocks activation of Smad2/3",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 22 279(43) 45076-84",
                "id": "15308665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Ha-Ras stimulation of the canonical Smad2/3 signalling pathway independently of TGFbeta production or activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Fibrogenesis Tissue Repair 2011 4(1) 8",
                "id": "21362163"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Table 1. Smad3 Dependence of TGFB1 Responses in Nme Cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2009 Aug 7(8) 1342-53",
                "id": "19671686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817d2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Transient transfection studies revealed that TGF beta 1 and its effector Smad3 are able to activate the P3 promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 7 276(49) 46661-70",
                "id": "11590145"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "By RT-PCR we have shown that TGFbeta up-regulates expression not only of plasminogen activator inhibitor type-1 (PAI-1), but also of the urokinase-type plasminogen activator receptor (uPAR), whose inhibition by specific antibodies blunted the TGFbeta angiogenic response in vitro. The SMAD2/3 and FAK signaling pathways were activated by TGFbeta in MVEC",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2009 Mar 1 77(5) 813-25",
                "id": "19041849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Jul 1 175(1) 547-54",
                "id": "15972691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817c8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Mar 15 172(6) 3814-21",
                "id": "15004187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Stable expression of Evi1 in non-transformed intestinal epithelial cells inhibited induction of some Smad3-dependent TGFbeta target genes, such as PAI1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jun 15 25(25) 3565-75",
                "id": "16462766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Transfection with a Smad3-expressing plasmid markedly increased Smad3 and ASMA protein expression, whereas transfection with an antisense Smad3 plasmid suppressed Smad3 and ASMA expression",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Sep 29(3 Pt 1) 397-404",
                "id": "12702545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817b5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Menin interacts with Smad3, and antisense menin suppresses transforming growth factor type beta-induced and Smad3-induced transcriptional activity by inhibiting Smad3/4-DNA binding at specific transcriptional regulatory sites",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Mar 27 98(7) 3837-42",
                "id": "11274402"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "BMP receptors activate Smad1, Smad5, and Smad8 (called BR-Smads in this review) whereas Smad2 and Smad3 are phosphorylated by the activin of Tgfbeta recepetors ALK3 and ALK6 can activate all three BR-Smads but ALK2 only phophorylates SMAD1 and SMAD5",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Jul 3 546(1) 133-9",
                "id": "12829249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Direct ChIP confirmed the rapid and specific binding of Smad3 to the tagln promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2008 Feb 1",
                "id": "18245174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "In HAWSMC, the TGF-1-induced increase in Nox4 transcripts was inhibited by transfection of siRNA against Smad3 but not Smad2 (Fig. 2C).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 Jun 292(6) L1543-55",
                "id": "17369289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Here we report that oncogenic Ras inhibits TGFbeta signaling in mammary and lung epithelial cells by negatively regulating the TGFbeta mediators Smad2 and Smad3.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad3, a downstream mediator of the TGF-beta signaling pathway, functions as a coregulator to enhance androgen receptor (AR)-mediated transactivation",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Mar 13 98(6) 3018-23",
                "id": "11248024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Treatment with TGF-beta and/or overexpression of SMAD2, -3, or -4 also resulted in a significant increase in myostatin promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C188-99",
                "id": "16885393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081798"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "cooperative induction of the LAMC1 promoter and the endogenous LAMC1 gene by TFE3 and Smad3 is augmented by the TGF-beta signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 29 277(13) 11375-84",
                "id": "11801598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408178e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Previous work from our laboratory demonstrated that Smad3, and not Smad2, is sufficient for stimulation of the rat FSH(beta) promoter",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2005 Jul 19(7) 1849-58",
                "id": "15761025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408178b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We now show that TGF-beta-activated Smad3 suppresses the function of MEF2",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Apr 7 23(7) 1557-66",
                "id": "15044954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408178a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We found that TGF-beta1 transiently induces SRF and SM22 transcription, and that this process is accompanied by transient increases of SRF and Smad3 binding to the SM22 promoter",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2003 Dec 35(12) 1407-20",
                "id": "14654367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081783"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 27 275(43) 33205-8",
                "id": "10973944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081782"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Erbin does not affect the level of TGFbeta-induced phosphorylation of Smad2/3, but physically sequesters Smad2/3 from their association with Smad4 and hence negatively modulates TGFbeta-dependent transcriptional responses and cell growth inhibition. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Jun 25",
                "id": "17591701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408177e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 16 278(20) 18408-18",
                "id": "12626500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081777"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad3 activity was decreased in P311-expressing cells, but was corrected by exogenous TGF-beta1 treatment, which also elevated TGF-beta1 mRNA level.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Mar 19 315(4) 1104-9",
                "id": "14985127"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081770"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "binding of Smad3/Smad4 and c-Jun to their corresponding DNA elements",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2003 Jun 27 92(12) 1288-95",
                "id": "12764024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408176f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "we found that cardiac allografts transplanted into Smad3-deficient mice developed accelerated intimal hyperplasia with increased infiltration of macrophages that expressed MCP-1.79",
              "citation": {
                "type": "PubMed",
                "name": "Panminerva Med 2005 Sep 47(3) 169-86",
                "id": "16462725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408176e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Atherosclerosis",
                "cell": "Macrophages",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "c-Jun NH(2)-terminal kinase tended to induce the phosphorylation of Smad2/3L in human colorectal adenoma-carcinoma sequence (phosphorylation increases formation of SMAD234 complex)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jan 1 65(1) 157-65",
                "id": "15665291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408176a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Fig.4 GW7845 inhibits TGFbeta1-dependent induction of ECM genes and activation of Smad3 without inducing toxicity in human HSC. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Nov 17 350(2) 385-91",
                "id": "17010940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081766"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "GnRH in a dose--(0.01 to 10 microM) and time--(5 to 30 min) dependent manner decreased the rate of Smad3 activation (phospho-Smad3, pSmad3), and altered Smad3 cellular distribution in both cell types.",
              "citation": {
                "type": "PubMed",
                "name": "Reprod Biol Endocrinol 2003 Dec 16 1 125",
                "id": "14678567"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408175f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We show in this report that PIAS3, a member of the protein inhibitor of activated STAT (PIAS) family, activates TGF-beta/Smad transcriptional responses.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Jan 6 101(1) 99-104",
                "id": "14691252"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081758"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jan 4(1) 51-8",
                "id": "11740493"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081755"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2001 Apr 59(4) 716-24",
                "id": "11259615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081747"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We cotransfected 795Csrp2-luc with Smad3?C, a dominant negative Smad3 expression plasmid that lacks C-terminal phosphorylation and activation sites (30). In transient transfection assays, Smad3?C decreased Csrp2 promoter activity by 43% in the absence of TGF? (Fig. 9A). Furthermore, Smad3?C reduced TGF? induction from 350 to 139% (Fig. 9A). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 May 30 283(22) 15003-14",
                "id": "18387947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408173b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "# Ariadne: Moreover, it was  recently shown that the expression of CTGF , which mediates the actions of TGF- eta and induces proliferation of fibroblasts and collagen synthesis, is driven  by Smad3 and Smad4 ( 22 ). [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 4 277(1) 407-15",
                "id": "11572876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081737"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 20 276(16) 13461-8",
                "id": "11278805"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081736"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 15 277(46) 43749-56",
                "id": "12226080"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081734"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "the transcription factors Smad3 and Smad4 mediate activin-stimulated activity of the rat FSHbeta promoter",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2003 Mar 17(3) 318-32",
                "id": "12554780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081732"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "TSF1 did not directly activate a Smads-dependent promoter from plasminogen activator inhibitor 1 gene, but it showed enhancement in co-operation with Smad3 and Smad4.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Sep 1 350 Pt 2 395-404",
                "id": "10947953"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408172b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "TGFb1 signaling activates receptor SMADs, SMAD2 and SMAD3, which associate with a variety of nuclear factors to regulate gene transcription",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Sep 17 285(38) 29044-8",
                "id": "20656683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081725"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th17 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Ras acting via Erk MAP kinases causes phosphorylation of Smad2 and Smad3 at specific sites in the region linking the DNA-binding domain and the transcriptional activation domain.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408171a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "These result suggest that TGF-beta1 stimulation of VEGF production by fibroblasts is regulated by Smad3 but not by Smad2 signaling",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Feb 11 327(2) 393-8",
                "id": "15629128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408170c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Overexpression of Smad3/4 enhanced the TGF-?1-induced BAFF mRNA expression, and overexpression of a DN-Smad3 abrogated BAFF transcription in a dose-dependent manner (Fig. 2A  ). ",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2008 Jun 83(6) 1431-9",
                "id": "18334541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408170a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2001 Apr 187(1) 117-23",
                "id": "11241356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "The present study indicated that TGF-beta-responsive ERK1/2 and JNK cascades negatively regulate Smad3-induced transcriptional activity as well as ALP activity and mineralization in osteoblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36024-31",
                "id": "12130649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816f7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 May 1 149(3) 667-82",
                "id": "10791980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "The results showed that Smad3 and Smad4, but not Smad1 or Smad2, mimicked the inhibitory effect of TGF-beta and abrogated interleukin-1beta (IL-1beta)-induced stimulation of MMP-1 promoter activity and NFkappaB-specific gene transcription in dermal fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 19 276(42) 38502-10",
                "id": "11502752"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Exposure to TNF-alpha activates transcription factors NF-kappaB, Smad3/4, and PPARalpha/gamma",
              "citation": {
                "type": "PubMed",
                "name": "J Am Coll Surg 2004 Jul 199(1) 87-95",
                "id": "15217635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ed"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 6 276(14) 10594-601",
                "id": "11152469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We show that expression of exogenous hZimp10 enhances the transcriptional activity of Smad3",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Aug 18 281(33) 23748-56",
                "id": "16777850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "p-Smad2/3 and Smad4 protein in murine lung fibroblasts induced by TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2006 7 16",
                "id": "16438734"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816e2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 2 275(22) 16709-16",
                "id": "10828062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Western blot analysis revealed that KLF2-transduced HUVECs contain lower levels of P-Smad2 and P-Smad3 compared with mock-transduced cells",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2007 Mar 27(3) 532-9",
                "id": "17194892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "C/EBPdelta was expressed with increasing amounts of Smad3, with or without Smad4.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 14 278(11) 9609-19",
                "id": "12524424"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816bd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Second, silencing of SMAD protein levels using short interfering RNAs revealed that TGFbeta-induced activation of the endogenous gadd45beta gene required SMAD3 and SMAD4 but not SMAD2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 13 279(7) 5278-87",
                "id": "14630914"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Tables 1,2, and 3 - Gene expression changes as a result of knockdown of SMAD2, SMAD3, or SMAD4 in the presence of TGFB1 in Hep3B cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 May 215(2) 422-33",
                "id": "17960585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "RLP is a Smad3-dependent immediate-early TGF-beta target gene, its expression being induced within 45 min.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Oct 1 383(Pt 1) 187-99",
                "id": "15239668"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816aa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We show that SRF significantly inhibits the TGF-beta1/Smad-dependent transcription by associating with Smad3.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jan 11 26(2) 173-85",
                "id": "16819512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "We now identify SARA (for Smad anchor for receptor activation), a FYVE domain protein that interacts directly with Smad2 and Smad3.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1998 Dec 11 95(6) 779-91",
                "id": "9865696"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "As indicated, activation of TGF-beta-Smad3/4 signaling first induces MKP-1 expression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 25 278(30) 27811-9",
                "id": "12734193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408169b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "FIGURE 9. TGF-beta1 induces snail-1 in hepatocytes in EMT state and lack of evidence for Akt/Erk1/2 activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 27 282(30) 22089-101",
                "id": "17513865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408169a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Short interfering RNA-mediated inhibition of Smad3 markedly suppressed ALK7-induced caspase-3 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28458-65",
                "id": "15107418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408168b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "The expression of JunD colocalised with pSmad 3 in fibrotic skin and silencing of Smad 3 or Smad 4 by siRNA prevented the induction of JunD by TGFbeta......The expression of JunD was analysed by real-time PCR, immunofluorescence, western blotting and immunohistochemistry. ",
              "citation": {
                "type": "PubMed",
                "name": "Ann Rheum Dis 2011 Jul 70(7) 1320-6",
                "id": "21515915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408168a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad7 was recently shown to antagonize TGF-beta-induced activation of signal-transducing Smad2 and Smad3 proteins",
              "citation": {
                "type": "PubMed",
                "name": "Mech Dev 2000 May 93(1-2) 71-81",
                "id": "10781941"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081689"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "WtTGFbetaRIII inhibited phosphorylation of Smad 2 and 3 (Fig. 3A) as well as Akt and ERK by TGF-beta (Fig. 3B).",
              "citation": {
                "type": "PubMed",
                "name": "Biomed Pharmacother 2010 Sep 64(7) 472-6",
                "id": "20359848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081676"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 28 278(13) 11227-36",
                "id": "12551947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408165e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "we found that MCP-1 is a direct gene target of TGF-beta via Smad3/4",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Feb 1 109(3) 987-94",
                "id": "17032917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408165a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Furthermore, acute and long-term pretreatment of ECs with thrombin or PAR1 peptide agonist suppressed the TGF-beta-induced serine phosphorylation of Smad2, a critical mediator of TGF-beta signaling. Moreover, activation of PAR1 led to a profound and spread cytosolic clustering formation of Smad2/3 and markedly prevented Smad2/3 nuclear translocation evoked by TGF-beta1.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Mar 1 105(5) 1977-85",
                "id": "15522964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081651"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 8 276(23) 19945-53",
                "id": "11262418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408164f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "TGFbeta stimulation triggers a transient increase in association of Dab2 with Smad2 and Smad3",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Jun 1 20(11) 2789-801",
                "id": "11387212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408164c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "A complex containing Smad3, the transcription factors E2F4/5 and DP1, and the corepressor p107 preexists in the cytoplasm. In response to TGFbeta, this complex moves into the nucleus and associates with Smad4, recognizing a composite Smad-E2F site on c-myc for repression",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2002 Jul 12 110(1) 19-32",
                "id": "12150994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081637"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "MDMX can inhibit the transcriptional activity of ectopically expressed SMAD1, SMAD2, SMAD3, and SMAD4",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1999 Oct 15 59(20) 5075-8",
                "id": "10537276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408162e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Table 1 Transcription factors activated by OxLDL",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37",
                "id": "18996472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408160b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Tsc-22 binds to and modulate the transcriptional activity of Smad3 and Smad4",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2005 Mar 271(1-2) 23-8",
                "id": "15881652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815f9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD3) actsIn tscript(p(HGNC:SMAD3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Feb 5 23(5) 1043-51",
                "id": "14762439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:STAT4)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:STAT4))",
        "directed": false,
        "label": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053937",
          "evidences": [
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": ". A GAS element from the promoter region of the IRF-4 gene was identified. Following stimulation of cells with IFN-alpha or IL-12, Stat4 was found to bind to this IRF-4 GAS element, as detected by EMSA and DNA affinity binding, implying that the IRF-4 gene is directly activated by both cytokines. Our results suggest that IFN-alpha and IL-12 may enhance innate and Th1 immune responses by inducing IRF-1, IRF-4, and IRF-8 gene expression.",
              "citation": {
                "type": "Other",
                "name": "cytokine 2003 nov 7 24(3) 81-90",
                "id": "14581002"
              },
              "metadata": {
                "created_by": "davidgaralf",
                "id": "54df921989e3620318d9399b"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "A GAS element from the promoter region of the IRF-4 gene was identified. Following stimulation of cells with IFN-alpha or IL-12, Stat4 was found to bind to this IRF-4 GAS element, as detected by EMSA and DNA affinity binding, implying that the IRF-4 gene is directly activated by both cytokines.",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine 2003 Nov 7 24(3) 81-90",
                "id": "14581002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "from full text - IFN-a initiates the activation of STAT-1 followed by the induction of IFIG [3537]. Although it is reported that IL-27 activates not only STAT-1, but also STAT-2, STAT-3, STAT-4 and STAT-5 in T cells [2,4,14,38], and activates STAT-3 in macrophages [39], it has not been clear whether the cytokine activates STAT-1 in macrophages. To determine whether IL-27 activates STAT-1 in CD4 T cells and MDM in our culture system, Western blot analysis was performed. The assay demonstrated that both cytokines induced the phosphorylation of STAT-1 in CD4 T cells and MDM (Fig. 2d).",
              "citation": {
                "type": "PubMed",
                "name": "AIDS 2008 Jan 2 22(1) 39-45",
                "id": "18090390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081822"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "PIASx becomes associated with Stat4 following IL-12 stimulation in vivo. PIASx inhibits IL-12-stimulated and Stat4-dependent gene activation in human T cells. PIASx does not inhibit the DNA binding activity of Stat4. Instead PIASx is present in the Stat4-DNA binding complex. Finally the inhibitory activity of PIASx on Stat4-mediated gene activation is abolished by the histone deacetylase inhibitor trichostatin A. Our results suggest that PIASx may function as a co-repressor of Stat4.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 13 278(24) 21327-30",
                "id": "12716907"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408173a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Signal transducer and activator of transcription 4 (STAT4) is critical for the response to IL-12, although there is a parallel pathway involving T box expressed in T cells (T-bet), and cells from mice double-deficient in STAT4 and T-bet are refractory to the inhibition of aTreg-cell development by IL-12. ",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2009 Aug 127(4) 587-95",
                "id": "19604309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408168d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Interleukin 12 (IL-12)-induced T helper 1 (Th1) development requires Stat4 activation. Using subtractive cloning, we identified ERM, an Ets transcription factor, to be a Th1-specific, IL-12-induced gene. IL-12-induction of ERM occurred in wild-type and Stat1-deficient, but not Stat4-deficient, T cells, suggesting ERM is Stat4-inducible.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1999 Mar 30 96(7) 3888-93",
                "id": "10097133"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081656"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Moreover, IL-4 and IL-5 production is increased in patient Th1 cultures though there are no defects in the development of Th2 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Jun 4 113(23) 5887-90",
                "id": "19359411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408163e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "In related studies, we show that the negative effect of GATA-3 on Th1 differentiation in T-bet-/- cells arises from its ability to suppress STAT4 levels, because if this is prevented by a STAT4-expressing retrovirus, normal Th1 differentiation is observed. (from text): As shown in Fig. 4(C and D), maintenance of STAT4 levels using this approach restored Th1 differentiation very effectively, even under suboptimal Th1 conditions, and this effect was associated with the down-regulation of GATA-3.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2006 Mar 20 203(3) 755-66",
                "id": "16520391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815e8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": " STAT4 is activated in response to IL-12, and is involved in the development of na?ve CD4+ T cells to the Th1 phenotype",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Aug 15 579(20) 4470-8",
                "id": "16081070"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081877"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "naive T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "from full text - Both cytokines (IL-12 and IL-23) activate TYK2 and JAK2 as well as STAT1, STAT3, STAT4, and STAT5 [60].",
              "citation": {
                "type": "PubMed",
                "name": "World J Gastroenterol 2008 Jul 21 14(27) 4280-8",
                "id": "18666314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081871"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "These results show that STAT4 up-regulates AP-1-mediated IFN-gamma promoter activation without directly binding to the promoter sequence, providing a mechanistic explanation for IL-12/IL-18-induced synergistic enhancement of IFN-gamma gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Feb 1 168(3) 1146-53",
                "id": "11801649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408186b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Table IV. Genes regulated by both IL-12 and STAT4 IL-12/STAT4-induced genes",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Jun 1 172(11) 6775-82",
                "id": "15153495"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081862"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "The JAK1-STAT1 and JAK2-STAT4 signaling pathways are known to be important for Th1 cell differentiation,",
              "citation": {
                "type": "PubMed",
                "name": "Self Nonself 2011 1 2(1) 35-42",
                "id": "21776333"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081856"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "The phosphorylated STAT proteins move to the nucleus, bind specific DNA elements, and direct transcription",
              "citation": {
                "type": "PubMed",
                "name": "Science 1994 Jun 3 264(5164) 1415-21",
                "id": "8197455"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081845"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": " IL-23 signaling activated Tyk2, Jak2, and STAT 1, 3, 4. ",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2003 Nov 19(5) 641-4",
                "id": "14614851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408183c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Y00964 Hexosaminidase B 2.1 2.4",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Aug 15 22(16) 4237-48",
                "id": "12912921"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081832"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Serine phosphorylation is required for full activation of STAT4-induced transcription and IFN-? expression and it has been shown that this essential phosphorylation step is mediated by p38 MAPK [78,79].",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2006 8(2) 205",
                "id": "16542479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Sep 1 96(5) 1844-52",
                "id": "10961885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817e7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "When CD4+ T lymphocytes of STAT4-deficient mice were stimulated in the presence of IL-12 and IFN-{gamma}, no induction of twist1 expression was detectable (Fig. 2 C).",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2008 Aug 4 205(8) 1889-901",
                "id": "18663125"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817cf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "we demonstrate that expression of IL12Rb1, IL12Rb2, MyD88, and IL-18R is IL12 inducible in a Stat4 dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Dec 15 165(12) 6803-8",
                "id": "11120802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817be"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "The JAK1-STAT1 and JAK2-STAT4 signaling pathways are known to be important for Th1 cell differentiation,",
              "citation": {
                "type": "PubMed",
                "name": "BMC Immunol 2011 12 51",
                "id": "21884580"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "in contrast to the direct recruitment of Stat4 by the IL-12 receptor, Stat4 activation by the human IFN-alpha receptor occurs through indirect recruitment by intermediates involving Stat2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 28 275(4) 2693-7",
                "id": "10644731"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "IL-23 activates the same Jak-stat signaling molecules as IL-12: Jak2, Tyk2, and stat1, -3, -4, and -5, but stat4 activation is substantially weaker and different DNA-binding stat complexes form in response to IL-23 compared with IL-12. IL-23R associates constitutively with Jak2 and in a ligand-dependent manner with stat3.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Jun 1 168(11) 5699-708",
                "id": "12023369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408176b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "IL-23 activates Stat4 in PHA blast T cells.",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2000 Nov 13(5) 715-25",
                "id": "11114383"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081762"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "IL-12 activates STAT4, which is a critical regulator of inflammation and T helper type I (Th1) lineage development in murine systems.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Jun 4 113(23) 5887-90",
                "id": "19359411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081751"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Overexpression of PTP-BL (WT) led to an inhibition in STAT4-mediated transactivation from this reporter construct, whereas overexpression of mutated PTP-BL (DC) led to a slight increase in reporter activity (IRF1 reporter).",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2007 Feb 26(2) 163-76",
                "id": "17306571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408174b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "The p38 mitogen-activated protein kinase (MAPK) signaling pathway is also activated in response to IL-12, followed by phosphorylation of STAT4 on serine 721, which is required for STAT4 full transcriptional activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2005 Dec 10(12) 1153-62",
                "id": "16324152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081711"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Jun 15 168(12) 6506-13",
                "id": "12055272"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816d0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2001 Sep 108(5) 739-47",
                "id": "11544280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816cf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "IL-12 mediates its biological activities through activation of the receptor-associated JAK family kinases and STAT4, which is recruited to phosphorylated Tyr-800 in the human IL-12 receptor beta2 subunit (IL-12Rbeta2). ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Oct 31 310(4) 1188-93",
                "id": "14559241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "Cytokines control the outcome of TH immunity, with IL-12, acting via signal transducer and activator of transcription 4 (STAT4), to promote TH1 development, whereas IL-4 promotes TH2 development via the actions of STAT6 (2).",
              "citation": {
                "type": "PubMed",
                "name": "Science 2001 Jun 8 292(5523) 1907-10",
                "id": "11397944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:STAT4) actsIn tscript(p(HGNC:STAT4))",
              "summary_text": "In addition, pulmonary levels of chemokines were decreased in the STAT4(-/-) mice, including CC chemokine ligand (CCL)5, CCL6, CCL11, and CCL17.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Apr 1 170(7) 3859-65",
                "id": "12646654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815f0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:SMAD7)",
        "relation": "decreases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "p(HGNC:SMAD7) decreases p(HGNC:FOXP3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405394e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:SMAD7) decreases p(HGNC:FOXP3)",
              "summary_text": "we demonstrate that TGF-beta is able to induce Foxp3 expression and subsequently a regulatory phenotype in CD4(+)CD25(-) peripheral murine T cells. Similarly, TGF-beta induced Foxp3 in human CD4(+)CD25(-) T cells. Moreover, we show that the inhibitory Smad7 protein that is normally induced by TGF-beta and limits TGF-beta signaling, is strongly down-regulated by Foxp3 at the transcriptional level.",
              "citation": {
                "type": "Other",
                "name": "j immunol. 2004 may 1;172(9):5149-53.",
                "id": "15100250"
              },
              "metadata": {
                "created_by": "davidgaralf",
                "id": "54df925a89e3620a348c7eaa"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD7) decreases p(HGNC:FOXP3)",
              "summary_text": "\"We demonstrate that TGF-beta induces a regulatory phenotype in CD4(+)CD25(-) T cells through the induction of Foxp3 and a positive autoregulatory loop of TGF-beta signaling due to the absence of Smad7.\"",
              "citation": {
                "type": "Other",
                "name": "J Immunol. 2004 May 1;172(9):5149-53.",
                "id": "15100250"
              },
              "metadata": {
                "created_by": "alejandroferreiromorales.cr",
                "id": "5474b91a89e36203f0827f64"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:SMAD7) decreases p(HGNC:FOXP3)",
              "summary_text": "SMAD7 overexpression in T cells using newly created transgenic mice rendered CD4(+)CD25(-) T cells resistant to the induction of FoxP3",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Aug 15 179(4) 2041-5",
                "id": "17675459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817c0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Tretinoin)",
        "relation": "increases",
        "target": "tscript(p(HGNC:SMAD3))",
        "directed": false,
        "label": "a(SCHEM:Tretinoin) increases tscript(p(HGNC:SMAD3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053935",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Tretinoin) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Herein we show that RA enhances TGF-beta signaling by increasing the expression and phosphorylation of Smad3, and this results in increased Foxp3 expression even in the presence of IL-6 or IL-21. RA also inhibits the expression of IL-6Ralpha, IRF-4, and IL-23R and thus inhibits Th17 development",
              "citation": {
                "type": "Other",
                "name": "j immunol 2008 aug 15 181(4) 2277-84",
                "id": "18684916"
              },
              "metadata": {
                "created_by": "davidgaralf",
                "id": "54e0ef7789e3620a34a61dca"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "regulatory t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Tretinoin) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Herein we show that RA enhances TGF-beta signaling by increasing the expression and phosphorylation of Smad3, and this results in increased Foxp3 expression even in the presence of IL-6 or IL-21. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Aug 15 181(4) 2277-84",
                "id": "18684916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816b5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCR5)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:CCR5))",
        "directed": false,
        "label": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053941",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Previous studies have shown that CCL16 is a low-affinity ligand for CCR1, CCR2, CCR5, and CCR8 and attracts monocytes and T cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Aug 1 173(3) 2078-83",
                "id": "15265943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081634"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "CCL3- and CCL4-triggered migration of GM-CSF-primed neutrophils was inhibited by the CCR5 antagonist TAK-779. Accordingly, freshly isolated neutrophils express CCR5. Extracellular signal-regulated kinases (ERK)-1/2 and p38 mitogen-activated protein kinase (MAPK) inhibitors blocked CCL3-induced migration of GM-CSF-primed neutrophils.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Mar 17(3) 355-63",
                "id": "15567066"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081876"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "HIV envelope binds to and signals through its primary cellular receptor, CD4, and through a coreceptor, either CC chemokine receptor 5 (CCR5) or CXC chemokine receptor 4 (CXCR4). Here, we evaluate the response of peripheral blood mononuclear cells to a panel of genetically diverse R5 and X4 envelope proteins. Modulation of gene expression was evaluated by using oligonucleotide microarrays. Activation of transcription factors was evaluated by using an array of oligonucleotides encoding transcription factor binding sites. Responses were strongly influenced by coreceptor specificity. Treatment of cells from CCR5delta32 homozygous donors with glycoprotein (gp)120 derived from an R5 virus demonstrated that the majority of responses elicited by R5 envelopes required engagement of CCR5. R5 envelopes, to a greater extent than X4 envelopes, induced the expression of genes belonging to mitogen-activated protein kinase signal transduction pathways and genes regulating the cell cycle. A number of genes induced by R5, but not X4, envelopes were also up-regulated in the resting CD4+ T cell population of HIV-infected individuals. These results suggest that R5 envelope facilitates replication of HIV in the pool of resting CD4+ T cells. Additionally, signaling by R5 gp120 may facilitate the transmission of R5 viruses by inducing a permissive environment for HIV replication.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Mar 7 103(10) 3746-51",
                "id": "16505369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081866"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "peripheral blood mononuclear cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
              "citation": {
                "type": "PubMed",
                "name": "Clin Lab Med 2008 Sep 28(3) 375-84, v",
                "id": "19028258"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408184f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Syk was also activated upon MIP1beta stimulation of CCR5 L1.2 transfectants or T-cells and associated with RAFTK. Overexpression of a dominant-negative Src-binding mutant of RAFTK (RAFTK(m402)) significantly attenuated Syk activation, whereas overexpression of wild-type RAFTK enhanced Syk activity, indicating that RAFTK acts upstream of CCR5-mediated Syk activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 9 275(23) 17263-8",
                "id": "10747947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081844"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "In vivo, different chemokines orchestrate the recruitment of  DCs into the lung depending on the inflammatory stimulus present.  In a rat model of inhaled heat-killed Moraxella catarrhalis,  the phenomenon seemed dependent on the expression of CCR1 and  CCR5, which are receptors for the chemokines CCL5 (regulated  on activation, normal T-cell expressed and secreted [RANTES])  and/or CCL3 (macrophage inflammatory protein [MIP]-1{alpha}) produced at the airway level ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2005 Sep 1 172(5) 530-51",
                "id": "15879415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "RANTES treatment of PM1 T cells results in the rapid phosphorylation-activation of CCR5, Jak2, and Jak3. RANTES-inducible Jak phosphorylation is insensitive to pertussis toxin inhibition, indicating that RANTES-CCR5-mediated tyrosine phosphorylation events are not coupled directly to Galpha(i) protein-mediated events. In addition to Jaks, several other proteins are rapidly phosphorylated on tyrosine residues in a RANTES-dependent manner, including the Src kinase p56(lck), which associates with Jak3",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 6 276(14) 11427-31",
                "id": "11278738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "The CCR5 chemokine receptor is a member of the G protein-coupled receptor (GPCR) family that is expressed by macrophages, memory T-lymphocytes and dendritic cells and is activated by chemotactic proteins (e.g. MIP-1alpha [CCL3], MIP-1beta [CCL4] and RANTES [CCL5])",
              "citation": {
                "type": "PubMed",
                "name": "Br J Pharmacol 2008 Apr 153(7) 1513-27",
                "id": "18223665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408169f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "these in vivo data demonstrate that Ccr1, Ccr2, and Ccr5 mediate the postischemic recruitment of neutrophils through effects on intravascular adherence and subsequent transmigration.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2006 Jan 79(1) 114-22",
                "id": "16275892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081697"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Taken together, these results showed that MIP- 1b released from ET-1treated PBMs was biologically functional in mediating chemotaxis of THP-1 cells via the CCR5 receptor.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Oct 15",
                "id": "20952681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081665"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "This study establishes CCR5 as a critical receptor guiding NK cell trafficking in host defense",
              "citation": {
                "type": "PubMed",
                "name": "PLoS Pathog 2006 Jun 2(6) e49",
                "id": "16789839"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081613"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Although the mechanisms of DC precursor recruitment to the lung mucosa are incompletely defined, CCR1 and CCR5 have been implicated under both homeostatic and pathogen-induced conditions",
              "citation": {
                "type": "PubMed",
                "name": "Cell Res 2010 Aug 20(8) 872-85",
                "id": "20603644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081602"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Anti-CCR1, anti-CCR5, or BX471 also inhibited the upregulation of beta1 integrin mRNA in myeloma cells induced by MIP-1alpha, as well as the adherence of myeloma cells to stromal cells and IL-6 production by stromal cells in response to myeloma cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Hematol 2005 Mar 33(3) 272-8",
                "id": "15730850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081868"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Expression of beta-arrestin2 also augmented chemokine receptor CCR5-mediated but not epidermal growth factor receptor-mediated chemotaxis, indicating the specific effect of beta-arrestin2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 49212-9",
                "id": "12370187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081838"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "CCR1, CCR2 and CCR5 mediate recruitment of both infiltrating macrophages",
              "citation": {
                "type": "PubMed",
                "name": "J Neuroinflammation 2007 4 14",
                "id": "17484785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817ec"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Eotaxin-3/CCL26 is an agonist for chemokine receptor 3 (CCR3) and a natural antagonist for CCR1, CCR2 and CCR5. ",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2010 May 130(1) 74-82",
                "id": "20059579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "In addition, CXCL12 selectively activates STAT 5 whereas CCL5 activates STAT 1.",
              "citation": {
                "type": "PubMed",
                "name": "Stem Cells 2005 Oct 27",
                "id": "16253981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Table 1.  Lymphoid chemokine receptors",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2004 Feb 25(2) 67-74",
                "id": "15102365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408175e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "In addition, CXCL12 selectively activates STAT 5 whereas CCL5 activates STAT 1.",
              "citation": {
                "type": "PubMed",
                "name": "Stem Cells 2005 Oct 27",
                "id": "16253981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "mesenchyme"
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Additional studies demonstrate that isolated CCR5 activation by R5 Env leads to both de novo expression of FasL and induction of susceptibility to Fas-mediated apoptosis in resting primary CD4 T cells",
              "citation": {
                "type": "PubMed",
                "name": "AIDS 2002 Jul 26 16(11) 1467-78",
                "id": "12131184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCR5) actsIn cat(p(HGNC:CCR5))",
              "summary_text": "Chemokine receptors signal through Galphai2 proteins to activate DOCK2 (dedicator of cytokinesis 2) and other guanine nucleotide exchange factors (GEFs), leading to the activation of RAC1 and RHOA. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 Sep 9(9) 630-44",
                "id": "19696767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081650"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TGFB1)",
        "relation": "increases",
        "target": "p(HGNC:CTLA4)",
        "directed": false,
        "label": "p(HGNC:TGFB1) increases p(HGNC:CTLA4)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405393a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TGFB1) increases p(HGNC:CTLA4)",
              "summary_text": "we report that negative CTLA-4 costimulation is necessary for generating phenotypically and functionally similar adaptive CD4+CD25+ suppressor cells. TGF-beta could not induce CD4+CD25- cells from CTLA-4(-/-) mice to express normal levels of FoxP3 or to develop suppressor activity. Moreover, blockade of CTLA-4 following activation of wild-type CD4+ cells abolished the ability of TGF-beta to induce FoxP3-expressing mouse suppressor cells. TGF-beta accelerated expression of CTLA-4, and time course studies suggested that CTLA-4 ligation of CD80 shortly after T cell activation enables TGF-beta to induce CD4+CD25- cells to express FoxP3 and develop suppressor activity",
              "citation": {
                "type": "Other",
                "name": "j immunol 2006 mar 15 176(6) 3321-9",
                "id": "16517699"
              },
              "metadata": {
                "created_by": "davidgaralf",
                "id": "54e128a889e3620a34b0858f"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "regulatory t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases p(HGNC:CTLA4)",
              "summary_text": "TGF-beta accelerated expression of CTLA-4, and time course studies suggested that CTLA-4 ligation of CD80 shortly after T cell activation enables TGF-beta to induce CD4+CD25- cells to express FoxP3 and develop suppressor activity. TGF-beta also enhanced CD4+ cell expression of CD80.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Mar 15 176(6) 3321-9",
                "id": "16517699"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815db"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FOXP3)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:FOXP3))",
        "directed": false,
        "label": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053968",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "Stimulation with PMA/PHA results in a dramatic activation of the reporters in Jurkat-T/Vxypuro cells, whereas both basal and PMA/PHA-induced NFAT and NF-?B luciferase activity was significantly decreased in Jurkat-T/FOXP3 cells (Fig. 2B)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Oct 12 362(1) 44-50",
                "id": "17706604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408177b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "(from text) These experiments demonstrated that GATA3 binds the palindromic FOXP3 promoter. To gain insights into the in vivo situation, we performed a chromatin immunoprecipitation (ChIP) using an anti-GATA3 antibody and showed that GATA3 binds to the FOXP3 promoter region in Th2 cells, but not in iTreg cells (Figure 7F). Taken together these data demonstrate that the GATA3-binding to the FOXP3 promoter is repressing FOXP3 expression.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS Biol 2007 Dec 5(12) e329",
                "id": "18162042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081879"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "We found that the Gpr83, Ecm1, Cmtm7, Nkg7, Socs2 and glutaredoxin genes are predominantly transcribed in fresh and activated natural Treg as well as in Foxp3-transduced cells",
              "citation": {
                "type": "PubMed",
                "name": "Int Immunol 2006 Aug 18(8) 1197-209",
                "id": "16772372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081685"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "Thus, these data indicate that Foxp3 specifically inhibits IL-17A mRNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jun 20 283(25) 17003-8",
                "id": "18434325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081644"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "In the present work, we demonstrate that Foxp3 can induce heme oxygenase-1 (HO-1) expression and subsequently such regulatory phenotypes as the suppression of nontransfected cells in a cell-cell contact-dependent manner as well as impaired proliferation and production of cytokines upon stimulation in Jurkat T cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Feb 25 327(4) 1066-71",
                "id": "15652505"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408163d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "NFAT2 is typically expressed at low levels in resting T cells, but is up-regulated by NFAT1 upon cellular activation. We demonstrate that transcription from the NFAT2 promoter is significantly suppressed by FOXP3....From Methods: \\\"Primary human CD4+ T cells were purified from whole blood\\\"",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2009 Jul 15 183(2) 907-15",
                "id": "19564342"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081612"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "Examination of IL-17 expression in heterozygous RORgammatGFP knock-in mice revealed that RORgammat+Foxp3+ lamina propria T cells produced much less IL-17 than RORgammat+Foxp3- cells, suggesting that Foxp3 may interfere with the ability of RORgammat to induce IL-17 (Fig. 1c). ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 May 8 453(7192) 236-40",
                "id": "18368049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081858"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "FoxP3 is the transcription factor driving CD4+ T cell differentiation towards T regulatory cells, which is known to attenuate T cell-mediated immune responses [86].",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cell Biol 2011 2011 470597",
                "id": "22190938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408182e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "CD4+ T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "The expression of FOXP3-induced surface molecules such as CD25 and CTLA-4 were not enhanced in FOXP3Delta2Delta7 transduced CD4+ T cells, ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2009 4(7) e6104",
                "id": "19568423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081746"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "HBZ inhibits Foxp3-mediated CTLA-4 and GITR expression in CD4+ T cells in vitro",
              "citation": {
                "type": "PubMed",
                "name": "PLoS Pathog 2011 7(2) e1001274",
                "id": "21347344"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408170d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "CD4+ T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "The absence of a functional Foxp3 leads to NF-?B and NFAT hyper-activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Apr 5 102(14) 5138-43",
                "id": "15790681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816fd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FOXP3) actsIn tscript(p(HGNC:FOXP3))",
              "summary_text": "Upon stimulation with PMA and ionomycin, the productions of IL-2 and IFN-? was significantly reduced in Foxp3-transfected Jurkat T cells, as compared with the cells transfected with the control vector pcDNA3 (Fig. 1B). Similar to its suppressive effect on the production of cytokines, Foxp3 transfer also suppressed cellular proliferation (Fig 1C). I",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Feb 25 327(4) 1066-71",
                "id": "15652505"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081653"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:IL7R)",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "p(HGNC:IL7R) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405396b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:IL7R) increases p(HGNC:FOXP3)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408179a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TGFB1)",
        "relation": "increases",
        "target": "p(HGNC:CD80)",
        "directed": false,
        "label": "p(HGNC:TGFB1) increases p(HGNC:CD80)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053939",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TGFB1) increases p(HGNC:CD80)",
              "summary_text": "TGF-beta accelerated expression of CTLA-4, and time course studies suggested that CTLA-4 ligation of CD80 shortly after T cell activation enables TGF-beta to induce CD4+CD25- cells to express FoxP3 and develop suppressor activity. TGF-beta also enhanced CD4+ cell expression of CD80.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Mar 15 176(6) 3321-9",
                "id": "16517699"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817b6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:CXCR3))",
        "relation": "increases",
        "target": "bp(GOBP:\"lymphocyte chemotaxis\")",
        "directed": false,
        "label": "cat(p(HGNC:CXCR3)) increases bp(GOBP:\"lymphocyte chemotaxis\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053959",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:CXCR3)) increases bp(GOBP:\"lymphocyte chemotaxis\")",
              "summary_text": "neutralization of CXCR3 reduced MIG/CXCL9-induced T lymphocyte proliferation and the number of IFN-gamma-positive spots",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Jun 15 172(12) 7417-24",
                "id": "15187119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081828"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:CXCR3)) increases bp(GOBP:\"lymphocyte chemotaxis\")",
              "summary_text": "supernatants harvested from stimulated PMN induced migration and rapid integrin-dependent adhesion of CXCR3-expressing lymphocytes; these activities were significantly reduced by neutralizing anti-MIG and anti-IP-10 Abs,",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Apr 15 162(8) 4928-37",
                "id": "10202039"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081694"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CXCR3)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:CXCR3))",
        "directed": false,
        "label": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405394b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "neutralization of CXCR3 reduced MIG/CXCL9-induced T lymphocyte proliferation and the number of IFN-gamma-positive spots",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Jun 15 172(12) 7417-24",
                "id": "15187119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408167b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "Chemokine receptors signal through Galphai2 proteins to activate DOCK2 (dedicator of cytokinesis 2) and other guanine nucleotide exchange factors (GEFs), leading to the activation of RAC1 and RHOA. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 Sep 9(9) 630-44",
                "id": "19696767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081721"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "The chemokine receptor CXCR3 is critical for the function of activated T cells. We studied the molecular mechanisms of CXCR3 signalling. The addition of CXCR3 ligands to normal human T cells expressing CXCR3 led to the tyrosine phosphorylation of multiple proteins. Addition of the same ligands to Jurkat T cells engineered to express CXCR3 induced tyrosine phosphorylation of proteins with molecular weights similar to those in normal cells. Immunoblotting with phosphotyrosine-specific antibodies identified Zeta-associated protein of 70,000 molecular weight (ZAP-70), linker for the activation of T cells (LAT), and phospholipase-C-gamma1 (PLCgamma1) to be among the proteins that become phosphorylated upon CXCR3 activation. ZAP-70 was phosphorylated on tyrosine 319, LAT on tyrosines 171 and 191, and PLCgamma1 on tyrosine 783",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2007 Apr 120(4) 467-85",
                "id": "17250586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "By using a CXCR3 ligand reporter mouse, we found that stromal cells predominately expressed the chemokine ligand CXCL9 whereas hematopoietic cells expressed CXCL10 in lymph nodes (LNs). Dendritic cell (DC)-derived CXCL10 facilitated T cell-DC interactions in LNs during T cell priming while both chemokines guided intranodal positioning of CD4(+) T cells to interfollicular and medullary zones. Thus, different chemokines acting on the same receptor can function locally to facilitate DC-T cell interactions and globally to influence intranodal positioning, and both functions contribute to Th1 cell differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2012 Dec 14 37(6) 1091-103",
                "id": "23123063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081720"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "the chemokine Mig, a ligand for CXCR3, activates the small GTPases RhoA and Rac1, induces a reorganization of the actin cytoskeleton, and triggers cell chemotaxis and modulation of integrin VLA-5- and VLA-4-dependent cell adhesion to fibronectin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 45098-105",
                "id": "11571298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081696"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "supernatants harvested from stimulated PMN induced migration and rapid integrin-dependent adhesion of CXCR3-expressing lymphocytes; these activities were significantly reduced by neutralizing anti-MIG and anti-IP-10 Abs,",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Apr 15 162(8) 4928-37",
                "id": "10202039"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081620"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "Activation of CXCR3 induces chemotactic responses to I-TAC and reorganization reorganization of the actin cytoskeleton in human airway epithelial cells (20).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Jul 291(1) C34-9",
                "id": "16467404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "the CXC chemokines Mig and interferon-? inducible protein 10 can be expressed and bound by endothelium stimulated with interferon-? and tumor necrosis factor (TNF) ?, and can induce the firm adhesion of T lymphocyte in shear flow via CXCR3.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Med 2003 Jan 81(1) 4-19",
                "id": "12545245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "CXCR3, CXCR4, CXCR5, and CCR6 were detected on human chondrocytes. CXCR3 and CXCR4 expression was increased in exponentially growing chondrocyte subcultures. Ligands of all receptors enhanced the release of MMPs 1, 3, and 13. Release of NAG and cathepsin B was significantly higher in chemokine-stimulated cultures than in unstimulated cultures.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2004 Jan 50(1) 112-22",
                "id": "14730607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408178f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
              "citation": {
                "type": "PubMed",
                "name": "Clin Lab Med 2008 Sep 28(3) 375-84, v",
                "id": "19028258"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408176c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "The ELR-negative CXC chemokines CXCL9, CXCL10, and CXCL11) are potent chemoattractants for mononuclear cells and act through their shared receptor, CXCR3.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Nov 1 171(9) 4844-52",
                "id": "14568964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081652"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "There is increased secretion of Cxcr3-activating chemokines in COPD airways",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48",
                "id": "15602009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408163a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CXCR3) actsIn cat(p(HGNC:CXCR3))",
              "summary_text": "Table 1.  Lymphoid chemokine receptors",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2004 Feb 25(2) 67-74",
                "id": "15102365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:GATA3))",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5303c3a189e36206c0366d62",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
              "summary_text": "GATA-3 affects Treg homeostasis and suppressive function, through binding to Foxp3 promoter, regulating Foxp3 and other Treg cell signature genes expression. GATA-3 prevents transition of Treg into Th17 cells.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21924928"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5303c3a089e36206c0366b6f"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
              "summary_text": "GATA-3 affects Treg homeostasis and suppressive function, through binding to Foxp3 promoter, regulating Foxp3 and other Treg cell signature genes expression. GATA-3 prevents transition of Treg into Th17 cells.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21924928"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5303c3a089e36206c0366bf5"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:GATA3)) increases p(HGNC:FOXP3)",
              "summary_text": "GATA-3 affects Treg homeostasis and suppressive function, through binding to Foxp3 promoter, regulating Foxp3 and other Treg cell signature genes expression. GATA-3 prevents transition of Treg into Th17 cells.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21924928"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5303c3a089e36206c0366aed"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:CREBBP))",
        "relation": "increases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "tscript(p(HGNC:CREBBP)) increases p(HGNC:FOXP3)",
        "metadata": {
          "casual": false,
          "createdBy": "mberra",
          "edgeId": "54fae00a89e36215ccbb27c8",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:CREBBP)) increases p(HGNC:FOXP3)",
              "summary_text": "CBP and p300 cooperate with several key Treg transcription factors that act on the Foxp3 promoter to promote Foxp3 production.",
              "citation": {
                "type": "Other",
                "name": "Mol Cell Biol. 2014 Nov;34(21):3993-4007. doi: 10.1128/MCB.00919-14. Epub 2014 Aug 25.",
                "id": "25154413"
              },
              "metadata": {
                "created_by": "mberra",
                "id": "54fae00a89e36215ccbb271f"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TSLP)",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:CRLF2))",
        "directed": false,
        "label": "p(HGNC:TSLP) directlyIncreases cat(p(HGNC:CRLF2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053954",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TSLP) directlyIncreases cat(p(HGNC:CRLF2))",
              "summary_text": "Interleukin-7 (IL-7), a cytokine produced by stromal cells, is required for thymic development and peripheral homeostasis of most major subsets of T cells. We examined whether regulatory T (Treg) cells also required the IL-7 pathway by analyzing IL-7Ralpha(-/-) mice. We observed a striking reduction in cells with the Treg surface phenotype (CD4, CD25, GITR (glucocorticoid-induced tumor necrosis factor [TNF]-like receptor), CD45RB, CD62L, CD103) or intracellular markers (cytotoxic T-lymphocyte-associated antigen-4, CTLA-4, and forkhead box transcription factor 3, Foxp3). Foxp3 transcripts were virtually absent in IL-7Ralpha(-/-) lymphoid tissues, and no Treg cell suppressive activity could be detected. There are 2 known ligands for IL-7Ralpha: IL-7 itself and thymic stromal lymphopoietin (TSLP).",
              "citation": {
                "type": "Other",
                "name": "blood 2008 oct 15 112(8) 3283-92",
                "id": "18664628"
              },
              "metadata": {
                "created_by": "herrerainsua.angel",
                "id": "54fc982289e36216682d7f6f"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "regulatory t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TSLP) directlyIncreases cat(p(HGNC:CRLF2))",
              "summary_text": "Combined deletion of IL-7 and TSLP receptor greatly reduced Treg cell development in the thymus but was not required for survival of mature peripheral Treg cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Oct 15 112(8) 3283-92",
                "id": "18664628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408161f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCL3)",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:CCR5))",
        "directed": false,
        "label": "p(HGNC:CCL3) directlyIncreases cat(p(HGNC:CCR5))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405395c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CCL3) directlyIncreases cat(p(HGNC:CCR5))",
              "summary_text": "The role of dendritic cells (DC) in transplantation is often overshadowed by the more prominent roles of T and B cells, which interact directly with and, in the absence of immunosuppressive therapy, destroy the allograft. It has become increasingly recognized, however, that these potent antigen-presenting cells exert control over the immune response and regulate the balance between tolerance and immunity to transplanted organs and tissues. The role that chemokines play in influencing DC function with impact on regulation of immune responses against the graft is only beginning to be understood. This article considers how the manipulation of DC trafficking during an alloimmune response can affect graft outcome.",
              "citation": {
                "type": "Other",
                "name": "clin lab med 2008 sep 28(3) 375-84, v",
                "id": "19028258"
              },
              "metadata": {
                "created_by": "herrerainsua.angel",
                "id": "54fcdbf189e3621668375645"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCL3) directlyIncreases cat(p(HGNC:CCR5))",
              "summary_text": "The role of dendritic cells (DC) in transplantation is often overshadowed by the more prominent roles of T and B cells, which interact directly with and, in the absence of immunosuppressive therapy, destroy the allograft. It has become increasingly recognized, however, that these potent antigen-presenting cells exert control over the immune response and regulate the balance between tolerance and immunity to transplanted organs and tissues. The role that chemokines play in influencing DC function with impact on regulation of immune responses against the graft is only beginning to be understood. This article considers how the manipulation of DC trafficking during an alloimmune response can affect graft outcome.",
              "citation": {
                "type": "Other",
                "name": "clin lab med 2008 sep 28(3) 375-84, v",
                "id": "19028258"
              },
              "metadata": {
                "created_by": "herrerainsua.angel",
                "id": "54fcdbf189e36216683755bc"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCL3) directlyIncreases cat(p(HGNC:CCR5))",
              "summary_text": "The role of dendritic cells (DC) in transplantation is often overshadowed by the more prominent roles of T and B cells, which interact directly with and, in the absence of immunosuppressive therapy, destroy the allograft. It has become increasingly recognized, however, that these potent antigen-presenting cells exert control over the immune response and regulate the balance between tolerance and immunity to transplanted organs and tissues. The role that chemokines play in influencing DC function with impact on regulation of immune responses against the graft is only beginning to be understood. This article considers how the manipulation of DC trafficking during an alloimmune response can affect graft outcome.",
              "citation": {
                "type": "Other",
                "name": "clin lab med 2008 sep 28(3) 375-84, v",
                "id": "19028258"
              },
              "metadata": {
                "created_by": "herrerainsua.angel",
                "id": "54fcdbf089e3621668375490"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCL3) directlyIncreases cat(p(HGNC:CCR5))",
              "summary_text": "The role of dendritic cells (DC) in transplantation is often overshadowed by the more prominent roles of T and B cells, which interact directly with and, in the absence of immunosuppressive therapy, destroy the allograft. It has become increasingly recognized, however, that these potent antigen-presenting cells exert control over the immune response and regulate the balance between tolerance and immunity to transplanted organs and tissues. The role that chemokines play in influencing DC function with impact on regulation of immune responses against the graft is only beginning to be understood. This article considers how the manipulation of DC trafficking during an alloimmune response can affect graft outcome.",
              "citation": {
                "type": "Other",
                "name": "clin lab med 2008 sep 28(3) 375-84, v",
                "id": "19028258"
              },
              "metadata": {
                "created_by": "herrerainsua.angel",
                "id": "54fcdbf089e362166837548f"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CCL3) directlyIncreases cat(p(HGNC:CCR5))",
              "summary_text": "Numerous studies have shown that immature human and mouse blood- and bone marrow-derived DC subsets express a panel of inflammatory chemokine receptors (CCR1-6,8,9, CXCR3,4, CX3CR1) [Table 1 and reviewed in (1-5)]. [Table 1 Chemokine receptors expressed by DC and the functional outcome of receptor ligation}]",
              "citation": {
                "type": "PubMed",
                "name": "Clin Lab Med 2008 Sep 28(3) 375-84, v",
                "id": "19028258"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:STAT3,pmod(\"p\",Y,705))",
        "relation": "increases",
        "target": "tscript(p(HGNC:STAT3))",
        "directed": false,
        "label": "p(HGNC:STAT3,pmod(\"p\",Y,705)) increases tscript(p(HGNC:STAT3))",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "5306a52b89e36201901f7021",
          "evidences": [
            {
              "bel_statement": "p(HGNC:STAT3,pmod(\"p\",Y,705)) increases tscript(p(HGNC:STAT3))",
              "summary_text": "Interferon- (IFN-) promotes a population of T-bet(+) CXCR3(+) regulatory T (Treg) cells that limit T helper 1 (Th1) cell-mediated pathology. Our studies demonstrate that interleukin-27 (IL-27) also promoted expression of T-bet and CXCR3 in Treg cells.",
              "citation": {
                "type": "Other",
                "name": "Hall AO1, Beiting DP, Tato C, John B, Oldenhove G, Lombana CG, Pritchard GH, Silver JS, Bouladoux N, Stumhofer JS, Harris TH, Grainger J, Wojno ED, Wagage S, Roos DS, Scott P, Turka LA, Cherry S, Reiner SL, Cua D, Belkaid Y, Elloso MM, Hunter CA.",
                "id": "22981537"
              },
              "metadata": {
                "created_by": "herrerainsua.angel",
                "id": "54fc338a89e36215ccd9023a"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "treg"
              }
            },
            {
              "bel_statement": "p(HGNC:STAT3,pmod(\"p\",Y,705)) increases tscript(p(HGNC:STAT3))",
              "summary_text": "To address whether nTreg cells respond to IL-27, we incubated naive CD25+ T cells or Foxp3GFP+ cells with IL-27. Whereas unstimulated cells had negligible amounts of pSTAT1 or pSTAT3, IL-27 induced pSTAT1 and pSTAT3 in 30%40% of nTreg cells (Figure 1A). Similarly, IL-27 induced pSTAT1 and pSTAT3 in 50%70% of iTreg cells (Figure 1B).",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22981537"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "5306a52b89e36201901f6f9d"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TGFB1)",
        "relation": "increases",
        "target": "tscript(p(HGNC:SMAD3))",
        "directed": false,
        "label": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c3405393e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "TGF-beta1 (1 ng/ml) significantly upregulated SMAD phosphorylation in COPD ASMC following 2-h stimulation (P < 0.05; n = 5; Fig. 4A); however, the differences were not significant for other ASMC types.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2012 Feb 1 302(3) L325-33",
                "id": "22003087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad3 activity was decreased in P311-expressing cells, but was corrected by exogenous TGF-beta1 treatment, which also elevated TGF-beta1 mRNA level.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Mar 19 315(4) 1104-9",
                "id": "14985127"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816b4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "However, Western blot analysis reveals that IGF-I selectively inhibits the TGF-beta-triggered activation Smad3 but not Smad2, while not altering expression of total Smads 2, 3, or 4. The phosphatidylinositol 3-kinase (PI3K) inhibitor, LY29004 reverses the ability of IGF-I to inhibit TGF-beta-induced transcriptional responses and the activation of Smad3, suggesting that the suppression of TGF-beta signaling by IGF-I is mediated through activation of PI3K. Moreover, we show that enforced expression of dominant-negative PI3K (DN-p85alpha) or phosphatidylinositol 3-phosphate-phosphatase, PTEN, also reverse the suppressive effect of IGF-I on TGF-beta-induced 3TP-luciferase reporter activity, whereas constitutively active PI3K (p110alphaCAAX) completely blocks TGF-beta-induced 3TP-luciferase reporter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38342-51",
                "id": "12876289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "TGFb1 signaling activates receptor SMADs, SMAD2 and SMAD3, which associate with a variety of nuclear factors to regulate gene transcription",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Sep 17 285(38) 29044-8",
                "id": "20656683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081706"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th17 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "In this study, we generated T cell-specific Smad2 conditional knockout (KO) mice and unexpectedly found that Smad2 and Smad3 were redundantly essential for TGF-beta-mediated induction of Foxp3-expressing regulatory T cells and suppression of IFN-gamma production in CD4(+) T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 15 185(2) 842-55",
                "id": "20548029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408180b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "regulatory T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Transforming growth factor-beta (TGF-beta) is a potent inhibitor of skeletal muscle differentiation, but the molecular mechanism and signaling events that lead to this inhibition are poorly characterized. Here we show that the TGF-beta intracellular effector Smad3, but not Smad2, mediates the inhibition of myogenic differentiation in MyoD-expressing C3H10T1/2 cells and C2C12 myoblasts by repressing the activity of the MyoD family of transcriptional factors. Central to the induction of myogenic differentiation is the function of the MyoD family of basic helix-loop-helix (bHLH) transcription factors, which include MyoD, myogenin, Myf5, and MRF4 and are collectively referred to as myogenic regulatory factors or MRFs",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Nov 15 15(22) 2950-66",
                "id": "11711431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081836"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "FIGURE 9. TGF-beta1 induces snail-1 in hepatocytes in EMT state and lack of evidence for Akt/Erk1/2 activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 27 282(30) 22089-101",
                "id": "17513865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340815fc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "TGF-beta phosphorylation of Smad2/3, an obligatory step of intracellular TGF-beta signaling, was also suppressed by VEGF. VEGF attenuation of TGF-beta action was also demonstrated in two other endothelial cell lines. In conclusion, VEGF attenuates TGF-beta action in the human endothelial cell, specifically at the level of transcription of PAI-1 gene and Smad2/3 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 31 279(53) 55104-8",
                "id": "15494412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081741"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "A recent study [22] provided evidence for the contribution of Smad1, in addition to Smad3, to TGF-bdependent stimulation of collagen and CCN2 genes in cultured dermal fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Opin Rheumatol 2007 Nov 19(6) 568-73",
                "id": "17917537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408174f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "By RT-PCR we have shown that TGFbeta up-regulates expression not only of plasminogen activator inhibitor type-1 (PAI-1), but also of the urokinase-type plasminogen activator receptor (uPAR), whose inhibition by specific antibodies blunted the TGFbeta angiogenic response in vitro. The SMAD2/3 and FAK signaling pathways were activated by TGFbeta in MVEC",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2009 Mar 1 77(5) 813-25",
                "id": "19041849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Here we report that epidermal growth factor (EGF) potentializes transforming growth factor beta (TGF-beta)-induced Smad3 transactivation in rat hepatocytes, an effect abrogated by TAM-67, a dominant negative mutant of AP-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 10524-31",
                "id": "11134003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817db"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "The expression of JunD colocalised with pSmad 3 in fibrotic skin and silencing of Smad 3 or Smad 4 by siRNA prevented the induction of JunD by TGFbeta......The expression of JunD was analysed by real-time PCR, immunofluorescence, western blotting and immunohistochemistry. ",
              "citation": {
                "type": "PubMed",
                "name": "Ann Rheum Dis 2011 Jul 70(7) 1320-6",
                "id": "21515915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081735"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Wnt and TGF-B pathways cooperate to suppress colon 125 and pancreatic 126 tumorigenesis through several direct interactions between these pathways: Axin, a negative regulator of the Wnt pathway, activates TGF-B signaling through binding Smad3",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Mar 20 23(9) 2078-93",
                "id": "15774796"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408171f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Previously we have reported that the intracellular effectors of TGF-beta, Smad3 and Smad4, functionally cooperate with Sp1 to activate the human p21 promoter in hepatoma HepG2 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 22 275(38) 29244-56",
                "id": "10878024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340816fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "C/EBPbeta and C/EBPdelta were found to physically interact with Smad3 and Smad4, and Smad3 cooperated with Smad4 and TGF-beta signaling to repress the transcriptional activity of C/EBPs. Thus, repression of the activity of C/EBPs by Smad3/4 at C/EBP binding sites inhibited transcription from the PPARgamma2 and leptin promoters.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 14 278(11) 9609-19",
                "id": "12524424"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408167e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "These result suggest that TGF-beta1 stimulation of VEGF production by fibroblasts is regulated by Smad3 but not by Smad2 signaling",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Feb 11 327(2) 393-8",
                "id": "15629128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408167d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Here we report that epidermal growth factor (EGF) potentializes transforming growth factor beta (TGF-beta)-induced Smad3 transactivation in rat hepatocytes, an effect abrogated by TAM-67, a dominant negative mutant of AP-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 10524-31",
                "id": "11134003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081670"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Furthermore, expression of dominant negative Smad3 or Smad4 in cells decreased or abolished the stimulation of beta(5) promoter activity by TGF-beta. Smad4 mutant also inhibited the up-regulation of surface beta(5) level by TGF-beta. Thus, TGF-beta increases expression of the integrin beta(5) gene by mechanisms involving Sp1/Sp3 and Smad transcription factors.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 17 275(46) 36400-6",
                "id": "10964912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081636"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "TGFbeta stimulates the gene coding for human alpha2(I)-collagen (COL1A2) by inducing binding of an Sp1-containing complex to an upstream promoter element (TGFbeta responsive element or TbRE) that contains a CAGA box. Here we report that the CAGA box of the TbRE is the binding site of the Smad3/Smad4 complex, and that the binding of the complex is required for TGFbeta-induced COL1A2 up-regulation. Recombinant Smad3 and Smad4 bind in vitro to the CAGA box of COL1A2; TGFbeta treatment of cultured fibroblasts induces Smad3/Smad4 binding to the TbRE; transient overexpression of Smad3 and Smad4 in fibroblasts transactivates TbRE-driven transcription;",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 15 275(50) 39237-45",
                "id": "11007770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081607"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "The changes in glucocorticoid binding were associated with identical changes in GR protein and mRNA levels Functional inactivation of Smad 2/3 and AP-1 limited the response to TGF-beta 1, indicating a role for these transcription factors TGF-beta 1 increases glucocorticoid binding and signaling in inflammatory cells through a Smad 2/3- and AP-1-mediated process",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int 2003 Jun 63(6) 2028-36",
                "id": "12753290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c340817a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Second, silencing of SMAD protein levels using short interfering RNAs revealed that TGFbeta-induced activation of the endogenous gadd45beta gene required SMAD3 and SMAD4 but not SMAD2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 13 279(7) 5278-87",
                "id": "14630914"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c3408185d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Neutralizing Ab to TGF-beta1 eliminated TMEV-induced IL-23 production and SMAD-3 activation in RAW264.7 cells, BMM, and SPM.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Oct 1 181(7) 4523-33",
                "id": "18802055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081819"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Smad3E suppressed Nrf2-mediated activation of the GCLC reporter. We demonstrate that TGF-beta increased ATF3 protein levels, as did transient overexpression of Smad3E. Ectopic expression of ATF3 was sufficient to suppress the GCLC reporter activity, as well as endogenous GCLC expression",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Feb 1 38(3) 375-87",
                "id": "15629866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081812"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "Primary astrocytes cultured from SBE-luc mice showed specific activation of the reporter in response to Smad2/3-activating TGF-beta family members. Treatment of mice with the endotoxin LPS resulted in a fast and vigorous, but transient activation of the reporter in the intestine",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Jul 1 175(1) 547-54",
                "id": "15972691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081781"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TGFB1) increases tscript(p(HGNC:SMAD3))",
              "summary_text": "We show that SRF significantly inhibits the TGF-beta1/Smad-dependent transcription by associating with Smad3.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jan 11 26(2) 173-85",
                "id": "16819512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081638"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"IFNA Family\")",
        "relation": "decreases",
        "target": "p(HGNC:GATA3)",
        "directed": false,
        "label": "p(SFAM:\"IFNA Family\") decreases p(HGNC:GATA3)",
        "metadata": {
          "casual": false,
          "createdBy": "mberra",
          "edgeId": "55114e0d89e3620b9c5b97f9",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"IFNA Family\") decreases p(HGNC:GATA3)",
              "summary_text": "Thus, IFN-/ disrupts the GATA3-autoactivation loop and promotes epigenetic silencing of a Th2-specific regulatory region within the GATA3 gene.",
              "citation": {
                "type": "Other",
                "name": "J Immunol. 2014 Jun 15;192(12):5687-94. doi: 10.4049/jimmunol.1301908. Epub 2014 May 9.\nIFN- suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells.\nHuber JP1, Gonzales-van Horn SR1, Roybal KT1, Gill MA2, Farrar JD3.",
                "id": "24813204"
              },
              "metadata": {
                "created_by": "mberra",
                "id": "55114e0d89e3620b9c5b9747"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:UBE2N)",
        "relation": "increases",
        "target": "p(HGNC:IL10)",
        "directed": false,
        "label": "p(HGNC:UBE2N) increases p(HGNC:IL10)",
        "metadata": {
          "casual": false,
          "createdBy": "q.lu",
          "edgeId": "53022c6489e3620bbcdfe89f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:UBE2N) increases p(HGNC:IL10)",
              "summary_text": "This function of Ubc13 involved its downstream target, the kinase IKK. The Ubc13-IKK signaling axis controlled the expression of specific Treg cell effector molecules, including IL-10 and SOCS1.",
              "citation": {
                "type": "Other",
                "name": "Nat Immunol. 2012 May;13(5):481-90. doi: 10.1038/ni.2267.",
                "id": "22484734"
              },
              "metadata": {
                "created_by": "alejandroferreiromorales.cr",
                "id": "548c362489e3620fe0a09315"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:UBE2N) increases p(HGNC:IL10)",
              "summary_text": "This function of Ubc13 involved its downstream target, the kinase IKK. The Ubc13-IKK signaling axis controlled the expression of specific Treg cell effector molecules, including IL-10 and SOCS1.",
              "citation": {
                "type": "Other",
                "name": "Nat Immunol. 2012 May;13(5):481-90. doi: 10.1038/ni.2267",
                "id": "22484734"
              },
              "metadata": {
                "created_by": "alejandroferreiromorales.cr",
                "id": "5474591d89e36203f045d6c6"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:UBE2N) increases p(HGNC:IL10)",
              "summary_text": "Ubc13-deficient Treg cells expressed Tgfb1 (which encodes TGF-); however, their expres-sion of Il10 (which encodes IL-10) was attenuated (Fig. 7b). We further confirmed those results by flow cytometry (Fig. 7c) and ELISA (Fig. 7d)",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22484734"
              },
              "metadata": {
                "created_by": "q.lu",
                "id": "53022c6489e3620bbcdfe82c"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "Treg"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:GATA3)",
        "relation": "positiveCorrelation",
        "target": "tscript(p(HGNC:GATA3))",
        "directed": false,
        "label": "p(HGNC:GATA3) positiveCorrelation tscript(p(HGNC:GATA3))",
        "metadata": {
          "casual": false,
          "createdBy": "mberra",
          "edgeId": "551151f589e3620b9c5e217d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:GATA3) positiveCorrelation tscript(p(HGNC:GATA3))",
              "summary_text": "Both autoactivation and inhibition of GATA-3 play a crucial role in this process.",
              "citation": {
                "type": "Other",
                "name": "Prog Biophys Mol Biol. 2004 Sep;86(1):45-76.\nTranscriptional control networks of cell differentiation: insights from helper T lymphocytes.\nMariani L1, Lhning M, Radbruch A, Hfer T.",
                "id": "15261525"
              },
              "metadata": {
                "created_by": "mberra",
                "id": "551151f589e3620b9c5e20c8"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:GATA3))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:FOXP3)",
        "directed": false,
        "label": "tscript(p(HGNC:GATA3)) directlyIncreases p(HGNC:FOXP3)",
        "metadata": {
          "casual": false,
          "createdBy": "mberra",
          "edgeId": "551150de89e3620b9c5dbfce",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:GATA3)) directlyIncreases p(HGNC:FOXP3)",
              "summary_text": "GATA-3 affects Treg homeostasis and suppressive function, through binding to Foxp3 promoter, regulating Foxp3 and other Treg cell signature genes expression. GATA-3 prevents transition of Treg into Th17 cells.",
              "citation": {
                "type": "Other",
                "name": "Immunity. 2011 Sep 23;35(3):337-48. doi: 10.1016/j.immuni.2011.08.012. Epub 2011 Sep 15.\nAn essential role of the transcription factor GATA-3 for the function of regulatory T cells.\nWang Y1, Su MA, Wan YY.",
                "id": "21924928"
              },
              "metadata": {
                "created_by": "mberra",
                "id": "551150de89e3620b9c5dbf1a"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TGFB1)",
        "relation": "increases",
        "target": "bp(GOBP:\"regulatory T cell differentiation\")",
        "directed": false,
        "label": "p(HGNC:TGFB1) increases bp(GOBP:\"regulatory T cell differentiation\")",
        "metadata": {
          "casual": false,
          "createdBy": "mnbk",
          "edgeId": "552981af89e3620d90dbb176",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TGFB1) increases bp(GOBP:\"regulatory T cell differentiation\")",
              "summary_text": "TGF-beta1 can promote the development of both Th17 effector and adaptive Treg cells, while the contemporaneous production of IL-6 contributes to the development of Th17 cells, but inhibits Treg cells",
              "citation": {
                "type": "Other",
                "name": "Clin Exp Allergy. 2006 Nov;36(11):1357-66.\n\nRegulation of the T cell response.\n\nRomagnani S1.",
                "id": "17083345"
              },
              "metadata": {
                "created_by": "mnbk",
                "id": "552981af89e3620d90dbb0bd"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:IL6)",
        "relation": "decreases",
        "target": "bp(GOBP:\"regulatory T cell differentiation\")",
        "directed": false,
        "label": "p(HGNC:IL6) decreases bp(GOBP:\"regulatory T cell differentiation\")",
        "metadata": {
          "casual": false,
          "createdBy": "mnbk",
          "edgeId": "5529828789e3620d90dbf904",
          "evidences": [
            {
              "bel_statement": "p(HGNC:IL6) decreases bp(GOBP:\"regulatory T cell differentiation\")",
              "summary_text": "production of IL-6 contributes to the development of Th17 cells, but inhibits Treg cells.",
              "citation": {
                "type": "Other",
                "name": "Clin Exp Allergy. 2006 Nov;36(11):1357-66.\n\nRegulation of the T cell response.\n\nRomagnani S",
                "id": "17083345"
              },
              "metadata": {
                "created_by": "mnbk",
                "id": "5529828689e3620d90dbf849"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CXCL16)",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:CXCR6))",
        "directed": false,
        "label": "p(HGNC:CXCL16) directlyIncreases cat(p(HGNC:CXCR6))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351bd3fbfd4c34053964",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CXCL16) directlyIncreases cat(p(HGNC:CXCR6))",
              "summary_text": "Since CXCL16 is induced by cytokines at sites of inflammation, neurodegeneration, ischemia and malignant transformation, it should attract CXCR6-positive glial precursor cells",
              "citation": {
                "type": "Other",
                "name": "Mol Cell Neurosci. 2008 Sep;39(1):133-41. doi: 10.1016/j.mcn.2008.03.009. Epub 2008 Apr 10.",
                "id": "18619850"
              },
              "metadata": {
                "created_by": "mberra",
                "id": "547377a689e36209900c591e"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "brain"
              }
            },
            {
              "bel_statement": "p(HGNC:CXCL16) directlyIncreases cat(p(HGNC:CXCR6))",
              "summary_text": "CXCR6, the receptor for CXCL16",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 30 279(5) 3188-96",
                "id": "14625285"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352cd3fbfd4c34081714"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      }
    ]
  }
}
